1	Diabetologia	NNP	O	Diabetologia	_	0	SENT_1	[p1l41t81r231b115],
2	(	CD	NUMBER	(	num	3	SENT_1	[p1l245t81r342b115],
3	2005	CD	DATE	2005	dep	1	SENT_1	[p1l245t81r342b115],
4	)	CD	NUMBER	)	number	5	SENT_1	[p1l245t81r342b115],
5	48	CD	NUMBER	48	dep	3	SENT_1	[p1l355t82r400b108],
6	:	:	O	:	_	0	SENT_1	[p1l355t82r400b108],
7	1029-1031	CD	DATE	1029-1031	dep	3	SENT_1	[p1l419t82r579b108],
8	DOI	NNP	O	DOI	dep	7	SENT_1	[p1l41t120r106b146],
9	10.1007	CD	NUMBER	10.1007	num	8	SENT_1	[p1l123t119r541b146],
10	/	:	O	/	punct	1	SENT_1	[p1l123t119r541b146],
11	sO0125-005-1731-5	NN	O	so0125-005-1731-5	dep	1	SENT_1	[p1l123t119r541b146],
12	RESEARCH	NN	O	research	nn	13	SENT_1	[p1l40t176r1056b264],
13	LETTER	NN	O	letter	dep	11	SENT_1	[p1l339t203r519b232],

1	T.	NNP	PERSON	T.	nn	2	SENT_2	[p1l42t339r75b369],
2	Klupa	NNP	PERSON	Klupa	_	0	SENT_2	[p1l92t339r206b378],
3	-	:	O	-	_	0	SENT_2	[p1l223t351r231b358],
4	E.	NNP	PERSON	E.	nn	6	SENT_2	[p1l248t339r285b369],
5	L.	NNP	PERSON	L.	nn	6	SENT_2	[p1l302t339r339b369],
6	Edghill	NNP	PERSON	Edghill	dep	2	SENT_2	[p1l357t339r490b378],
7	-	:	O	-	_	0	SENT_2	[p1l506t351r514b358],
8	J.	NNP	PERSON	J.	nn	9	SENT_2	[p1l530t339r561b369],
9	Nazim	NNP	PERSON	Nazim	dep	6	SENT_2	[p1l578t339r697b369],
10	-	:	O	-	_	0	SENT_2	[p1l713t351r721b358],
11	J.	NNP	PERSON	J.	nn	12	SENT_2	[p1l737t339r768b369],
12	Sieradzki	NNP	PERSON	Sieradzki	dep	6	SENT_2	[p1l786t339r959b369],
13	S.	NNP	PERSON	S.	nn	14	SENT_2	[p1l975t351r983b358, p1l42t386r73b417],
14	Ellard	NNP	PERSON	Ellard	dep	12	SENT_2	[p1l90t387r206b417],
15	-	:	O	-	_	0	SENT_2	[p1l224t398r231b406],
16	A.	NN	PERSON	a.	dep	6	SENT_2	[p1l247t386r288b417],
17	T.	NNP	PERSON	T.	nn	18	SENT_2	[p1l305t387r339b417],
18	Hattersley	NNP	PERSON	Hattersley	dep	16	SENT_2	[p1l356t387r546b426],
19	-	:	O	-	_	0	SENT_2	[p1l560t398r568b406],
20	M.	NNP	PERSON	M.	nn	24	SENT_2	[p1l585t387r634b417],
21	T.	NNP	PERSON	T.	nn	24	SENT_2	[p1l652t387r686b417],
22	Malecki	NNP	PERSON	Malecki	nn	24	SENT_2	[p1l702t386r850b417],
23	The	NNP	O	The	nn	24	SENT_2	[p1l41t459r145b512],
24	identification	NN	O	identification	dep	6	SENT_2	[p1l173t459r552b512],
25	of	IN	O	of	_	0	SENT_2	[p1l581t459r639b512],
26	a	DT	O	a	det	28	SENT_2	[p1l663t473r695b512],
27	R201H	NN	O	r201h	nn	28	SENT_2	[p1l724t458r922b512],
28	mutation	NN	O	mutation	prep_of	24	SENT_2	[p1l952t459r1206b512],
29	in	IN	O	in	dep	2	SENT_2	[p1l1236t459r1284b511],
30	KCNIII	NNP	LOCATION	KCNIII	pobj	29	SENT_2	[p1l1314t458r1558b522],
31	,	,	O	,	_	0	SENT_2	[p1l1314t458r1558b522],
32	which	WDT	O	which	nsubj	33	SENT_2	[p1l1584t459r1747b512],
33	encodes	VBZ	O	encode	rcmod	30	SENT_2	[p1l42t542r279b595],
34	Kir6	NN	O	kir6	nn	35	SENT_2	[p1l308t541r506b605],
35	.2	NN	NUMBER	.2	dobj	33	SENT_2	[p1l308t541r506b605],
36	,	,	O	,	_	0	SENT_2	[p1l308t541r506b605],
37	and	CC	O	and	_	0	SENT_2	[p1l534t542r635b595],
38	successful	JJ	O	successful	amod	39	SENT_2	[p1l663t541r965b595],
39	transfer	NN	O	transfer	conj_and	35	SENT_2	[p1l992t541r1226b595],
40	to	TO	O	to	_	0	SENT_2	[p1l1250t544r1309b595],
41	sustained-release	JJ	O	sustained-release	amod	43	SENT_2	[p1l1336t542r1845b595],
42	sulphonylurea	NN	O	sulphonylurea	nn	43	SENT_2	[p1l41t624r441b687],
43	therapy	NN	O	therapy	prep_to	39	SENT_2	[p1l466t624r686b687],
44	in	IN	O	in	_	0	SENT_2	[p1l711t624r759b676],
45	a	DT	O	a	det	57	SENT_2	[p1l786t638r818b677],
46	subject	JJ	O	subject	amod	57	SENT_2	[p1l844t624r1055b687],
47	with	IN	O	with	_	0	SENT_2	[p1l1080t624r1198b677],
48	neonatal	JJ	O	neonatal	amod	49	SENT_2	[p1l1228t624r1474b677],
49	diabetes	NN	O	diabetes	prep_with	46	SENT_2	[p1l1502t624r1764b677],
50	:	:	O	:	_	0	SENT_2	[p1l1502t624r1764b677],
51	evidence	NN	O	evidence	dep	49	SENT_2	[p1l42t707r291b759],
52	for	IN	O	for	_	0	SENT_2	[p1l316t706r401b759],
53	heterogeneity	NN	O	heterogeneity	prep_for	51	SENT_2	[p1l428t707r825b769],
54	of	IN	O	of	_	0	SENT_2	[p1l849t706r907b759],
55	beta	NN	O	beta	nn	56	SENT_2	[p1l934t707r1057b759],
56	cell	NN	O	cell	prep_of	53	SENT_2	[p1l1084t707r1182b759],
57	function	NN	O	function	prep_in	43	SENT_2	[p1l1209t706r1445b759],
58	among	IN	O	among	_	0	SENT_2	[p1l1474t719r1668b769],
59	carriers	NNS	O	carrier	prep_among	57	SENT_2	[p1l1692t707r1916b759],
60	of	IN	O	of	_	0	SENT_2	[p1l42t788r100b842],
61	the	DT	O	the	det	63	SENT_2	[p1l123t789r216b842],
62	R201H	NN	O	r201h	nn	63	SENT_2	[p1l245t788r443b842],
63	mutation	NN	O	mutation	prep_of	59	SENT_2	[p1l473t789r727b842],

1	Received	VBN	O	receive	_	0	SENT_3	[p1l41t895r185b921],
2	:	:	O	:	_	0	SENT_3	[p1l41t895r185b921],
3	20	CD	DATE	20	num	4	SENT_3	[p1l201t895r237b921],
4	September	NNP	DATE	September	dobj	1	SENT_3	[p1l253t895r409b929],
5	2004	CD	DATE	2004	num	4	SENT_3	[p1l421t895r494b921],
6	/	:	O	/	punct	7	SENT_3	[p1l508t895r519b922],
7	Accepted	JJ	O	accepted	dep	4	SENT_3	[p1l531t895r678b929],
8	:	:	O	:	_	0	SENT_3	[p1l531t895r678b929],
9	17	CD	DATE	17	num	10	SENT_3	[p1l697t895r729b922],
10	January	NNP	DATE	January	dep	7	SENT_3	[p1l743t896r858b929],
11	2005	CD	DATE	2005	num	10	SENT_3	[p1l871t895r943b921],
12	/	:	O	/	punct	7	SENT_3	[p1l958t895r968b922],
13	Published	VBN	O	publish	partmod	4	SENT_3	[p1l981t895r1126b921],
14	online	NN	O	online	prep	13	SENT_3	[p1l1140t895r1239b921],
15	:	:	O	:	_	0	SENT_3	[p1l1140t895r1239b921],
16	19	CD	DATE	19	num	17	SENT_3	[p1l1258t895r1290b922],
17	April	NNP	DATE	April	dep	4	SENT_3	[p1l1304t895r1381b929],
18	2005	CD	DATE	2005	num	17	SENT_3	[p1l1395t895r1466b921],
19	©	CD	NUMBER	©	num	20	SENT_3	[p1l19t939r85b1005],
20	Springer-Verlag	NNP	O	Springer-Verlag	dep	17	SENT_3	[p1l122t937r609b1008],
21	2005	CD	DATE	2005	num	20	SENT_3	[p1l638t939r788b993],

1	To	TO	O	to	_	0	SENT_4	[p1l15t1168r105b1230],
2	the	DT	O	the	det	4	SENT_4	[p1l139t1165r247b1230],
3	Editor	NNP	O	Editor	nn	4	SENT_4	[p1l281t1165r506b1230],
4	Diabetes	NNP	O	Diabetes	prep_to	15	SENT_4	[p1l14t1264r326b1329],
5	caused	VBN	O	cause	partmod	4	SENT_4	[p1l362t1264r606b1329],
6	by	IN	O	by	_	0	SENT_4	[p1l636t1264r727b1347],
7	severe	JJ	O	severe	amod	8	SENT_4	[p1l762t1285r985b1329],
8	mutations	NNS	O	mutation	agent	5	SENT_4	[p1l1018t1264r1372b1329],
9	in	IN	O	in	_	0	SENT_4	[p1l1407t1264r1475b1328],
10	beta	NN	O	beta	prep_in	8	SENT_4	[p1l1505t1264r1656b1329],
11	cell	NN	O	cell	nn	12	SENT_4	[p1l1689t1264r1815b1329],
12	genes	NNS	O	gene	nsubjpass	15	SENT_4	[p1l1848t1285r2050b1347],
13	is	VBZ	O	be	auxpass	15	SENT_4	[p1l2085t1264r2140b1329],
14	usually	RB	O	usually	advmod	15	SENT_4	[p1l12t1363r274b1447],
15	diagnosed	VBN	O	diagnose	_	0	SENT_4	[p1l307t1363r672b1447],
16	as	IN	O	as	_	0	SENT_4	[p1l705t1385r775b1428],
17	neonatal	JJ	O	neonatal	amod	19	SENT_4	[p1l807t1363r1112b1428],
18	diabetes	NN	O	diabetes	nn	19	SENT_4	[p1l1146t1363r1436b1428],
19	[	NN	O	[	prep_as	15	SENT_4	[p1l1476t1365r1567b1445],
20	1	CD	NUMBER	1	number	21	SENT_4	[p1l1476t1365r1567b1445],
21	]	CD	NUMBER	]	dep	19	SENT_4	[p1l1476t1365r1567b1445],
22	or	CC	O	or	_	0	SENT_4	[p1l1605t1385r1679b1428],
23	MODY	NNP	O	MODY	conj_or	19	SENT_4	[p1l1709t1365r1984b1428],
24	[	CD	NUMBER	[	number	25	SENT_4	[p1l2022t1365r2136b1445],
25	2	CD	NUMBER	2	num	26	SENT_4	[p1l2022t1365r2136b1445],
26	]	NN	O	]	dep	23	SENT_4	[p1l2022t1365r2136b1445],
27	.	.	O	.	_	0	SENT_4	[p1l2022t1365r2136b1445],

1	Activating	VBG	O	activate	dep	19	SENT_5	[p1l13t1462r393b1545],
2	mutations	NNS	O	mutation	dobj	1	SENT_5	[p1l433t1462r786b1527],
3	in	IN	O	in	_	0	SENT_5	[p1l830t1462r897b1526],
4	KCJNII	NNP	LOCATION	KCJNII	prep_in	1	SENT_5	[p1l933t1463r1235b1527],
5	,	,	O	,	_	0	SENT_5	[p1l1247t1516r1261b1541],
6	the	DT	O	the	det	7	SENT_5	[p1l1304t1462r1412b1527],
7	gene	NN	O	gene	appos	4	SENT_5	[p1l1455t1483r1622b1545],
8	encoding	VBG	O	encode	partmod	7	SENT_5	[p1l1664t1462r1993b1545],
9	the	DT	O	the	det	12	SENT_5	[p1l2032t1462r2141b1527],
10	ATP-sensitive	JJ	O	atp-sensitive	amod	12	SENT_5	[p1l13t1561r518b1626],
11	potassium	NN	O	potassium	nn	12	SENT_5	[p1l537t1561r905b1645],
12	channel	NN	O	channel	dobj	8	SENT_5	[p1l926t1561r1204b1626],
13	subunit	NN	O	subunit	nn	15	SENT_5	[p1l1226t1561r1491b1626],
14	Kir6	NN	O	kir6	nn	15	SENT_5	[p1l1509t1561r1760b1640],
15	.2	NN	NUMBER	.2	dep	12	SENT_5	[p1l1509t1561r1760b1640],
16	,	,	O	,	_	0	SENT_5	[p1l1509t1561r1760b1640],
17	have	VBP	O	have	aux	19	SENT_5	[p1l1782t1561r1951b1626],
18	been	VBN	O	be	auxpass	19	SENT_5	[p1l1971t1561r2142b1626],
19	described	VBN	O	describe	_	0	SENT_5	[p1l15t1660r359b1726],
20	in	IN	O	in	_	0	SENT_5	[p1l385t1661r453b1724],
21	very-early-onset	JJ	O	very-early-onset	amod	23	SENT_5	[p1l476t1661r1067b1744],
22	diabetes	NN	O	diabetes	nn	23	SENT_5	[p1l1092t1660r1383b1726],
23	(	NN	O	(	prep_in	19	SENT_5	[p1l1412t1661r1532b1744],
24	<	JJR	O	<	amod	23	SENT_5	[p1l1412t1661r1532b1744],
25	6	CD	DURATION	6	num	26	SENT_5	[p1l1412t1661r1532b1744],
26	months	NNS	NUMBER	month	tmod	24	SENT_5	[p1l1559t1661r1852b1744],
27	)	RB	O	)	advmod	28	SENT_5	[p1l1559t1661r1852b1744],
28	characterised	VBN	O	characterise	partmod	23	SENT_5	[p1l1881t1660r2140b1726, p1l13t1759r253b1824],
29	by	IN	O	by	_	0	SENT_5	[p1l282t1759r373b1843],
30	a	DT	O	a	det	32	SENT_5	[p1l405t1781r443b1824],
31	profound	JJ	O	profound	amod	32	SENT_5	[p1l471t1759r805b1843],
32	impairment	NN	O	impairment	agent	28	SENT_5	[p1l837t1759r1251b1843],
33	of	IN	O	of	_	0	SENT_5	[p1l1283t1759r1365b1824],
34	insulin	NN	O	insulin	nn	36	SENT_5	[p1l1387t1759r1630b1824],
35	secretion	NN	O	secretion	nn	36	SENT_5	[p1l1664t1759r1985b1824],
36	[	NN	O	[	prep_of	32	SENT_5	[p1l2022t1761r2136b1841],
37	3	CD	NUMBER	3	num	38	SENT_5	[p1l2022t1761r2136b1841],
38	]	NN	O	]	nsubjpass	19	SENT_5	[p1l2022t1761r2136b1841],
39	.	.	O	.	_	0	SENT_5	[p1l2022t1761r2136b1841],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l13t1861r130b1924],
2	screened	VBD	O	screen	_	0	SENT_6	[p1l167t1858r479b1924],
3	KCJNI1	NN	O	kcjni1	dobj	2	SENT_6	[p1l509t1860r811b1924],
4	in	IN	O	in	_	0	SENT_6	[p1l853t1859r921b1922],
5	25	CD	NUMBER	25	num	7	SENT_6	[p1l955t1860r1038b1923],
6	Polish	JJ	MISC	polish	amod	7	SENT_6	[p1l1077t1858r1302b1924],
7	patients	NNS	O	patient	prep_in	2	SENT_6	[p1l1334t1859r1612b1942],
8	who	WP	O	who	nsubjpass	10	SENT_6	[p1l1647t1859r1801b1924],
9	were	VBD	O	be	auxpass	10	SENT_6	[p1l1835t1880r2008b1924],
10	diagnosed	VBN	O	diagnose	dep	2	SENT_6	[p1l2045t1859r2140b1924, p1l16t1957r311b2041],
11	before	IN	O	before	_	0	SENT_6	[p1l332t1957r561b2022],
12	2	CD	DURATION	2	num	13	SENT_6	[p1l586t1959r626b2021],
13	years	NNS	NUMBER	year	prep_before	10	SENT_6	[p1l651t1979r839b2041],
14	of	IN	O	of	_	0	SENT_6	[p1l865t1957r948b2022],
15	age	NN	O	age	prep_of	13	SENT_6	[p1l962t1979r1083b2041],
16	and	CC	O	and	_	0	SENT_6	[p1l1109t1957r1238b2022],
17	who	WP	O	who	nsubj	19	SENT_6	[p1l1260t1957r1413b2022],
18	had	VBD	O	have	aux	19	SENT_6	[p1l1438t1957r1569b2022],
19	been	VBN	O	be	conj_and	10	SENT_6	[p1l1590t1957r1761b2022],
20	on	IN	O	on	_	0	SENT_6	[p1l1786t1979r1874b2022],
21	insulin	NN	O	insulin	prep_on	19	SENT_6	[p1l1898t1957r2142b2022],
22	from	IN	O	from	_	0	SENT_6	[p1l16t2057r189b2122],
23	diagnosis	NN	O	diagnosis	prep_from	21	SENT_6	[p1l207t2056r544b2140],
24	to	TO	O	to	_	0	SENT_6	[p1l565t2066r631b2122],
25	the	DT	O	the	det	26	SENT_6	[p1l652t2056r760b2122],
26	time	NN	O	time	prep_to	19	SENT_6	[p1l779t2057r936b2122],
27	they	PRP	O	they	nsubjpass	29	SENT_6	[p1l956t2056r1111b2140],
28	were	VBD	O	be	auxpass	29	SENT_6	[p1l1129t2078r1301b2122],
29	studied	VBN	O	study	rcmod	26	SENT_6	[p1l1324t2056r1582b2122],
30	(	FW	O	(	nsubj	31	SENT_6	[p1l1602t2057r1824b2140],
31	mean	VB	O	mean	ccomp	29	SENT_6	[p1l1602t2057r1824b2140],
32	duration	NN	O	duration	dobj	31	SENT_6	[p1l1844t2057r2142b2122],
33	8.7	CD	DURATION	8.7	num	34	SENT_6	[p1l18t2157r123b2220],
34	years	NNS	NUMBER	year	tmod	35	SENT_6	[p1l149t2156r385b2239],
35	)	RB	O	)	amod	32	SENT_6	[p1l149t2156r385b2239],
36	.	.	O	.	_	0	SENT_6	[p1l149t2156r385b2239],

1	Five	CD	NUMBER	five	num	2	SENT_7	[p1l415t2155r572b2220],
2	individuals	NNS	O	individual	nsubjpass	4	SENT_7	[p1l599t2155r996b2220],
3	were	VBD	O	be	auxpass	4	SENT_7	[p1l1021t2177r1194b2220],
4	diagnosed	VBN	O	diagnose	_	0	SENT_7	[p1l1220t2155r1586b2239],
5	during	IN	O	during	_	0	SENT_7	[p1l1611t2155r1843b2239],
6	the	DT	DURATION	the	det	9	SENT_7	[p1l1867t2155r1975b2220],
7	first	JJ	DURATION	first	amod	9	SENT_7	[p1l2002t2155r2143b2220],
8	6	CD	DURATION	6	num	9	SENT_7	[p1l16t2256r55b2319],
9	months	NNS	NUMBER	month	prep_during	4	SENT_7	[p1l81t2255r345b2320],
10	of	IN	O	of	_	0	SENT_7	[p1l372t2255r455b2320],
11	life	NN	O	life	prep_of	9	SENT_7	[p1l469t2254r601b2320],
12	.	.	O	.	_	0	SENT_7	[p1l469t2254r601b2320],

1	All	DT	O	all	det	2	SENT_8	[p1l630t2254r743b2318],
2	patients	NNS	O	patient	nsubj	3	SENT_8	[p1l766t2255r1044b2338],
3	diagnosed	VBD	O	diagnose	_	0	SENT_8	[p1l1072t2254r1437b2338],
4	before	IN	O	before	mark	21	SENT_8	[p1l1459t2254r1688b2320],
5	6	CD	DURATION	6	num	6	SENT_8	[p1l1714t2256r1753b2319],
6	months	NNS	NUMBER	month	nsubj	21	SENT_8	[p1l1779t2254r2043b2320],
7	of	IN	O	of	_	0	SENT_8	[p1l2070t2255r2153b2320],
8	age	NN	O	age	prep_of	6	SENT_8	[p1l16t2374r157b2436],
9	,	,	O	,	_	0	SENT_8	[p1l16t2374r157b2436],
10	and	CC	O	and	_	0	SENT_8	[p1l186t2353r315b2418],
11	15	CD	TIME	15	nsubj	21	SENT_8	[p1l347t2355r421b2418],
12	of	IN	TIME	of	_	0	SENT_8	[p1l452t2353r535b2418],
13	20	CD	TIME	20	prep_of	11	SENT_8	[p1l548t2355r634b2418],
14	of	IN	O	of	_	0	SENT_8	[p1l662t2353r745b2418],
15	those	DT	O	those	prep_of	11	SENT_8	[p1l757t2353r945b2418],
16	diagnosed	VBN	O	diagnose	partmod	15	SENT_8	[p1l972t2353r1338b2436],
17	after	IN	O	after	_	0	SENT_8	[p1l1362t2353r1524b2418],
18	6	CD	DURATION	6	num	19	SENT_8	[p1l1549t2355r1588b2418],
19	months	NNS	NUMBER	month	prep_after	16	SENT_8	[p1l1613t2353r1898b2432],
20	,	,	O	,	_	0	SENT_8	[p1l1613t2353r1898b2432],
21	had	VBD	O	have	advcl	3	SENT_8	[p1l1925t2353r2056b2418],
22	at	IN	O	at	quantmod	24	SENT_8	[p1l2080t2362r2143b2418],
23	least	JJS	O	least	mwe	22	SENT_8	[p1l15t2452r178b2518],
24	one	CD	NUMBER	one	num	26	SENT_8	[p1l212t2474r339b2518],
25	diabetic	JJ	O	diabetic	amod	26	SENT_8	[p1l376t2452r656b2518],
26	f1rst	NN	O	f1rst	dobj	21	SENT_8	[p1l695t2453r862b2518],
27	-	:	O	-	_	0	SENT_8	[p1l695t2453r862b2518],
28	or	CC	O	or	_	0	SENT_8	[p1l900t2474r974b2518],
29	second-degree	JJ	O	second-degree	conj_or	26	SENT_8	[p1l1008t2452r1524b2536],
30	relative	JJ	O	relative	advmod	21	SENT_8	[p1l1559t2453r1845b2518],
31	.	.	O	.	_	0	SENT_8	[p1l1559t2453r1845b2518],

1	Type	NN	O	type	nsubjpass	7	SENT_9	[p1l1886t2455r2062b2536],
2	1	CD	NUMBER	1	num	4	SENT_9	[p1l2108t2454r2131b2516],
3	diabetes-related	JJ	O	diabetes-related	amod	4	SENT_9	[p1l15t2551r583b2616],
4	antibodies	NNS	O	antibody	dep	1	SENT_9	[p1l611t2551r977b2616],
5	were	VBD	O	be	auxpass	7	SENT_9	[p1l1004t2572r1177b2616],
6	not	RB	O	not	neg	7	SENT_9	[p1l1204t2560r1321b2616],
7	found	VBN	O	find	_	0	SENT_9	[p1l1348t2551r1557b2616],
8	in	IN	O	in	_	0	SENT_9	[p1l1584t2551r1652b2615],
9	the	DT	O	the	det	11	SENT_9	[p1l1677t2551r1785b2616],
10	four	CD	NUMBER	four	num	11	SENT_9	[p1l1815t2551r1963b2616],
11	subjects	NNS	O	subject	prep_in	7	SENT_9	[p1l1991t2551r2140b2616, p1l6t2651r172b2734],
12	who	WP	O	who	nsubjpass	14	SENT_9	[p1l191t2650r344b2716],
13	were	VBD	O	be	auxpass	14	SENT_9	[p1l364t2672r535b2716],
14	tested	VBN	O	test	rcmod	11	SENT_9	[p1l553t2650r760b2716],
15	at	IN	O	at	_	0	SENT_9	[p1l779t2659r841b2715],
16	diagnosis	NN	O	diagnosis	prep_at	14	SENT_9	[p1l859t2650r1213b2734],
17	;	:	O	;	_	0	SENT_9	[p1l859t2650r1213b2734],
18	the	DT	O	the	det	19	SENT_9	[p1l1234t2651r1341b2716],
19	others	NNS	O	other	nsubjpass	22	SENT_9	[p1l1362t2650r1574b2716],
20	were	VBD	O	be	auxpass	22	SENT_9	[p1l1593t2672r1765b2716],
21	not	RB	O	not	neg	22	SENT_9	[p1l1783t2659r1898b2716],
22	tested	VBN	O	test	parataxis	7	SENT_9	[p1l1915t2650r2136b2716],
23	.	.	O	.	_	0	SENT_9	[p1l1915t2650r2136b2716],

1	The	DT	O	the	det	3	SENT_10	[p1l15t2749r151b2814],
2	intronless	JJ	O	intronless	amod	3	SENT_10	[p1l175t2749r515b2814],
3	gene	NN	O	gene	nsubj	25	SENT_10	[p1l538t2770r703b2832],
4	was	VBD	O	be	auxpass	5	SENT_10	[p1l724t2770r861b2814],
5	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_10	[p1l885t2749r1222b2832],
6	in	IN	O	in	_	0	SENT_10	[p1l1243t2749r1311b2813],
7	three	CD	NUMBER	three	num	9	SENT_10	[p1l1330t2749r1505b2814],
8	overlapping	VBG	O	overlap	amod	9	SENT_10	[p1l1529t2749r1951b2832],
9	fragments	NNS	O	fragment	prep_in	5	SENT_10	[p1l1975t2749r2140b2833, p1l13t2857r223b2914],
10	using	VBG	O	use	partmod	9	SENT_10	[p1l244t2849r439b2932],
11	primers	NNS	O	primer	dobj	10	SENT_10	[p1l460t2849r733b2932],
12	with	IN	O	with	_	0	SENT_10	[p1l755t2848r915b2914],
13	M13	NN	O	m13	nn	15	SENT_10	[p1l936t2850r1099b2913],
14	universal	JJ	O	universal	amod	15	SENT_10	[p1l1126t2849r1456b2914],
15	sequences	NNS	O	sequence	prep_with	11	SENT_10	[p1l1481t2870r1841b2932],
16	at	IN	O	at	_	0	SENT_10	[p1l1866t2857r1929b2913],
17	the	DT	O	the	det	20	SENT_10	[p1l1948t2848r2056b2914],
18	5	CD	NUMBER	5	num	20	SENT_10	[p1l2081t2851r2116b2913],
19	’	NN	O	’	nn	20	SENT_10	[p1l2129t2850r2141b2877],
20	end	NN	O	end	prep_at	10	SENT_10	[p1l16t2947r145b3012],
21	of	IN	O	of	_	0	SENT_10	[p1l182t2947r265b3012],
22	tailed	VBN	O	tail	prepc_of	20	SENT_10	[p1l290t2947r489b3012],
23	forward	RB	O	forward	advmod	22	SENT_10	[p1l527t2947r809b3012],
24	and	CC	O	and	_	0	SENT_10	[p1l847t2947r976b3012],
25	reverse	VB	O	reverse	conj_and	5	SENT_10	[p1l1011t2968r1268b3012],
26	primers	NNS	O	primer	dobj	25	SENT_10	[p1l1305t2947r1578b3030],
27	(	RB	O	(	dep	28	SENT_10	[p1l1619t2947r1843b3030],
28	Table	NNP	O	Table	dep	26	SENT_10	[p1l1619t2947r1843b3030],
29	1	CD	NUMBER	1	number	30	SENT_10	[p1l1891t2947r1973b3030],
30	)	CD	NUMBER	)	num	28	SENT_10	[p1l1891t2947r1973b3030],
31	,	,	O	,	_	0	SENT_10	[p1l1891t2947r1973b3030],
32	folT	NN	O	folt	appos	26	SENT_10	[p1l2016t2947r2140b3012, p1l15t3227r69b3280],
33	.	.	O	.	_	0	SENT_10	[p1l2016t2947r2140b3012, p1l15t3227r69b3280],

1	Klupa	NN	PERSON	klupa	nsubj	6	SENT_11	[p1l101t3224r290b3295],
2	and	CC	O	and	_	0	SENT_11	[p1l319t3224r429b3280],
3	E.	NNP	PERSON	E.	nn	5	SENT_11	[p1l456t3227r517b3280],
4	L.	NNP	PERSON	L.	nn	5	SENT_11	[p1l549t3227r610b3280],
5	Edghill	NNP	PERSON	Edghill	nsubj	6	SENT_11	[p1l642t3224r869b3295],
6	contributed	VBD	O	contribute	_	0	SENT_11	[p1l898t3224r1249b3280],
7	equally	RB	O	equally	advmod	6	SENT_11	[p1l1278t3224r1503b3295],
8	to	TO	O	to	_	0	SENT_11	[p1l1530t3232r1588b3280],
9	this	DT	O	this	det	10	SENT_11	[p1l1616t3224r1725b3280],
10	work	NN	O	work	prep_to	6	SENT_11	[p1l1754t3224r1915b3280],

1	T.	NNP	PERSON	T.	nn	2	SENT_12	[p2l15t41r69b94],
2	Klupa	NNP	PERSON	Klupa	_	0	SENT_12	[p2l101t39r290b110],
3	-	:	O	-	_	0	SENT_12	[p2l321t66r330b75],
4	J.	NNP	PERSON	J.	nn	5	SENT_12	[p2l363t41r407b94],
5	Sieradzki	NNP	PERSON	Sieradzki	dep	2	SENT_12	[p2l442t39r728b95],
6	-	:	O	-	_	0	SENT_12	[p2l762t66r770b75],
7	M.	NNP	PERSON	M.	nn	9	SENT_12	[p2l803t41r885b94],
8	T.	NNP	PERSON	T.	nn	9	SENT_12	[p2l919t41r973b94],
9	Malecki	NNP	PERSON	Malecki	dep	5	SENT_12	[p2l1005t39r1257b94],
10	(	CD	NUMBER	(	num	12	SENT_12	[p2l1287t36r1420b109],
11	)	NNP	O	)	nn	12	SENT_12	[p2l1287t36r1420b109],
12	Department	NNP	ORGANIZATION	Department	nsubj	32	SENT_12	[p2l14t121r378b189],
13	of	IN	ORGANIZATION	of	_	0	SENT_12	[p2l407t118r478b174],
14	Metabolic	JJ	ORGANIZATION	metabolic	amod	15	SENT_12	[p2l496t118r807b174],
15	Diseases	NNS	ORGANIZATION	disease	prep_of	12	SENT_12	[p2l836t118r1122b186],
16	,	,	O	,	_	0	SENT_12	[p2l836t118r1122b186],
17	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_12	[p2l1153t118r1405b174],
18	College	NNP	ORGANIZATION	College	appos	15	SENT_12	[p2l1434t118r1689b189],
19	,	,	O	,	_	0	SENT_12	[p2l1434t118r1689b189],
20	J	NNP	O	J	nn	22	SENT_12	[p2l14t200r43b253],
21	agiellonian	NNP	O	agiellonian	nn	22	SENT_12	[p2l46t197r387b268],
22	University	NNP	ORGANIZATION	University	appos	15	SENT_12	[p2l414t197r752b268],
23	,	,	O	,	_	0	SENT_12	[p2l414t197r752b268],
24	15	CD	NUMBER	15	num	26	SENT_12	[p2l22t277r86b331],
25	Kopemika	NNP	LOCATION	Kopemika	nn	26	SENT_12	[p2l118t276r446b347],
26	Street	NNP	LOCATION	Street	appos	15	SENT_12	[p2l476t277r667b343],
27	,	,	O	,	_	0	SENT_12	[p2l476t277r667b343],
28	31-501	CD	NUMBER	31-501	num	31	SENT_12	[p2l16t357r224b411],
29	Krakow	NNP	LOCATION	Krakow	nn	31	SENT_12	[p2l261t356r522b423],
30	,	,	O	,	_	0	SENT_12	[p2l261t356r522b423],
31	Poland	NNP	LOCATION	Poland	appos	15	SENT_12	[p2l552t356r767b412],
32	e-mail	VB	O	e-mail	rcmod	9	SENT_12	[p2l15t435r225b491],
33	:	:	O	:	_	0	SENT_12	[p2l15t435r225b491],
34	mmalecki@cm-uj.krakow.pl	JJ	O	mmalecki@cm-uj.krakow.pl	amod	35	SENT_12	[p2l257t435r1141b506],
35	Tel.	NNP	O	Tel.	dep	5	SENT_12	[p2l15t514r125b570],
36	:	:	O	:	_	0	SENT_12	[p2l137t533r146b570],
37	+48	CD	NUMBER	+48	dep	35	SENT_12	[p2l179t516r323b570],
38	-	:	O	-	_	0	SENT_12	[p2l179t516r323b570],
39	1	CD	DATE	1	dep	5	SENT_12	[p2l335t516r355b569],
40	2-4248305	CD	NUMBER	2-4248305	num	41	SENT_12	[p2l366t516r698b570],
41	Fax	NN	O	fax	dep	39	SENT_12	[p2l14t596r145b650],
42	:	:	O	:	_	0	SENT_12	[p2l14t596r145b650],
43	+48	CD	NUMBER	+48	dep	39	SENT_12	[p2l178t595r699b650],
44	-	:	O	-	_	0	SENT_12	[p2l178t595r699b650],
45	l2-4219786	NN	O	l2-4219786	dep	43	SENT_12	[p2l178t595r699b650],

1	E.	NNP	PERSON	E.	_	0	SENT_13	[p2l14t757r74b810],
2	L.	NNP	PERSON	L.	nn	3	SENT_13	[p2l107t757r168b810],
3	Edghill	NNP	PERSON	Edghill	dep	1	SENT_13	[p2l200t754r426b826],
4	-	:	O	-	_	0	SENT_13	[p2l459t782r468b791],
5	S.	NNP	PERSON	S.	nn	6	SENT_13	[p2l504t756r557b810],
6	Ellard	NNP	PERSON	Ellard	dep	1	SENT_13	[p2l589t754r776b810],
7	-	:	O	-	_	0	SENT_13	[p2l808t782r817b791],
8	A.	NN	ORGANIZATION	a.	nn	11	SENT_13	[p2l849t756r919b810],
9	T.	NNP	ORGANIZATION	T.	nn	11	SENT_13	[p2l952t757r1006b810],
10	Hattersley	NNP	ORGANIZATION	Hattersley	nn	11	SENT_13	[p2l1038t754r1354b826],
11	Institute	NNP	ORGANIZATION	Institute	dep	6	SENT_13	[p2l14t834r264b890],
12	of	IN	ORGANIZATION	of	_	0	SENT_13	[p2l294t834r365b890],
13	Biomedical	NNP	ORGANIZATION	Biomedical	prep_of	11	SENT_13	[p2l383t834r738b890],
14	and	CC	ORGANIZATION	and	_	0	SENT_13	[p2l769t834r879b890],
15	Clinical	JJ	ORGANIZATION	clinical	amod	16	SENT_13	[p2l907t834r1148b890],
16	Science	NN	ORGANIZATION	science	dep	6	SENT_13	[p2l1180t834r1432b902],
17	,	,	O	,	_	0	SENT_13	[p2l1180t834r1432b902],
18	Peninsula	NNP	ORGANIZATION	Peninsula	nn	20	SENT_13	[p2l14t923r315b979],
19	Medical	NNP	ORGANIZATION	Medical	nn	20	SENT_13	[p2l342t923r593b979],
20	School	NNP	ORGANIZATION	School	appos	16	SENT_13	[p2l625t923r852b990],
21	,	,	O	,	_	0	SENT_13	[p2l625t923r852b990],
22	Exeter	NNP	LOCATION	Exeter	appos	16	SENT_13	[p2l14t1005r228b1070],
23	,	,	O	,	_	0	SENT_13	[p2l14t1005r228b1070],
24	UK	NNP	LOCATION	UK	appos	16	SENT_13	[p2l258t1005r371b1059],

1	J.	NNP	ORGANIZATION	J.	nn	3	SENT_14	[p2l14t1166r57b1220],
2	Nazim	NNP	ORGANIZATION	Nazim	nn	3	SENT_14	[p2l87t1163r295b1219],
3	Department	NNP	ORGANIZATION	Department	nsubj	22	SENT_14	[p2l14t1246r378b1315],
4	of	IN	ORGANIZATION	of	_	0	SENT_14	[p2l407t1244r478b1300],
5	Paediatric	NNP	ORGANIZATION	Paediatric	nn	6	SENT_14	[p2l496t1244r801b1300],
6	Endocrinology	NNP	ORGANIZATION	Endocrinology	prep_of	3	SENT_14	[p2l831t1244r1303b1315],
7	,	,	O	,	_	0	SENT_14	[p2l831t1244r1303b1315],
8	Polish-American	NNP	ORGANIZATION	Polish-American	nn	9	SENT_14	[p2l13t1323r537b1379],
9	Children	NNP	ORGANIZATION	Children	poss	21	SENT_14	[p2l566t1323r884b1379],
10	’s	POS	ORGANIZATION	’s	_	0	SENT_14	[p2l566t1323r884b1379],
11	Hospital	NNP	ORGANIZATION	Hospital	nn	21	SENT_14	[p2l914t1323r1191b1394],
12	,	,	O	,	_	0	SENT_14	[p2l914t1323r1191b1394],
13	Medical	NNP	ORGANIZATION	Medical	appos	21	SENT_14	[p2l14t1402r265b1457],
14	College	NNP	ORGANIZATION	College	nn	21	SENT_14	[p2l295t1402r550b1473],
15	,	,	O	,	_	0	SENT_14	[p2l295t1402r550b1473],
16	Jagiellonian	NNP	ORGANIZATION	Jagiellonian	appos	21	SENT_14	[p2l581t1402r954b1473],
17	University	NNP	ORGANIZATION	University	nn	21	SENT_14	[p2l981t1402r1319b1473],
18	,	,	O	,	_	0	SENT_14	[p2l981t1402r1319b1473],
19	Krakow	NNP	LOCATION	Krakow	dep	21	SENT_14	[p2l14t1482r274b1548],
20	,	,	O	,	_	0	SENT_14	[p2l14t1482r274b1548],
21	Poland	NNP	LOCATION	Poland	nsubj	22	SENT_14	[p2l305t1482r520b1538],
22	lowed	VBN	O	low	_	0	SENT_14	[p2l9t1570r230b1636],
23	by	IN	O	by	_	0	SENT_14	[p2l268t1570r360b1655],
24	direct	JJ	O	direct	amod	25	SENT_14	[p2l402t1570r606b1636],
25	sequencing	NN	O	sequencing	prep_by	22	SENT_14	[p2l648t1570r1072b1655],
26	.	.	O	.	_	0	SENT_14	[p2l648t1570r1072b1655],

1	All	DT	O	all	det	3	SENT_15	[p2l1117t1570r1232b1635],
2	study	NN	O	study	nn	3	SENT_15	[p2l1276t1570r1470b1655],
3	subjects	NNS	O	subject	nsubj	4	SENT_15	[p2l1513t1570r1799b1655],
4	gave	VBD	O	give	_	0	SENT_15	[p2l1843t1592r2012b1655],
5	informed	VBN	O	inform	amod	6	SENT_15	[p2l2055t1570r2150b1635, p2l10t1670r269b1735],
6	consent	NN	O	consent	dobj	4	SENT_15	[p2l313t1679r606b1735],
7	.	.	O	.	_	0	SENT_15	[p2l313t1679r606b1735],

1	The	DT	O	the	det	2	SENT_16	[p2l655t1669r793b1735],
2	project	NN	O	project	nsubjpass	4	SENT_16	[p2l834t1670r1088b1754],
3	was	VBD	O	be	auxpass	4	SENT_16	[p2l1128t1691r1267b1735],
4	approved	VBN	O	approve	_	0	SENT_16	[p2l1314t1669r1651b1754],
5	by	IN	O	by	_	0	SENT_16	[p2l1691t1669r1783b1754],
6	the	DT	O	the	det	9	SENT_16	[p2l1825t1670r1934b1735],
7	local	JJ	O	local	amod	9	SENT_16	[p2l1979t1669r2152b1735],
8	ethics	NNS	O	ethic	nn	9	SENT_16	[p2l9t1768r215b1834],
9	committee	NN	O	committee	agent	4	SENT_16	[p2l239t1768r618b1834],
10	and	CC	O	and	_	0	SENT_16	[p2l642t1768r771b1834],
11	was	VBD	O	be	auxpass	12	SENT_16	[p2l790t1790r929b1834],
12	conducted	VBN	O	conduct	conj_and	4	SENT_16	[p2l953t1768r1326b1834],
13	in	IN	O	in	_	0	SENT_16	[p2l1347t1768r1415b1833],
14	accordance	NN	O	accordance	prep_in	12	SENT_16	[p2l1436t1768r1840b1834],
15	with	IN	O	with	_	0	SENT_16	[p2l1862t1768r2023b1834],
16	the	DT	O	the	prep_with	12	SENT_16	[p2l2042t1768r2151b1834],

1	Declaration	NN	O	declaration	_	0	SENT_17	[p2l8t1868r430b1934],
2	of	IN	O	of	_	0	SENT_17	[p2l458t1868r542b1933],
3	Helsinki	NNP	LOCATION	Helsinki	prep_of	1	SENT_17	[p2l557t1867r881b1933],
4	.	.	O	.	_	0	SENT_17	[p2l557t1867r881b1933],

1	A	DT	O	a	det	8	SENT_18	[p2l99t1968r165b2031],
2	heterozygous	JJ	O	heterozygous	amod	8	SENT_18	[p2l194t1966r678b2051],
3	R20lH	NN	O	r20lh	nn	8	SENT_18	[p2l710t1968r973b2032],
4	missense	NN	O	missense	nn	8	SENT_18	[p2l1003t1966r1330b2032],
5	mutation	NN	O	mutation	nn	8	SENT_18	[p2l1361t1966r1684b2032],
6	(	CD	NUMBER	(	num	8	SENT_18	[p2l1716t1966r2150b2050],
7	c.	NN	O	c.	nn	8	SENT_18	[p2l1716t1966r2150b2050],
8	60lC	NN	O	60lc	nsubjpass	13	SENT_18	[p2l1716t1966r2150b2050],
9	>	JJR	O	>	amod	11	SENT_18	[p2l1716t1966r2150b2050],
10	A	DT	O	a	det	11	SENT_18	[p2l1716t1966r2150b2050],
11	)	NN	O	)	dep	8	SENT_18	[p2l1716t1966r2150b2050],
12	was	VBD	O	be	auxpass	13	SENT_18	[p2l7t2087r146b2132],
13	found	VBN	O	find	_	0	SENT_18	[p2l186t2066r397b2132],
14	in	IN	O	in	_	0	SENT_18	[p2l434t2066r502b2130],
15	a	DT	O	a	det	17	SENT_18	[p2l539t2087r578b2131],
16	single	JJ	O	single	amod	17	SENT_18	[p2l616t2065r827b2150],
17	patient	NN	O	patient	prep_in	13	SENT_18	[p2l864t2066r1128b2150],
18	.	.	O	.	_	0	SENT_18	[p2l864t2066r1128b2150],

1	This	DT	O	this	det	2	SENT_19	[p2l1171t2065r1329b2131],
2	child	NN	O	child	nsubj	4	SENT_19	[p2l1369t2065r1548b2132],
3	was	VBD	O	be	cop	4	SENT_19	[p2l1583t2087r1722b2132],
4	bom	NN	O	bom	_	0	SENT_19	[p2l1758t2065r1926b2131],
5	at	IN	O	at	_	0	SENT_19	[p2l1964t2075r2027b2131],
6	40	CD	DURATION	40	num	7	SENT_19	[p2l2062t2067r2150b2131],
7	weeks	NNS	NUMBER	week	prep_at	4	SENT_19	[p2l7t2164r257b2230],
8	’	CD	NUMBER	’	num	9	SENT_19	[p2l7t2164r257b2230],
9	gestation	NN	O	gestation	dep	7	SENT_19	[p2l294t2164r620b2249],
10	and	CC	O	and	_	0	SENT_19	[p2l652t2164r782b2230],
11	weighed	VBD	O	weigh	conj_and	4	SENT_19	[p2l809t2164r1119b2249],
12	2,450	CD	NUMBER	2,450	num	13	SENT_19	[p2l1148t2166r1351b2244],
13	g.	NN	O	g.	dobj	11	SENT_19	[p2l1384t2186r1444b2249],
14	He	PRP	O	he	nsubjpass	16	SENT_19	[p2l1479t2167r1583b2230],
15	was	VBD	O	be	auxpass	16	SENT_19	[p2l1612t2186r1751b2230],
16	diagnosed	VBN	O	diagnose	rcmod	13	SENT_19	[p2l1784t2164r2153b2249],
17	with	IN	O	with	_	0	SENT_19	[p2l7t2263r167b2330],
18	diabetes	NN	O	diabetes	prep_with	16	SENT_19	[p2l188t2263r475b2330],
19	during	IN	O	during	_	0	SENT_19	[p2l499t2264r730b2348],
20	the	DT	O	the	det	22	SENT_19	[p2l751t2263r858b2329],
21	third	JJ	ORDINAL	third	amod	22	SENT_19	[p2l880t2263r1048b2330],
22	week	NN	DURATION	week	prep_during	16	SENT_19	[p2l1067t2263r1258b2330],
23	of	IN	O	of	_	0	SENT_19	[p2l1278t2264r1362b2329],
24	life	NN	O	life	prep_of	22	SENT_19	[p2l1372t2263r1486b2329],
25	based	VBN	O	base	_	0	SENT_19	[p2l1506t2263r1712b2330],
26	on	IN	O	on	prepc_based_on	16	SENT_19	[p2l1732t2285r1821b2329],
27	a	DT	O	a	det	29	SENT_19	[p2l1843t2285r1881b2329],
28	plasma	NN	O	plasma	nn	29	SENT_19	[p2l1898t2263r2153b2348],
29	glucose	NN	O	glucose	pobj	16	SENT_19	[p2l9t2362r280b2446],
30	of	IN	O	of	_	0	SENT_19	[p2l311t2362r394b2428],
31	35-50	CD	NUMBER	35-50	num	32	SENT_19	[p2l413t2364r635b2428],
32	mmol/l	NN	O	mmol/l	prep_of	29	SENT_19	[p2l664t2362r941b2442],
33	,	,	O	,	_	0	SENT_19	[p2l664t2362r941b2442],
34	without	IN	O	without	_	0	SENT_19	[p2l973t2362r1247b2428],
35	ketoacidosis	NN	O	ketoacidosis	prep_without	16	SENT_19	[p2l1274t2362r1734b2442],
36	,	,	O	,	_	0	SENT_19	[p2l1274t2362r1734b2442],
37	which	WDT	O	which	nsubjpass	39	SENT_19	[p2l1765t2362r1985b2428],
38	was	VBD	O	be	auxpass	39	SENT_19	[p2l2013t2383r2150b2428],
39	measured	VBN	O	measure	rcmod	35	SENT_19	[p2l7t2461r351b2528],
40	when	WRB	O	when	advmod	42	SENT_19	[p2l379t2461r576b2528],
41	he	PRP	O	he	nsubj	42	SENT_19	[p2l604t2461r688b2527],
42	presented	VBD	O	present	advcl	39	SENT_19	[p2l716t2461r1060b2546],
43	with	IN	O	with	_	0	SENT_19	[p2l1089t2461r1249b2528],
44	pneumonia	NN	O	pneumonia	prep_with	42	SENT_19	[p2l1276t2462r1677b2546],
45	and	CC	O	and	_	0	SENT_19	[p2l1708t2462r1836b2527],
46	bilateral	JJ	O	bilateral	amod	49	SENT_19	[p2l1864t2461r2153b2527],
47	acute	JJ	O	acute	amod	49	SENT_19	[p2l9t2569r193b2625],
48	otitis	NN	O	otitis	nn	49	SENT_19	[p2l213t2560r383b2625],
49	media	NNS	O	media	conj_and	44	SENT_19	[p2l402t2560r636b2625],
50	.	.	O	.	_	0	SENT_19	[p2l402t2560r636b2625],

1	The	DT	O	the	det	2	SENT_20	[p2l661t2560r796b2625],
2	patient	NN	O	patient	nsubjpass	4	SENT_20	[p2l813t2560r1056b2643],
3	was	VBD	O	be	auxpass	4	SENT_20	[p2l1071t2581r1209b2625],
4	treated	VBN	O	treat	_	0	SENT_20	[p2l1227t2560r1468b2625],
5	with	IN	O	with	_	0	SENT_20	[p2l1483t2560r1642b2625],
6	insulin	NN	O	insulin	prep_with	4	SENT_20	[p2l1660t2560r1917b2639],
7	,	,	O	,	_	0	SENT_20	[p2l1660t2560r1917b2639],
8	with	IN	O	with	_	0	SENT_20	[p2l1938t2560r2097b2625],
9	a	DT	O	a	det	10	SENT_20	[p2l2115t2581r2153b2625],
10	dose	NN	O	dose	prep_with	4	SENT_20	[p2l9t2658r169b2725],
11	of	IN	O	of	_	0	SENT_20	[p2l213t2659r295b2724],
12	0.7-1	CD	NUMBER	0.7-1	num	14	SENT_20	[p2l326t2660r590b2725],
13	.0	CD	NUMBER	.0	num	14	SENT_20	[p2l326t2660r590b2725],
14	U/kg	NN	O	u/kg	prep_of	10	SENT_20	[p2l631t2658r811b2743],
15	used	VBN	O	use	dep	14	SENT_20	[p2l850t2658r1016b2725],
16	initially	RB	O	initially	advmod	15	SENT_20	[p2l1056t2658r1327b2743],
17	and	CC	O	and	_	0	SENT_20	[p2l1368t2658r1496b2725],
18	subsequently	RB	O	subsequently	advmod	19	SENT_20	[p2l1539t2658r2001b2743],
19	decreased	VBN	O	decrease	dep	14	SENT_20	[p2l2042t2658r2150b2724, p2l9t2757r288b2823],
20	.	.	O	.	_	0	SENT_20	[p2l2042t2658r2150b2724, p2l9t2757r288b2823],

1	At	IN	O	at	_	0	SENT_21	[p2l321t2758r412b2822],
2	9	CD	DURATION	9	num	3	SENT_21	[p2l440t2759r479b2823],
3	years	NNS	NUMBER	year	prep_at	18	SENT_21	[p2l509t2778r714b2841],
4	,	,	O	,	_	0	SENT_21	[p2l509t2778r714b2841],
5	11	CD	DURATION	11	num	6	SENT_21	[p2l756t2759r822b2822],
6	months	NNS	NUMBER	month	nsubj	18	SENT_21	[p2l860t2757r1121b2823],
7	he	PRP	O	he	nsubj	8	SENT_21	[p2l1150t2757r1233b2823],
8	weighed	VBD	O	weigh	rcmod	6	SENT_21	[p2l1261t2757r1565b2841],
9	27.5	CD	NUMBER	27.5	num	10	SENT_21	[p2l1593t2759r1743b2823],
10	kg	NN	O	kg	dobj	8	SENT_21	[p2l1776t2757r1865b2841],
11	and	CC	O	and	_	0	SENT_21	[p2l1895t2757r2022b2823],
12	his	PRP$	O	he	poss	15	SENT_21	[p2l2049t2757r2151b2823],
13	daily	JJ	SET	daily	amod	15	SENT_21	[p2l9t2856r184b2941],
14	insulin	NN	O	insulin	nn	15	SENT_21	[p2l219t2857r459b2923],
15	requirement	NN	O	requirement	conj_and	10	SENT_21	[p2l492t2857r921b2941],
16	was	VBD	O	be	cop	18	SENT_21	[p2l953t2878r1090b2923],
17	7	CD	NUMBER	7	num	18	SENT_21	[p2l1127t2859r1166b2923],
18	U	NNP	O	U	_	0	SENT_21	[p2l1203t2859r1268b2923],
19	(	CD	NUMBER	(	num	18	SENT_21	[p2l1304t2857r1481b2941],
20	0.25	CD	NUMBER	0.25	num	22	SENT_21	[p2l1304t2857r1481b2941],
21	U/kg	NN	O	u/kg	nn	22	SENT_21	[p2l1520t2856r1727b2941],
22	)	NN	O	)	dep	18	SENT_21	[p2l1520t2856r1727b2941],
23	as	IN	O	as	_	0	SENT_21	[p2l1764t2878r1833b2922],
24	a	DT	O	a	det	27	SENT_21	[p2l1871t2878r1909b2922],
25	single	JJ	O	single	amod	27	SENT_21	[p2l1945t2856r2152b2941],
26	morning	NN	TIME	morning	nn	27	SENT_21	[p2l7t2955r308b3040],
27	injection	NN	O	injection	prep_as	22	SENT_21	[p2l334t2955r641b3039],
28	of	IN	O	of	_	0	SENT_21	[p2l665t2955r748b3021],
29	intermediate-acting	JJ	O	intermediate-acting	amod	30	SENT_21	[p2l762t2955r1445b3039],
30	insulin	NN	O	insulin	prep_of	27	SENT_21	[p2l1471t2955r1727b3021],
31	.	.	O	.	_	0	SENT_21	[p2l1471t2955r1727b3021],

1	Despite	IN	O	despite	_	0	SENT_22	[p2l1757t2955r2027b3039],
2	little	JJ	O	little	amod	3	SENT_22	[p2l2053t2955r2151b3020, p2l7t3054r93b3120],
3	modiﬁcation	NN	O	modiﬁcation	prep_despite	9	SENT_22	[p2l123t3055r579b3121],
4	to	TO	O	to	_	0	SENT_22	[p2l607t3063r674b3120],
5	his	PRP$	O	he	poss	6	SENT_22	[p2l705t3054r807b3120],
6	diet	NN	O	diet	prep_to	3	SENT_22	[p2l839t3055r971b3121],
7	he	PRP	O	he	nsubj	16	SENT_22	[p2l999t3054r1083b3120],
8	rarely	RB	O	rarely	advmod	9	SENT_22	[p2l1111t3054r1318b3139],
9	experienced	VBD	O	experience	_	0	SENT_22	[p2l1349t3054r1778b3139],
10	hyperglycaemia	NN	O	hyperglycaemia	dobj	9	SENT_22	[p2l1805t3054r2150b3139, p2l9t3153r261b3218],
11	above	IN	O	above	_	0	SENT_22	[p2l288t3153r499b3218],
12	11	CD	NUMBER	11	num	13	SENT_22	[p2l536t3155r603b3217],
13	mmol/l	NN	O	mmol/l	prep_above	9	SENT_22	[p2l640t3153r917b3232],
14	,	,	O	,	_	0	SENT_22	[p2l640t3153r917b3232],
15	and	CC	O	and	_	0	SENT_22	[p2l948t3153r1077b3218],
16	had	VBD	O	have	conj_and	9	SENT_22	[p2l1102t3153r1233b3218],
17	an	DT	O	a	det	19	SENT_22	[p2l1260t3174r1344b3218],
18	HbA1c	NN	O	hba1c	nn	19	SENT_22	[p2l1369t3153r1616b3232],
19	level	NN	O	level	dobj	16	SENT_22	[p2l1646t3153r1816b3218],
20	of	IN	O	of	_	0	SENT_22	[p2l1845t3153r1928b3218],
21	6.6	CD	PERCENT	6.6	num	22	SENT_22	[p2l1946t3154r2148b3220],
22	%	NN	PERCENT	%	prep_of	19	SENT_22	[p2l1946t3154r2148b3220],
23	.	.	O	.	_	0	SENT_22	[p2l1946t3154r2148b3220],

1	These	DT	O	these	det	2	SENT_23	[p2l9t3251r219b3317],
2	observations	NNS	O	observation	nsubj	3	SENT_23	[p2l240t3252r688b3318],
3	suggested	VBD	O	suggest	_	0	SENT_23	[p2l710t3251r1061b3336],
4	endogenous	JJ	O	endogenous	amod	7	SENT_23	[p2l1079t3251r1504b3336],
5	beta	NN	O	beta	nn	7	SENT_23	[p2l1523t3251r1674b3317],
6	cell	NN	O	cell	nn	7	SENT_23	[p2l1691t3251r1816b3317],
7	function	NN	O	function	dobj	3	SENT_23	[p2l1835t3252r2149b3331],
8	,	,	O	,	_	0	SENT_23	[p2l1835t3252r2149b3331],
9	which	WDT	O	which	nsubjpass	11	SENT_23	[p2l7t3350r227b3416],
10	was	VBD	O	be	auxpass	11	SENT_23	[p2l252t3371r390b3416],
11	confirmed	VBN	O	confirm	rcmod	7	SENT_23	[p2l420t3350r786b3416],
12	by	IN	O	by	_	0	SENT_23	[p2l809t3350r901b3434],
13	a	DT	O	a	det	16	SENT_23	[p2l929t3371r967b3415],
14	fasting	JJ	O	fasting	amod	16	SENT_23	[p2l995t3350r1233b3434],
15	plasma	NN	O	plasma	nn	16	SENT_23	[p2l1258t3350r1515b3434],
16	C-peptide	NN	O	c-peptide	agent	11	SENT_23	[p2l1541t3350r1890b3434],
17	of	IN	O	of	_	0	SENT_23	[p2l1919t3350r2003b3416],
18	443	CD	NUMBER	443	num	20	SENT_23	[p2l2017t3352r2146b3416],
19	pmol/l	NN	O	pmol/l	nn	20	SENT_23	[p2l6t3449r240b3534],
20	(	NN	O	(	prep_of	16	SENT_23	[p2l274t3449r573b3534],
21	glucose	NN	O	glucose	nn	24	SENT_23	[p2l274t3449r573b3534],
22	6.7	CD	NUMBER	6.7	num	24	SENT_23	[p2l609t3451r715b3516],
23	mmol/l	NN	O	mmol/l	nn	24	SENT_23	[p2l750t3449r1035b3534],
24	)	NN	O	)	dep	20	SENT_23	[p2l750t3449r1035b3534],
25	and	CC	O	and	_	0	SENT_23	[p2l1071t3449r1199b3516],
26	an	DT	O	a	det	27	SENT_23	[p2l1233t3471r1315b3515],
27	increase	NN	O	increase	conj_and	20	SENT_23	[p2l1349t3450r1636b3515],
28	in	IN	O	in	_	0	SENT_23	[p2l1671t3450r1739b3514],
29	plasma	NN	O	plasma	nn	31	SENT_23	[p2l1768t3450r2023b3534],
30	insulin	NN	O	insulin	nn	31	SENT_23	[p2l2057t3450r2150b3514, p2l10t3548r181b3614],
31	concentration	NN	O	concentration	prep_in	27	SENT_23	[p2l208t3548r691b3614],
32	of	IN	O	of	_	0	SENT_23	[p2l718t3548r802b3614],
33	70	CD	NUMBER	70	num	34	SENT_23	[p2l818t3550r904b3614],
34	pmol/l	NN	O	pmol/l	prep_of	31	SENT_23	[p2l929t3548r1164b3632],
35	during	IN	O	during	_	0	SENT_23	[p2l1191t3548r1422b3632],
36	an	DT	O	a	det	39	SENT_23	[p2l1450t3569r1533b3613],
37	IVGTT	NN	O	ivgtt	nn	39	SENT_23	[p2l1559t3549r1826b3614],
38	(	CD	NUMBER	(	num	39	SENT_23	[p2l1855t3548r2016b3632],
39	Fig	NN	O	fig	prep_during	11	SENT_23	[p2l1855t3548r2016b3632],
40	.	.	O	.	_	0	SENT_23	[p2l1855t3548r2016b3632],

1	1	CD	NUMBER	1	_	0	SENT_24	[p2l2058t3548r2138b3632],
2	)	NN	O	)	dep	1	SENT_24	[p2l2058t3548r2138b3632],
3	.	.	O	.	_	0	SENT_24	[p2l2058t3548r2138b3632],

1	As	IN	O	as	mark	8	SENT_25	[p2l99t3649r198b3713],
2	patients	NNS	O	patient	nsubj	8	SENT_25	[p2l222t3647r503b3732],
3	with	IN	O	with	_	0	SENT_25	[p2l529t3647r690b3713],
4	Kir6	NN	O	kir6	nn	6	SENT_25	[p2l715t3647r945b3713],
5	.2	NN	NUMBER	.2	nn	6	SENT_25	[p2l715t3647r945b3713],
6	diabetes	NN	O	diabetes	prep_with	2	SENT_25	[p2l975t3647r1267b3713],
7	may	MD	O	may	aux	8	SENT_25	[p2l1294t3669r1450b3732],
8	respond	VB	O	respond	advcl	13	SENT_25	[p2l1473t3647r1762b3732],
9	to	TO	O	to	_	0	SENT_25	[p2l1786t3656r1853b3713],
10	sulphonylureas	NNS	O	sulphonylurea	prep_to	8	SENT_25	[p2l1882t3647r2150b3732, p2l7t3746r334b3830],
11	,	,	O	,	_	0	SENT_25	[p2l1882t3647r2150b3732, p2l7t3746r334b3830],
12	we	PRP	O	we	nsubj	13	SENT_25	[p2l370t3767r474b3812],
13	assessed	VBD	O	assess	_	0	SENT_25	[p2l511t3746r817b3812],
14	whether	IN	O	whether	complm	17	SENT_25	[p2l848t3746r1143b3812],
15	this	DT	O	this	det	16	SENT_25	[p2l1174t3746r1302b3812],
16	patient	NN	O	patient	nsubj	17	SENT_25	[p2l1335t3746r1584b3830],
17	could	MD	O	could	ccomp	13	SENT_25	[p2l1618t3746r1818b3812],
18	successfully	RB	O	successfully	advmod	17	SENT_25	[p2l1854t3767r2150b3812, p3l10t19r181b104],

1	transfer	NN	O	transfer	nsubj	5	SENT_26	[p3l225t19r508b85],
2	to	TO	O	to	_	0	SENT_26	[p3l551t28r619b85],
3	sulphonylurea	NN	O	sulphonylurea	nn	4	SENT_26	[p3l669t19r1193b104],
4	tablets	NNS	O	tablet	prep_to	1	SENT_26	[p3l1236t19r1474b85],
5	[	VBP	O	[	_	0	SENT_26	[p3l1528t21r1616b102],
6	3	CD	NUMBER	3	dobj	5	SENT_26	[p3l1528t21r1616b102],
7	,	,	O	,	_	0	SENT_26	[p3l1528t21r1616b102],
8	4	CD	NUMBER	4	num	9	SENT_26	[p3l1665t21r1758b102],
9	]	NN	O	]	appos	6	SENT_26	[p3l1665t21r1758b102],
10	.	.	O	.	_	0	SENT_26	[p3l1665t21r1758b102],

1	Glipizide	NN	MISC	glipizide	nn	4	SENT_27	[p3l1811t19r2151b104],
2	gastrointestinal	JJ	O	gastrointestinal	amod	4	SENT_27	[p3l9t118r560b202],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_27	[p3l605t118r1005b202],
4	system	NN	O	system	nsubjpass	14	SENT_27	[p3l1054t127r1303b202],
5	(	CD	NUMBER	(	num	6	SENT_27	[p3l1348t118r1625b202],
6	GITS	NNS	O	git	dep	7	SENT_27	[p3l1348t118r1625b202],
7	)	RB	O	)	amod	4	SENT_27	[p3l1348t118r1625b202],
8	,	,	O	,	_	0	SENT_27	[p3l1348t118r1625b202],
9	a	DT	O	a	det	11	SENT_27	[p3l1675t139r1713b183],
10	controlledrelease	NN	O	controlledrelease	nn	11	SENT_27	[p3l1757t118r2150b184, p3l7t217r256b283],
11	sulphonylurea	NN	O	sulphonylurea	appos	4	SENT_27	[p3l290t217r813b302],
12	,	,	O	,	_	0	SENT_27	[p3l290t217r813b302],
13	was	VBD	O	be	auxpass	14	SENT_27	[p3l844t239r982b283],
14	introduced	VBN	O	introduce	_	0	SENT_27	[p3l1014t217r1395b283],
15	[	CD	NUMBER	[	number	16	SENT_27	[p3l1429t219r1542b300],
16	5	CD	NUMBER	5	num	17	SENT_27	[p3l1429t219r1542b300],
17	]	NN	O	]	dobj	14	SENT_27	[p3l1429t219r1542b300],
18	.	.	O	.	_	0	SENT_27	[p3l1429t219r1542b300],

1	A	DT	O	a	det	2	SENT_28	[p3l1576t219r1641b282],
2	dose	NN	O	dose	nsubjpass	7	SENT_28	[p3l1671t217r1832b283],
3	of	IN	O	of	_	0	SENT_28	[p3l1864t217r1947b283],
4	5	CD	NUMBER	5	num	5	SENT_28	[p3l1967t220r2003b283],
5	mg	NN	O	mg	prep_of	2	SENT_28	[p3l2037t239r2152b302],
6	was	VBD	O	be	auxpass	7	SENT_28	[p3l7t337r144b382],
7	administered	VBN	O	administer	_	0	SENT_28	[p3l184t316r643b382],
8	for	IN	O	for	_	0	SENT_28	[p3l681t316r784b382],
9	2	CD	DURATION	2	num	10	SENT_28	[p3l818t318r859b381],
10	days	NNS	NUMBER	day	prep_for	7	SENT_28	[p3l900t316r1082b400],
11	,	,	O	,	_	0	SENT_28	[p3l900t316r1082b400],
12	then	RB	O	then	advmod	14	SENT_28	[p3l1120t316r1275b382],
13	10	CD	NUMBER	10	num	14	SENT_28	[p3l1320t318r1399b382],
14	mg	NN	O	mg	appos	10	SENT_28	[p3l1436t337r1572b400],
15	;	:	O	;	_	0	SENT_28	[p3l1436t337r1572b400],
16	insulin	NN	O	insulin	nsubjpass	20	SENT_28	[p3l1613t316r1855b382],
17	was	VBD	O	be	auxpass	20	SENT_28	[p3l1890t337r2027b382],
18	simultaneously	RB	O	simultaneously	advmod	20	SENT_28	[p3l2068t316r2150b382, p3l7t415r490b500],
19	slowly	RB	O	slowly	advmod	20	SENT_28	[p3l516t415r752b500],
20	withdrawn	VBN	O	withdraw	parataxis	7	SENT_28	[p3l774t415r1158b481],
21	over	IN	O	over	_	0	SENT_28	[p3l1183t437r1343b481],
22	a	DT	O	a	det	23	SENT_28	[p3l1366t437r1404b481],
23	period	NN	O	period	prep_over	20	SENT_28	[p3l1425t415r1655b500],
24	of	IN	O	of	_	0	SENT_28	[p3l1679t415r1762b481],
25	5	CD	DURATION	5	num	26	SENT_28	[p3l1778t418r1813b481],
26	days	NNS	NUMBER	day	prep_of	23	SENT_28	[p3l1845t415r2023b500],
27	.	.	O	.	_	0	SENT_28	[p3l1845t415r2023b500],

1	As	IN	O	as	mark	4	SENT_29	[p3l2052t417r2151b481],
2	the	DT	O	the	det	3	SENT_29	[p3l7t514r114b579],
3	patient	NN	O	patient	nsubj	4	SENT_29	[p3l134t514r382b597],
4	experienced	VBD	O	experience	advcl	26	SENT_29	[p3l404t514r841b597],
5	a	DT	O	a	det	8	SENT_29	[p3l864t535r901b578],
6	few	JJ	O	few	amod	8	SENT_29	[p3l923t514r1055b579],
7	mild	JJ	O	mild	amod	8	SENT_29	[p3l1075t514r1242b579],
8	hypo	NN	O	hypo	dobj	4	SENT_29	[p3l1261t514r1442b597],
9	glycaemic	JJ	O	glycaemic	amod	10	SENT_29	[p3l1447t514r1816b597],
10	episodes	NNS	O	episode	npadvmod	4	SENT_29	[p3l1842t514r2150b597],
11	during	IN	O	during	_	0	SENT_29	[p3l9t612r244b697],
12	the	DT	DURATION	the	det	15	SENT_29	[p3l262t612r371b678],
13	first	JJ	DURATION	first	amod	15	SENT_29	[p3l393t612r534b678],
14	2	CD	DURATION	2	num	15	SENT_29	[p3l552t614r593b677],
15	days	NNS	NUMBER	day	prep_during	4	SENT_29	[p3l615t612r778b697],
16	after	IN	O	after	_	0	SENT_29	[p3l800t612r963b678],
17	the	DT	O	the	det	18	SENT_29	[p3l978t612r1087b678],
18	discontinuation	NN	O	discontinuation	prep_after	4	SENT_29	[p3l1109t612r1668b678],
19	of	IN	O	of	_	0	SENT_29	[p3l1688t612r1771b678],
20	insulin	NN	O	insulin	prep_of	18	SENT_29	[p3l1780t612r2025b678],
21	the	DT	O	the	det	24	SENT_29	[p3l2042t612r2151b678],
22	glipizide	NN	O	glipizide	nn	24	SENT_29	[p3l9t711r323b794],
23	GITS	NNS	O	git	nn	24	SENT_29	[p3l353t712r548b776],
24	dose	NN	O	dose	nsubjpass	26	SENT_29	[p3l581t711r744b776],
25	was	VBD	O	be	auxpass	26	SENT_29	[p3l771t732r911b776],
26	decreased	VBN	O	decrease	_	0	SENT_29	[p3l942t711r1298b776],
27	to	TO	O	to	_	0	SENT_29	[p3l1323t720r1391b776],
28	5	CD	NUMBER	5	num	29	SENT_29	[p3l1423t714r1459b776],
29	mg	NN	O	mg	prep_to	26	SENT_29	[p3l1491t732r1624b794],
30	.	.	O	.	_	0	SENT_29	[p3l1491t732r1624b794],

1	While	IN	O	while	mark	2	SENT_30	[p3l1657t711r1877b776],
2	on	IN	O	on	advcl	14	SENT_30	[p3l1907t732r1996b776],
3	this	DT	O	this	det	4	SENT_30	[p3l2022t711r2150b776],
4	dose	NN	O	dose	pobj	2	SENT_30	[p3l9t809r193b889],
5	,	,	O	,	_	0	SENT_30	[p3l9t809r193b889],
6	a	DT	DURATION	a	det	8	SENT_30	[p3l229t831r267b875],
7	day	NN	DURATION	day	nn	8	SENT_30	[p3l298t809r428b894],
8	profile	NN	O	profile	nsubj	14	SENT_30	[p3l456t809r696b894],
9	of	IN	O	of	_	0	SENT_30	[p3l730t809r813b875],
10	his	PRP$	O	he	poss	13	SENT_30	[p3l832t809r936b875],
11	capillary	JJ	O	capillary	amod	13	SENT_30	[p3l970t809r1284b894],
12	glucose	NN	O	glucose	nn	13	SENT_30	[p3l1316t809r1590b894],
13	concentrations	NNS	O	concentration	prep_of	8	SENT_30	[p3l1624t809r2150b875],
14	revealed	VBD	O	reveal	_	0	SENT_30	[p3l7t908r315b973],
15	that	IN	O	that	complm	22	SENT_30	[p3l346t908r482b972],
16	they	PRP	O	they	nsubj	22	SENT_30	[p3l513t908r670b991],
17	were	VBD	O	be	cop	22	SENT_30	[p3l701t929r875b973],
18	between	IN	O	between	quantmod	19	SENT_30	[p3l908t908r1212b973],
19	4	CD	NUMBER	4	num	22	SENT_30	[p3l1245t909r1287b972],
20	and	CC	NUMBER	and	_	0	SENT_30	[p3l1324t908r1454b973],
21	6	CD	NUMBER	6	num	22	SENT_30	[p3l1487t909r1527b973],
22	mmol/1	NN	O	mmol/1	ccomp	14	SENT_30	[p3l1562t908r1844b987],
23	;	:	O	;	_	0	SENT_30	[p3l1562t908r1844b987],
24	a	DT	O	a	det	25	SENT_30	[p3l1883t929r1922b972],
25	result	NN	O	result	dep	22	SENT_30	[p3l1952t908r2153b973],
26	confirmed	VBN	O	confirm	partmod	25	SENT_30	[p3l9t1006r372b1072],
27	by	IN	O	by	_	0	SENT_30	[p3l392t1006r483b1091],
28	a	DT	O	a	det	30	SENT_30	[p3l506t1028r544b1072],
29	72-h	JJ	O	72-h	amod	30	SENT_30	[p3l567t1006r729b1072],
30	record	NN	O	record	agent	26	SENT_30	[p3l749t1006r975b1072],
31	obtained	VBN	O	obtain	partmod	30	SENT_30	[p3l998t1006r1302b1072],
32	using	VBG	O	use	xcomp	31	SENT_30	[p3l1322t1006r1515b1091],
33	a	DT	O	a	det	37	SENT_30	[p3l1540t1028r1578b1072],
34	continuous	JJ	O	continuous	amod	37	SENT_30	[p3l1600t1006r1986b1072],
35	glucose	NN	O	glucose	nn	37	SENT_30	[p3l2012t1006r2150b1091, p3l9t1126r163b1170],
36	monitoring	NN	O	monitoring	nn	37	SENT_30	[p3l188t1105r581b1188],
37	system	NN	O	system	nsubj	38	SENT_30	[p3l609t1114r853b1188],
38	(	CD	NUMBER	(	xcomp	32	SENT_30	[p3l878t1105r1291b1188],
39	Medtronic	NNP	ORGANIZATION	Medtronic	nn	45	SENT_30	[p3l878t1105r1291b1188],
40	,	,	O	,	_	0	SENT_30	[p3l878t1105r1291b1188],
41	Northridge	NNP	ORGANIZATION	Northridge	appos	45	SENT_30	[p3l1316t1105r1725b1188],
42	,	,	O	,	_	0	SENT_30	[p3l1316t1105r1725b1188],
43	CA	NNP	O	CA	appos	45	SENT_30	[p3l1754t1106r1895b1184],
44	,	,	O	,	_	0	SENT_30	[p3l1754t1106r1895b1184],
45	USA	NNP	LOCATION	USA	dep	38	SENT_30	[p3l1921t1105r2147b1188],
46	)	CD	NUMBER	)	num	45	SENT_30	[p3l1921t1105r2147b1188],
47	.	.	O	.	_	0	SENT_30	[p3l1921t1105r2147b1188],

1	The	DT	O	the	det	2	SENT_31	[p3l9t1203r147b1269],
2	IVGTT	NNP	O	IVGTT	nsubjpass	4	SENT_31	[p3l181t1205r451b1269],
3	was	VBD	O	be	auxpass	4	SENT_31	[p3l478t1225r617b1269],
4	repeated	VBN	O	repeat	_	0	SENT_31	[p3l651t1203r958b1288],
5	3	CD	DURATION	3	num	6	SENT_31	[p3l992t1205r1027b1269],
6	weeks	NNS	NUMBER	week	dep	13	SENT_31	[p3l1066t1203r1291b1269],
7	after	IN	O	after	dep	13	SENT_31	[p3l1328t1203r1491b1269],
8	a	DT	O	a	det	11	SENT_31	[p3l1523t1225r1561b1269],
9	stable	JJ	O	stable	amod	11	SENT_31	[p3l1596t1203r1802b1269],
10	glipizide	NN	O	glipizide	nn	11	SENT_31	[p3l1837t1203r2151b1288],
11	dose	NN	O	dose	nsubjpass	13	SENT_31	[p3l9t1302r172b1367],
12	was	VBD	O	be	auxpass	13	SENT_31	[p3l192t1323r332b1367],
13	achieved	VBN	O	achieve	ccomp	4	SENT_31	[p3l355t1302r693b1367],
14	.	.	O	.	_	0	SENT_31	[p3l355t1302r693b1367],

1	At	IN	O	at	_	0	SENT_32	[p3l717t1303r808b1366],
2	this	DT	O	this	det	3	SENT_32	[p3l826t1302r954b1367],
3	time	NN	O	time	prep_at	12	SENT_32	[p3l976t1302r1134b1367],
4	the	DT	O	the	det	5	SENT_32	[p3l1154t1302r1263b1367],
5	patient	NN	O	patient	poss	9	SENT_32	[p3l1282t1302r1588b1385],
6	’s	POS	O	’s	_	0	SENT_32	[p3l1282t1302r1588b1385],
7	fasting	NN	O	fasting	nn	9	SENT_32	[p3l1612t1302r1854b1385],
8	glucose	NN	O	glucose	nn	9	SENT_32	[p3l1876t1302r2151b1385],
9	level	NN	O	level	nsubj	12	SENT_32	[p3l9t1400r177b1466],
10	was	VBD	O	be	cop	12	SENT_32	[p3l195t1422r332b1466],
11	5.4	CD	NUMBER	5.4	num	12	SENT_32	[p3l353t1402r459b1466],
12	mmol/l	NN	O	mmol/l	_	0	SENT_32	[p3l478t1400r754b1480],
13	,	,	O	,	_	0	SENT_32	[p3l478t1400r754b1480],
14	and	CC	O	and	_	0	SENT_32	[p3l775t1400r903b1466],
15	his	PRP$	O	he	poss	17	SENT_32	[p3l919t1400r1021b1466],
16	C-peptide	NN	MISC	c-peptide	nn	17	SENT_32	[p3l1041t1400r1387b1485],
17	level	NN	O	level	nsubj	20	SENT_32	[p3l1407t1400r1575b1466],
18	was	VBD	O	be	cop	20	SENT_32	[p3l1592t1422r1730b1466],
19	347	CD	NUMBER	347	num	20	SENT_32	[p3l1750t1402r1879b1466],
20	pmol/1	NN	O	pmol/1	conj_and	12	SENT_32	[p3l1898t1400r2148b1485],
21	.	.	O	.	_	0	SENT_32	[p3l1898t1400r2148b1485],

1	1030	CD	DATE	1030	_	0	SENT_33	[p3l17t1525r162b1579],

1	Table	NNP	O	Table	_	0	SENT_34	[p3l10t1675r191b1728],
2	1	CD	NUMBER	1	num	1	SENT_34	[p3l234t1674r263b1727],
3	The	DT	O	the	det	5	SENT_34	[p3l320t1672r438b1728],
4	primer	NN	O	primer	nn	5	SENT_34	[p3l475t1672r684b1744],
5	set	NN	O	set	dep	1	SENT_34	[p3l722t1680r806b1728],
6	used	VBN	O	use	partmod	1	SENT_34	[p3l841t1672r985b1728],
7	to	TO	O	to	aux	8	SENT_34	[p3l1022t1680r1080b1728],
8	amplify	VB	O	amplify	xcomp	6	SENT_34	[p3l1121t1672r1361b1744],
9	KCNJII	NNP	O	KCNJII	dobj	8	SENT_34	[p3l1395t1673r1678b1740],
10	,	,	O	,	_	0	SENT_34	[p3l1395t1673r1678b1740],
11	the	DT	O	the	det	12	SENT_34	[p3l1719t1672r1812b1728],
12	gene	NN	O	gene	appos	9	SENT_34	[p3l1852t1691r1996b1744],
13	that	WDT	O	that	nsubj	14	SENT_34	[p3l2035t1672r2151b1728],
14	encodes	VBZ	O	encode	rcmod	12	SENT_34	[p3l10t1753r257b1809],
15	Kir6	NN	O	kir6	nn	16	SENT_34	[p3l286t1753r503b1821],
16	.2	NN	NUMBER	.2	dobj	14	SENT_34	[p3l286t1753r503b1821],
17	,	,	O	,	_	0	SENT_34	[p3l286t1753r503b1821],
18	with	IN	O	with	_	0	SENT_34	[p3l534t1753r672b1809],
19	M13	NN	O	m13	nn	20	SENT_34	[p3l700t1754r841b1809],
20	tails	NNS	O	tail	prep_with	8	SENT_34	[p3l874t1753r1000b1809],

1	Fragment	NN	O	fragment	_	0	SENT_35	[p3l8t1930r307b1999],
2	5	CD	NUMBER	5	num	3	SENT_35	[p3l355t1928r502b1983],
3	’	NN	O	’	dep	1	SENT_35	[p3l355t1928r502b1983],
4	.	.	O	.	_	0	SENT_35	[p3l355t1928r502b1983],

1	—	NN	O	—	_	0	SENT_36	[p3l355t1928r502b1983],
2	.	.	O	.	_	0	SENT_36	[p3l355t1928r502b1983],

1	3	CD	NUMBER	3	_	0	SENT_37	[p3l355t1928r502b1983],
2	’	NN	O	’	dep	1	SENT_37	[p3l355t1928r502b1983],
3	Forward	RB	O	forward	advmod	5	SENT_37	[p3l531t1927r795b1983],
4	5	CD	NUMBER	5	num	5	SENT_37	[p3l1272t1929r1420b1983],
5	’	NN	O	’	rcmod	2	SENT_37	[p3l1272t1929r1420b1983],
6	.	.	O	.	_	0	SENT_37	[p3l1272t1929r1420b1983],

1	—	NN	O	—	_	0	SENT_38	[p3l1272t1929r1420b1983],
2	.	.	O	.	_	0	SENT_38	[p3l1272t1929r1420b1983],

1	3	CD	NUMBER	3	_	0	SENT_39	[p3l1272t1929r1420b1983],
2	’	NN	O	’	nn	5	SENT_39	[p3l1272t1929r1420b1983],
3	Reverse	NN	O	reverse	nn	5	SENT_39	[p3l1448t1930r1697b1983],
4	primer	NN	O	primer	nn	5	SENT_39	[p3l351t2028r560b2101],
5	primer	NN	O	primer	dep	1	SENT_39	[p3l1268t2028r1477b2101],

1	B	NN	O	b	nn	16	SENT_40	[p3l8t2202r56b2255],
2	TGT	NN	O	tgt	nn	16	SENT_40	[p3l354t2201r502b2256],
3	AAA	NN	O	aaa	nn	16	SENT_40	[p3l524t2201r693b2255],
4	ACG	NN	O	acg	nn	16	SENT_40	[p3l720t2201r885b2256],
5	ACG	NN	O	acg	nn	16	SENT_40	[p3l912t2201r1077b2256],
6	CAG	NN	O	cag	nn	16	SENT_40	[p3l1271t2201r1434b2256],
7	GAA	NN	O	gaa	nn	16	SENT_40	[p3l1463t2201r1630b2256],
8	ACA	NN	O	aca	nn	16	SENT_40	[p3l1657t2201r1822b2256],
9	GCT	NN	O	gct	nn	16	SENT_40	[p3l1851t2201r2004b2256],
10	GCC	NN	O	gcc	nn	16	SENT_40	[p3l379t2303r535b2358],
11	AGT	NN	O	agt	nn	16	SENT_40	[p3l565t2303r724b2358],
12	CCG	NN	O	ccg	nn	16	SENT_40	[p3l754t2303r913b2358],
13	AGA	NN	O	aga	nn	16	SENT_40	[p3l940t2303r1109b2358],
14	ATG	NN	O	atg	nn	16	SENT_40	[p3l1294t2303r1446b2358],
15	ACC	NN	O	acc	nn	16	SENT_40	[p3l1473t2303r1632b2358],
16	TAG	NN	O	tag	_	0	SENT_40	[p3l1662t2303r1815b2358],
17	TCA	NNP	O	TCA	nn	21	SENT_40	[p3l1844t2303r1998b2358],
18	GGA	NNP	O	GGA	nn	21	SENT_40	[p3l379t2405r546b2460],
19	CTC	NNP	O	CTC	nn	21	SENT_40	[p3l575t2405r722b2460],
20	TGC	NNP	O	TGC	nn	21	SENT_40	[p3l753t2405r905b2460],
21	AGT	NNP	O	AGT	dep	16	SENT_40	[p3l933t2405r1093b2460],
22	GA	NNP	O	GA	nn	26	SENT_40	[p3l1123t2405r1233b2460],
23	CTT	NNP	O	CTT	nn	26	SENT_40	[p3l1296t2405r1440b2460],
24	GGA	NNP	O	GGA	nn	26	SENT_40	[p3l1470t2405r1637b2460],
25	CCT	NNP	O	CCT	nn	26	SENT_40	[p3l1666t2405r1816b2460],
26	CAA	NNP	O	CAA	dep	16	SENT_40	[p3l1846t2405r2008b2460],

1	TGG	NNP	O	TGG	nn	2	SENT_41	[p3l1296t2507r1454b2562],
2	AG	NNP	O	AG	_	0	SENT_41	[p3l1481t2507r1593b2562],

1	C	NN	O	c	nn	3	SENT_42	[p3l10t2608r57b2663],
2	TGT	NN	O	tgt	nn	3	SENT_42	[p3l354t2608r502b2664],
3	AAA	NN	O	aaa	dep	21	SENT_42	[p3l524t2608r693b2662],
4	ACG	NN	O	acg	nn	11	SENT_42	[p3l720t2608r885b2664],
5	ACG	NN	O	acg	nn	11	SENT_42	[p3l912t2608r1077b2663],
6	CAG	NN	O	cag	nn	11	SENT_42	[p3l1271t2608r1434b2664],
7	GAA	NN	O	gaa	nn	11	SENT_42	[p3l1463t2608r1630b2663],
8	ACA	NN	O	aca	nn	11	SENT_42	[p3l1657t2608r1822b2663],
9	GCT	NN	O	gct	nn	11	SENT_42	[p3l1851t2608r2004b2664],
10	GCC	NN	O	gcc	nn	11	SENT_42	[p3l379t2710r535b2765],
11	AGT	NN	O	agt	dep	3	SENT_42	[p3l564t2710r724b2765],
12	CTG	NNP	O	CTG	nn	16	SENT_42	[p3l754t2710r908b2765],
13	CTG	NNP	O	CTG	nn	16	SENT_42	[p3l937t2710r1091b2765],
14	ATG	NN	O	atg	nn	16	SENT_42	[p3l1294t2710r1446b2765],
15	ACC	NNP	O	ACC	nn	16	SENT_42	[p3l1472t2710r1632b2765],
16	CAC	NNP	O	CAC	dep	21	SENT_42	[p3l1663t2710r1820b2765],
17	GCC	NNP	O	GCC	nn	21	SENT_42	[p3l1851t2710r2007b2765],
18	AGC	NNP	O	AGC	nn	21	SENT_42	[p3l376t2812r539b2867],
19	CCT	NNP	O	CCT	nn	21	SENT_42	[p3l571t2812r720b2867],
20	GTG	NNP	O	GTG	nn	21	SENT_42	[p3l750t2812r907b2867],
21	TCA	NNP	ORGANIZATION	TCA	dep	26	SENT_42	[p3l937t2812r1091b2867],
22	CC	NN	O	cc	dep	21	SENT_42	[p3l1120t2812r1220b2867],
23	TTC	NN	O	ttc	nn	26	SENT_42	[p3l1296t2812r1439b2867],
24	CAG	NN	O	cag	nn	26	SENT_42	[p3l1470t2812r1633b2867],
25	GAT	NN	O	gat	nn	26	SENT_42	[p3l1662t2812r1811b2867],
26	GAC	NN	O	gac	_	0	SENT_42	[p3l1841t2812r2002b2867],

1	GAT	NN	O	gat	_	0	SENT_43	[p3l1296t2913r1445b2969],

1	D	NN	O	d	nn	16	SENT_44	[p3l8t3016r62b3069],
2	TGT	NN	O	tgt	nn	16	SENT_44	[p3l353t3015r502b3070],
3	AAA	NN	O	aaa	nn	16	SENT_44	[p3l524t3015r693b3069],
4	ACG	NN	O	acg	nn	16	SENT_44	[p3l720t3015r885b3070],
5	ACG	NN	O	acg	nn	16	SENT_44	[p3l912t3015r1077b3070],
6	CAG	NN	O	cag	nn	16	SENT_44	[p3l1271t3015r1434b3070],
7	GAA	NN	O	gaa	nn	16	SENT_44	[p3l1463t3015r1630b3070],
8	ACA	NN	O	aca	nn	16	SENT_44	[p3l1657t3015r1822b3070],
9	GCT	NN	O	gct	nn	16	SENT_44	[p3l1851t3015r2004b3070],
10	GCC	NN	O	gcc	nn	16	SENT_44	[p3l379t3117r535b3172],
11	AGT	NN	O	agt	nn	16	SENT_44	[p3l558t3117r717b3172],
12	CTA	NN	O	cta	nn	16	SENT_44	[p3l740t3117r889b3172],
13	CCA	NN	O	cca	nn	16	SENT_44	[p3l911t3117r1070b3172],
14	TGT	NN	O	tgt	nn	16	SENT_44	[p3l1084t3117r1232b3172],
15	ATG	NN	O	atg	nn	16	SENT_44	[p3l1294t3117r1446b3172],
16	ACC	NN	O	acc	_	0	SENT_44	[p3l1473t3117r1632b3172],
17	CCA	NNP	O	CCA	nn	21	SENT_44	[p3l1663t3117r1822b3172],
18	CAT	NNP	O	CAT	nn	21	SENT_44	[p3l1851t3117r1996b3172],
19	CAT	NNP	O	CAT	nn	21	SENT_44	[p3l379t3219r523b3274],
20	TGA	NNP	O	TGA	nn	21	SENT_44	[p3l546t3219r704b3274],
21	TGC	NNP	O	TGC	dep	16	SENT_44	[p3l718t3219r870b3274],
22	TGC	NNP	O	TGC	nn	27	SENT_44	[p3l894t3219r1046b3274],
23	CAA	NNP	O	CAA	nn	27	SENT_44	[p3l1070t3219r1233b3274],
24	GGT	NNP	O	GGT	nn	27	SENT_44	[p3l1296t3219r1453b3274],
25	CCG	NNP	O	CCG	nn	27	SENT_44	[p3l1483t3219r1641b3274],
26	TGT	NNP	O	TGT	nn	27	SENT_44	[p3l1671t3219r1820b3274],
27	GTA	NNP	O	GTA	dep	16	SENT_44	[p3l1849t3219r2002b3274],

1	CAC	NNP	O	CAC	_	0	SENT_45	[p3l1296t3321r1453b3376],
2	AC	NN	O	ac	dep	1	SENT_45	[p3l1482t3321r1588b3376],

1	An	DT	O	a	det	3	SENT_46	[p3l8t3458r103b3512],
2	annealing	NN	O	annealing	nn	3	SENT_46	[p3l132t3456r432b3529],
3	temperature	NN	O	temperature	nsubjpass	9	SENT_46	[p3l461t3464r829b3529],
4	of	IN	O	of	_	0	SENT_46	[p3l860t3456r931b3513],
5	62	CD	NUMBER	62	number	6	SENT_46	[p3l951t3458r1108b3513],
6	°	CD	NUMBER	°	num	7	SENT_46	[p3l951t3458r1108b3513],
7	C	NN	O	c	prep_of	3	SENT_46	[p3l951t3458r1108b3513],
8	was	VBD	O	be	auxpass	9	SENT_46	[p3l1138t3475r1257b3513],
9	used	VBN	O	use	_	0	SENT_46	[p3l1285t3456r1429b3513],
10	for	IN	O	for	_	0	SENT_46	[p3l1458t3456r1547b3513],
11	all	DT	O	all	det	14	SENT_46	[p3l1574t3456r1648b3512],
12	three	CD	NUMBER	three	num	14	SENT_46	[p3l1676t3456r1829b3513],
13	PCR	NN	O	pcr	nn	14	SENT_46	[p3l1857t3458r2007b3513],
14	protocols	NNS	O	protocol	prep_for	9	SENT_46	[p3l32t3547r321b3620],

1	The	DT	O	the	det	3	SENT_47	[p4l10t86r146b151],
2	peak	JJ	O	peak	amod	3	SENT_47	[p4l163t86r335b170],
3	increase	NN	O	increase	nsubj	12	SENT_47	[p4l353t86r640b151],
4	in	IN	O	in	_	0	SENT_47	[p4l660t86r728b150],
5	insulin	NN	O	insulin	nn	6	SENT_47	[p4l746t86r987b151],
6	concentration	NN	O	concentration	prep_in	3	SENT_47	[p4l1006t86r1488b151],
7	during	IN	O	during	_	0	SENT_47	[p4l1507t86r1738b170],
8	the	DT	O	the	det	9	SENT_47	[p4l1756t86r1863b151],
9	IVGTT	NNP	O	IVGTT	prep_during	6	SENT_47	[p4l1883t88r2150b151],
10	was	VBD	O	be	cop	12	SENT_47	[p4l8t206r146b250],
11	197	CD	NUMBER	197	num	12	SENT_47	[p4l188t186r312b250],
12	pmol/l	NN	O	pmol/l	_	0	SENT_47	[p4l343t185r916b268],
13	—	CD	NUMBER	—	npadvmod	14	SENT_47	[p4l343t185r916b268],
14	almost	RB	O	almost	advmod	12	SENT_47	[p4l343t185r916b268],
15	three	CD	NUMBER	three	num	16	SENT_47	[p4l944t185r1122b250],
16	times	NNS	O	time	npadvmod	17	SENT_47	[p4l1153t185r1343b250],
17	higher	JJR	O	higher	advmod	12	SENT_47	[p4l1374t185r1603b268],
18	than	IN	O	than	mark	20	SENT_47	[p4l1630t185r1784b249],
19	that	DT	O	that	nsubj	20	SENT_47	[p4l1812t185r1946b249],
20	measured	VBN	O	measure	dep	17	SENT_47	[p4l1973t206r2149b250, p4l12t284r202b349],
21	prior	RB	O	prior	_	0	SENT_47	[p4l225t284r401b368],
22	to	TO	O	to	_	0	SENT_47	[p4l423t293r490b349],
23	sulphonylurea	NN	O	sulphonylurea	nn	24	SENT_47	[p4l521t284r1026b368],
24	treatment	NN	O	treatment	prep_prior_to	20	SENT_47	[p4l1050t293r1385b349],
25	(	CD	NUMBER	(	num	26	SENT_47	[p4l1412t284r1574b368],
26	Fig	NN	O	fig	dobj	20	SENT_47	[p4l1412t284r1574b368],
27	.	.	O	.	_	0	SENT_47	[p4l1412t284r1574b368],

1	1	CD	NUMBER	1	_	0	SENT_48	[p4l1615t284r1696b367],
2	)	NN	O	)	dep	1	SENT_48	[p4l1615t284r1696b367],
3	.	.	O	.	_	0	SENT_48	[p4l1615t284r1696b367],

1	Four	CD	NUMBER	four	num	2	SENT_49	[p4l101t386r266b449],
2	individuals	NNS	O	individual	nsubj	10	SENT_49	[p4l289t383r662b449],
3	on	IN	O	on	_	0	SENT_49	[p4l689t405r776b449],
4	the	DT	O	the	det	6	SENT_49	[p4l798t384r902b449],
5	maternal	JJ	O	maternal	amod	6	SENT_49	[p4l926t383r1223b449],
6	side	NN	O	side	prep_on	2	SENT_49	[p4l1250t384r1383b449],
7	of	IN	O	of	_	0	SENT_49	[p4l1409t384r1490b449],
8	his	PRP$	O	he	poss	9	SENT_49	[p4l1501t383r1599b449],
9	family	NN	O	family	prep_of	6	SENT_49	[p4l1627t384r1847b467],
10	had	VBD	O	have	_	0	SENT_49	[p4l1870t383r1996b449],
11	diabetes	NNS	O	diabetes	dobj	10	SENT_49	[p4l2021t383r2148b449, p4l7t482r341b547],
12	.	.	O	.	_	0	SENT_49	[p4l2021t383r2148b449, p4l7t482r341b547],

1	The	DT	O	the	det	2	SENT_50	[p4l2021t383r2148b449, p4l7t482r341b547],
2	mother	NN	O	mother	nsubj	18	SENT_50	[p4l363t482r622b547],
3	developed	VBD	O	develop	_	0	SENT_50	[p4l642t482r1015b566],
4	gestational	JJ	O	gestational	amod	5	SENT_50	[p4l1036t482r1426b566],
5	diabetes	NN	O	diabetes	dobj	3	SENT_50	[p4l1450t482r1742b547],
6	at	IN	O	at	_	0	SENT_50	[p4l1767t491r1830b547],
7	31	CD	DURATION	31	num	8	SENT_50	[p4l1852t484r1929b547],
8	years	NNS	NUMBER	year	prep_at	3	SENT_50	[p4l1960t504r2148b566],
9	of	IN	O	of	_	0	SENT_50	[p4l10t582r94b647],
10	age	NN	O	age	prep_of	8	SENT_50	[p4l109t603r252b665],
11	,	,	O	,	_	0	SENT_50	[p4l109t603r252b665],
12	during	IN	O	during	dep	3	SENT_50	[p4l282t582r517b665],
13	her	PRP$	O	she	poss	15	SENT_50	[p4l542t582r659b647],
14	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_50	[p4l684t582r826b647],
15	pregnancy	NN	O	pregnancy	pobj	12	SENT_50	[p4l849t603r1242b665],
16	,	,	O	,	_	0	SENT_50	[p4l849t603r1242b665],
17	and	CC	O	and	_	0	SENT_50	[p4l1273t581r1403b647],
18	remained	VBD	O	remain	conj_and	3	SENT_50	[p4l1426t581r1764b647],
19	on	IN	O	on	_	0	SENT_50	[p4l1790t603r1880b647],
20	insulin	NN	O	insulin	prep_on	18	SENT_50	[p4l1905t581r2150b647],
21	until	IN	O	until	_	0	SENT_50	[p4l7t680r173b745],
22	the	DT	O	the	det	23	SENT_50	[p4l204t680r312b745],
23	delivery	NN	O	delivery	prep_until	18	SENT_50	[p4l346t680r641b764],
24	of	IN	O	of	_	0	SENT_50	[p4l673t680r756b745],
25	the	DT	O	the	det	26	SENT_50	[p4l776t680r884b745],
26	proband	NN	O	proband	prep_of	23	SENT_50	[p4l915t680r1232b764],
27	.	.	O	.	_	0	SENT_50	[p4l915t680r1232b764],

1	She	PRP	O	she	nsubjpass	4	SENT_51	[p4l1273t680r1403b745],
2	was	VBD	O	be	auxpass	4	SENT_51	[p4l1434t702r1573b745],
3	also	RB	O	also	advmod	4	SENT_51	[p4l1607t680r1748b745],
4	diagnosed	VBN	O	diagnose	_	0	SENT_51	[p4l1783t680r2151b764],
5	with	IN	O	with	_	0	SENT_51	[p4l8t779r169b845],
6	diabetes	NN	O	diabetes	prep_with	4	SENT_51	[p4l199t779r491b845],
7	during	IN	O	during	_	0	SENT_51	[p4l524t779r758b863],
8	her	PRP$	O	she	poss	10	SENT_51	[p4l787t779r904b845],
9	second	JJ	ORDINAL	second	amod	10	SENT_51	[p4l934t779r1184b845],
10	pregnancy	NN	O	pregnancy	prep_during	4	SENT_51	[p4l1210t801r1604b863],
11	,	,	O	,	_	0	SENT_51	[p4l1210t801r1604b863],
12	and	CC	O	and	_	0	SENT_51	[p4l1638t780r1767b845],
13	an	DT	O	a	det	14	SENT_51	[p4l1797t801r1881b844],
14	OGTT	NN	O	ogtt	nsubj	20	SENT_51	[p4l1910t781r2149b845],
15	performed	VBN	O	perform	partmod	14	SENT_51	[p4l7t878r386b962],
16	6	CD	DURATION	6	num	17	SENT_51	[p4l408t880r447b943],
17	weeks	NNS	NUMBER	week	tmod	15	SENT_51	[p4l470t878r695b943],
18	after	IN	O	after	_	0	SENT_51	[p4l720t878r884b943],
19	delivery	NN	O	delivery	prep_after	15	SENT_51	[p4l904t878r1198b962],
20	showed	VBD	O	show	conj_and	4	SENT_51	[p4l1222t878r1498b943],
21	that	IN	O	that	complm	24	SENT_51	[p4l1518t878r1653b943],
22	she	PRP	O	she	nsubj	24	SENT_51	[p4l1676t878r1791b943],
23	remained	VBD	O	remain	cop	24	SENT_51	[p4l1813t878r2151b943],
24	diabetic	JJ	O	diabetic	ccomp	20	SENT_51	[p4l10t977r298b1043],
25	.	.	O	.	_	0	SENT_51	[p4l10t977r298b1043],

1	She	PRP	O	she	nsubj	9	SENT_52	[p4l337t977r463b1043],
2	is	VBZ	O	be	auxpass	3	SENT_52	[p4l495t978r548b1043],
3	treated	VBN	O	treat	_	0	SENT_52	[p4l579t977r815b1043],
4	by	IN	O	by	_	0	SENT_52	[p4l842t977r932b1061],
5	diet	NN	O	diet	agent	3	SENT_52	[p4l963t977r1091b1043],
6	and	CC	O	and	_	0	SENT_52	[p4l1121t978r1247b1043],
7	does	VBZ	O	do	aux	9	SENT_52	[p4l1277t977r1434b1043],
8	not	RB	O	not	neg	9	SENT_52	[p4l1465t987r1578b1043],
9	have	VB	O	have	conj_and	3	SENT_52	[p4l1606t977r1771b1043],
10	type	NN	O	type	amod	13	SENT_52	[p4l1801t987r1951b1061],
11	1	CD	NUMBER	1	number	10	SENT_52	[p4l1991t979r2015b1041],
12	diabetes-related	JJ	O	diabetes-related	amod	13	SENT_52	[p4l2056t977r2148b1043, p4l10t1076r489b1141],
13	antibodies	NNS	O	antibody	dobj	9	SENT_52	[p4l531t1076r903b1141],
14	.	.	O	.	_	0	SENT_52	[p4l531t1076r903b1141],

1	Three	CD	NUMBER	three	num	4	SENT_53	[p4l952t1076r1154b1141],
2	other	JJ	O	other	amod	4	SENT_53	[p4l1198t1076r1378b1141],
3	distant	JJ	O	distant	amod	4	SENT_53	[p4l1419t1076r1650b1141],
4	relatives	NNS	O	relative	nsubj	5	SENT_53	[p4l1689t1076r1979b1141],
5	had	VBD	O	have	_	0	SENT_53	[p4l2022t1076r2151b1141],
6	typical	JJ	O	typical	amod	8	SENT_53	[p4l8t1175r244b1259],
7	late-onset	JJ	O	late-onset	amod	8	SENT_53	[p4l268t1175r603b1241],
8	type	NN	O	type	dobj	5	SENT_53	[p4l624t1184r774b1259],
9	2	CD	NUMBER	2	num	10	SENT_53	[p4l798t1177r839b1239],
10	diabetes	NN	O	diabetes	dep	8	SENT_53	[p4l866t1175r1165b1241],
11	.	.	O	.	_	0	SENT_53	[p4l866t1175r1165b1241],

1	These	DT	O	these	nsubj	12	SENT_54	[p4l1195t1176r1401b1241],
2	were	VBD	O	be	cop	3	SENT_54	[p4l1425t1197r1593b1241],
3	aged	JJ	O	aged	_	0	SENT_54	[p4l1619t1176r1784b1259],
4	>	JJR	O	>	dep	3	SENT_54	[p4l1806t1177r1942b1240],
5	40	CD	DURATION	40	num	6	SENT_54	[p4l1806t1177r1942b1240],
6	years	NNS	NUMBER	year	tmod	3	SENT_54	[p4l1966t1197r2148b1259],
7	at	IN	O	at	_	0	SENT_54	[p4l10t1283r74b1339],
8	diagnosis	NN	O	diagnosis	prep_at	3	SENT_54	[p4l91t1274r424b1358],
9	and	CC	O	and	_	0	SENT_54	[p4l446t1274r574b1339],
10	do	VBP	O	do	aux	12	SENT_54	[p4l593t1274r679b1339],
11	not	RB	O	not	neg	12	SENT_54	[p4l698t1283r813b1339],
12	require	VB	O	require	conj_and	3	SENT_54	[p4l830t1274r1079b1357],
13	insulin	NN	O	insulin	nn	14	SENT_54	[p4l1101t1274r1342b1339],
14	treatment	NN	O	treatment	dobj	12	SENT_54	[p4l1358t1283r1710b1339],
15	.	.	O	.	_	0	SENT_54	[p4l1358t1283r1710b1339],

1	The	DT	O	the	det	3	SENT_55	[p4l1735t1274r1870b1339],
2	R20lH	NN	O	r20lh	nn	3	SENT_55	[p4l1890t1276r2150b1339],
3	mutation	NN	O	mutation	nsubj	6	SENT_55	[p4l8t1374r331b1439],
4	was	VBD	O	be	cop	6	SENT_55	[p4l358t1395r497b1439],
5	not	RB	O	not	neg	6	SENT_55	[p4l526t1383r643b1439],
6	present	JJ	DATE	present	_	0	SENT_55	[p4l668t1382r932b1457],
7	in	IN	O	in	_	0	SENT_55	[p4l961t1374r1029b1437],
8	the	DT	O	the	det	9	SENT_55	[p4l1056t1373r1165b1439],
9	proband	NN	O	proband	poss	12	SENT_55	[p4l1192t1373r1550b1457],
10	’s	POS	O	’s	_	0	SENT_55	[p4l1192t1373r1550b1457],
11	diabetic	JJ	O	diabetic	amod	12	SENT_55	[p4l1582t1373r1864b1439],
12	mother	NN	O	mother	prep_in	6	SENT_55	[p4l1894t1373r2152b1439],
13	or	CC	O	or	_	0	SENT_55	[p4l10t1493r85b1537],
14	in	IN	O	in	_	0	SENT_55	[p4l111t1472r179b1536],
15	three	CD	NUMBER	three	num	18	SENT_55	[p4l206t1472r385b1537],
16	other	JJ	O	other	amod	18	SENT_55	[p4l414t1472r600b1537],
17	family	NN	O	family	nn	18	SENT_55	[p4l627t1472r860b1555],
18	members	NNS	O	member	prep_in	6	SENT_55	[p4l887t1472r1216b1537],
19	examined	VBN	O	examine	partmod	18	SENT_55	[p4l1249t1472r1618b1551],
20	,	,	O	,	_	0	SENT_55	[p4l1249t1472r1618b1551],
21	including	VBG	O	include	_	0	SENT_55	[p4l1651t1472r1992b1555],
22	one	CD	NUMBER	one	prep_including	18	SENT_55	[p4l2022t1493r2149b1537],
23	diabetic	JJ	O	diabetic	amod	24	SENT_55	[p4l9t1570r290b1635],
24	relative	JJ	O	relative	amod	22	SENT_55	[p4l328t1570r614b1635],
25	.	.	O	.	_	0	SENT_55	[p4l328t1570r614b1635],

1	The	DT	O	the	det	2	SENT_56	[p4l657t1570r793b1635],
2	proband	NN	O	proband	poss	4	SENT_56	[p4l829t1570r1186b1653],
3	’s	POS	O	’s	_	0	SENT_56	[p4l829t1570r1186b1653],
4	father	NN	O	father	nsubj	7	SENT_56	[p4l1225t1570r1434b1635],
5	was	VBD	O	be	cop	7	SENT_56	[p4l1466t1591r1605b1635],
6	not	RB	O	not	neg	7	SENT_56	[p4l1642t1579r1759b1635],
7	available	JJ	O	available	_	0	SENT_56	[p4l1795t1570r2138b1649],
8	;	:	O	;	_	0	SENT_56	[p4l1795t1570r2138b1649],
9	however	RB	O	however	advmod	14	SENT_56	[p4l7t1668r336b1747],
10	,	,	O	,	_	0	SENT_56	[p4l7t1668r336b1747],
11	he	PRP	O	he	nsubjpass	14	SENT_56	[p4l369t1668r453b1734],
12	is	VBZ	O	be	auxpass	14	SENT_56	[p4l486t1668r541b1734],
13	not	RB	O	not	neg	14	SENT_56	[p4l573t1677r690b1734],
14	known	VBN	O	know	parataxis	7	SENT_56	[p4l719t1668r967b1734],
15	to	TO	O	to	aux	16	SENT_56	[p4l997t1677r1063b1734],
16	have	VB	O	have	xcomp	14	SENT_56	[p4l1096t1668r1266b1734],
17	diabetes	NN	O	diabetes	dobj	16	SENT_56	[p4l1300t1668r1610b1734],
18	.	.	O	.	_	0	SENT_56	[p4l1300t1668r1610b1734],

1	It	PRP	O	it	nsubj	4	SENT_57	[p4l1647t1671r1701b1733],
2	is	VBZ	O	be	cop	4	SENT_57	[p4l1731t1668r1786b1734],
3	therefore	RB	O	therefore	advmod	4	SENT_57	[p4l1818t1668r2141b1734],
4	likely	JJ	O	likely	dep	20	SENT_57	[p4l9t1766r212b1849],
5	the	DT	O	the	det	6	SENT_57	[p4l231t1766r340b1831],
6	proband	NN	O	proband	nsubj	7	SENT_57	[p4l359t1766r658b1849],
7	has	VBZ	O	have	ccomp	4	SENT_57	[p4l677t1766r795b1831],
8	a	DT	O	a	det	10	SENT_57	[p4l819t1787r856b1831],
9	new	JJ	O	new	amod	10	SENT_57	[p4l874t1787r1025b1831],
10	mutation	NN	O	mutation	dobj	7	SENT_57	[p4l1044t1766r1384b1845],
11	,	,	O	,	_	0	SENT_57	[p4l1044t1766r1384b1845],
12	as	RB	O	as	advmod	16	SENT_57	[p4l1410t1787r1480b1831],
13	is	VBZ	O	be	cop	16	SENT_57	[p4l1503t1766r1558b1831],
14	usually	RB	O	usually	advmod	16	SENT_57	[p4l1578t1766r1841b1849],
15	the	DT	O	the	det	16	SENT_57	[p4l1860t1766r1968b1831],
16	case	NN	O	case	dep	10	SENT_57	[p4l1991t1787r2142b1831],
17	with	IN	O	with	_	0	SENT_57	[p4l7t1864r167b1930],
18	KCNJ11	NN	O	kcnj11	nn	19	SENT_57	[p4l190t1866r493b1930],
19	mutations	NNS	O	mutation	prep_with	16	SENT_57	[p4l527t1864r881b1930],
20	[	VBP	O	[	_	0	SENT_57	[p4l916t1866r1003b1946],
21	3	CD	NUMBER	3	nsubj	20	SENT_57	[p4l916t1866r1003b1946],
22	,	,	O	,	_	0	SENT_57	[p4l916t1866r1003b1946],
23	4	CD	NUMBER	4	num	24	SENT_57	[p4l1033t1866r1124b1946],
24	]	NN	O	]	appos	21	SENT_57	[p4l1033t1866r1124b1946],
25	.	.	O	.	_	0	SENT_57	[p4l1033t1866r1124b1946],

1	Our	PRP$	O	we	poss	2	SENT_58	[p4l101t1963r241b2027],
2	data	NNS	O	datum	nsubj	3	SENT_58	[p4l259t1962r407b2027],
3	support	VBP	O	support	_	0	SENT_58	[p4l428t1971r697b2045],
4	earlier	JJR	O	earlier	amod	5	SENT_58	[p4l716t1962r944b2027],
5	reports	NNS	O	report	nsubj	17	SENT_58	[p4l960t1971r1207b2045],
6	suggesting	VBG	O	suggest	partmod	5	SENT_58	[p4l1231t1962r1615b2045],
7	that	IN	O	that	complm	14	SENT_58	[p4l1634t1962r1769b2027],
8	mutations	NNS	O	mutation	nsubjpass	14	SENT_58	[p4l1786t1962r2140b2027],
9	in	IN	O	in	_	0	SENT_58	[p4l9t2060r76b2124],
10	Kir6	NN	O	kir6	nn	11	SENT_58	[p4l92t2060r315b2125],
11	.2	NN	NUMBER	.2	prep_in	8	SENT_58	[p4l92t2060r315b2125],
12	are	VBP	O	be	auxpass	14	SENT_58	[p4l337t2082r439b2125],
13	usually	RB	O	usually	advmod	14	SENT_58	[p4l455t2060r710b2144],
14	found	VBN	O	find	ccomp	6	SENT_58	[p4l728t2060r933b2125],
15	in	IN	O	in	_	0	SENT_58	[p4l950t2060r1018b2124],
16	patients	NNS	O	patient	prep_in	14	SENT_58	[p4l1030t2060r1302b2144],
17	diagnosed	VBD	O	diagnose	ccomp	3	SENT_58	[p4l1321t2060r1678b2144],
18	at	IN	O	at	_	0	SENT_58	[p4l1695t2069r1757b2125],
19	<	JJR	O	<	prep_at	17	SENT_58	[p4l1772t2062r1859b2125],
20	3	CD	DURATION	3	num	21	SENT_58	[p4l1772t2062r1859b2125],
21	months	NNS	NUMBER	month	tmod	19	SENT_58	[p4l1882t2060r2141b2125],
22	of	IN	O	of	_	0	SENT_58	[p4l9t2158r92b2223],
23	age	NN	O	age	prep_of	19	SENT_58	[p4l121t2179r242b2241],
24	[	CD	NUMBER	[	number	25	SENT_58	[p4l287t2159r374b2240],
25	3	CD	NUMBER	3	num	23	SENT_58	[p4l287t2159r374b2240],
26	,	,	O	,	_	0	SENT_58	[p4l287t2159r374b2240],
27	4	CD	NUMBER	4	num	28	SENT_58	[p4l415t2159r483b2240],
28	]	NN	O	]	appos	19	SENT_58	[p4l415t2159r483b2240],
29	and	CC	O	and	_	0	SENT_58	[p4l528t2158r657b2223],
30	that	IN	O	that	complm	34	SENT_58	[p4l694t2158r829b2222],
31	these	DT	O	these	det	32	SENT_58	[p4l865t2158r1049b2223],
32	mutations	NNS	O	mutation	nsubj	34	SENT_58	[p4l1087t2158r1442b2223],
33	are	VBP	O	be	cop	34	SENT_58	[p4l1484t2179r1588b2223],
34	uncommon	JJ	O	uncommon	conj_and	17	SENT_58	[p4l1626t2179r2036b2223],
35	in	IN	O	in	_	0	SENT_58	[p4l2075t2158r2144b2222],
36	those	DT	O	those	det	40	SENT_58	[p4l7t2256r197b2321],
37	aged	JJ	O	aged	amod	40	SENT_58	[p4l225t2256r394b2340],
38	>	JJR	O	>	dep	37	SENT_58	[p4l418t2258r511b2321],
39	6	CD	DURATION	6	num	40	SENT_58	[p4l418t2258r511b2321],
40	months	NNS	NUMBER	month	prep_in	34	SENT_58	[p4l537t2256r802b2321],
41	[	CD	NUMBER	[	number	42	SENT_58	[p4l835t2258r950b2338],
42	6	CD	NUMBER	6	num	43	SENT_58	[p4l835t2258r950b2338],
43	]	NN	O	]	dep	40	SENT_58	[p4l835t2258r950b2338],
44	.	.	O	.	_	0	SENT_58	[p4l835t2258r950b2338],

1	Although	IN	O	although	mark	4	SENT_59	[p4l979t2256r1323b2340],
2	the	DT	O	the	det	3	SENT_59	[p4l1347t2256r1456b2321],
3	proband	NN	O	proband	nsubj	4	SENT_59	[p4l1480t2256r1780b2340],
4	had	VBD	O	have	advcl	15	SENT_59	[p4l1803t2256r1934b2321],
5	other	JJ	O	other	amod	6	SENT_59	[p4l1960t2256r2145b2321],
6	relatives	NNS	O	relative	dobj	4	SENT_59	[p4l7t2354r309b2419],
7	who	WP	O	who	nsubj	8	SENT_59	[p4l341t2354r495b2419],
8	had	VBD	O	have	rcmod	6	SENT_59	[p4l527t2354r658b2419],
9	diabetes	NNS	O	diabetes	dobj	8	SENT_59	[p4l689t2354r1001b2433],
10	,	,	O	,	_	0	SENT_59	[p4l689t2354r1001b2433],
11	these	DT	O	these	det	12	SENT_59	[p4l1035t2354r1219b2419],
12	individuals	NNS	O	individual	nsubj	15	SENT_59	[p4l1252t2354r1650b2419],
13	did	VBD	O	do	aux	15	SENT_59	[p4l1685t2354r1799b2419],
14	not	RB	O	not	neg	15	SENT_59	[p4l1827t2363r1944b2419],
15	have	VB	O	have	_	0	SENT_59	[p4l1972t2354r2142b2419],
16	the	DT	O	the	det	17	SENT_59	[p4l7t2452r115b2517],
17	mutation	NN	O	mutation	dobj	15	SENT_59	[p4l135t2452r475b2531],
18	,	,	O	,	_	0	SENT_59	[p4l135t2452r475b2531],
19	thus	RB	O	thus	advmod	20	SENT_59	[p4l497t2452r646b2517],
20	demonstrating	VBG	O	demonstrate	partmod	17	SENT_59	[p4l668t2452r1183b2536],
21	heterogeneity	NN	O	heterogeneity	dobj	20	SENT_59	[p4l1203t2452r1695b2536],
22	of	IN	O	of	_	0	SENT_59	[p4l1716t2452r1799b2517],
23	aetiology	NN	O	aetiology	prep_of	21	SENT_59	[p4l1808t2452r2143b2536],
24	in	IN	O	in	_	0	SENT_59	[p4l9t2550r77b2614],
25	this	DT	O	this	det	26	SENT_59	[p4l95t2550r222b2615],
26	family	NN	O	family	prep_in	23	SENT_59	[p4l245t2550r484b2633],
27	.	.	O	.	_	0	SENT_59	[p4l245t2550r484b2633],

1	A	DT	O	a	det	3	SENT_60	[p4l509t2551r574b2614],
2	family	NN	O	family	nn	3	SENT_60	[p4l597t2550r825b2633],
3	history	NN	O	history	nsubj	9	SENT_60	[p4l844t2550r1092b2633],
4	of	IN	O	of	_	0	SENT_60	[p4l1112t2550r1196b2615],
5	later-onset	JJ	O	later-onset	amod	6	SENT_60	[p4l1205t2550r1577b2615],
6	diabetes	NN	O	diabetes	prep_of	3	SENT_60	[p4l1596t2550r1883b2615],
7	should	MD	O	should	aux	9	SENT_60	[p4l1908t2550r2144b2615],
8	not	RB	O	not	neg	9	SENT_60	[p4l7t2657r124b2713],
9	inﬂuence	VB	O	inﬂuence	_	0	SENT_60	[p4l149t2648r482b2713],
10	the	DT	O	the	det	11	SENT_60	[p4l508t2648r616b2713],
11	decision	NN	O	decision	dobj	9	SENT_60	[p4l644t2648r944b2713],
12	to	TO	O	to	aux	13	SENT_60	[p4l968t2657r1035b2713],
13	test	VB	O	test	infmod	11	SENT_60	[p4l1063t2657r1188b2713],
14	for	IN	O	for	_	0	SENT_60	[p4l1214t2648r1317b2713],
15	Kir6	NN	O	kir6	nn	17	SENT_60	[p4l1340t2648r1570b2713],
16	.2	NN	NUMBER	.2	nn	17	SENT_60	[p4l1340t2648r1570b2713],
17	mutations	NNS	O	mutation	prep_for	13	SENT_60	[p4l1598t2648r1972b2713],
18	.	.	O	.	_	0	SENT_60	[p4l1598t2648r1972b2713],

1	The	DT	O	the	_	0	SENT_61	[p4l2005t2648r2142b2713],

1	R20lH	NN	O	r20lh	nn	2	SENT_62	[p4l8t2747r270b2811],
2	mutation	NN	O	mutation	nsubjpass	11	SENT_62	[p4l299t2746r621b2811],
3	found	VBN	O	find	partmod	2	SENT_62	[p4l652t2746r862b2811],
4	in	IN	O	in	_	0	SENT_62	[p4l892t2746r960b2810],
5	this	DT	O	this	det	7	SENT_62	[p4l988t2746r1116b2811],
6	Polish	JJ	MISC	polish	amod	7	SENT_62	[p4l1147t2746r1374b2811],
7	child	NN	O	child	prep_in	3	SENT_62	[p4l1404t2746r1583b2811],
8	has	VBZ	O	have	aux	11	SENT_62	[p4l1611t2746r1729b2811],
9	previously	RB	DATE	previously	advmod	11	SENT_62	[p4l1759t2746r2143b2829],
10	been	VBN	O	be	auxpass	11	SENT_62	[p4l6t2844r178b2909],
11	described	VBN	O	describe	dep	34	SENT_62	[p4l201t2844r547b2909],
12	in	IN	O	in	_	0	SENT_62	[p4l570t2844r637b2908],
13	neonatal	JJ	O	neonatal	amod	14	SENT_62	[p4l659t2844r965b2909],
14	diabetes	NN	O	diabetes	prep_in	11	SENT_62	[p4l989t2844r1302b2923],
15	,	,	O	,	_	0	SENT_62	[p4l989t2844r1302b2923],
16	and	CC	O	and	_	0	SENT_62	[p4l1330t2844r1459b2910],
17	has	VBZ	O	have	aux	19	SENT_62	[p4l1479t2844r1598b2909],
18	been	VBN	O	be	auxpass	19	SENT_62	[p4l1621t2844r1793b2909],
19	shown	VBN	O	show	conj_and	11	SENT_62	[p4l1817t2844r2052b2909],
20	to	TO	O	to	aux	21	SENT_62	[p4l2073t2853r2140b2909],
21	reduce	VB	O	reduce	xcomp	19	SENT_62	[p4l7t2942r246b3007],
22	the	DT	O	the	det	23	SENT_62	[p4l275t2942r384b3007],
23	response	NN	O	response	dobj	21	SENT_62	[p4l413t2963r729b3025],
24	of	IN	O	of	_	0	SENT_62	[p4l760t2942r843b3007],
25	the	DT	O	the	det	28	SENT_62	[p4l860t2942r969b3007],
26	Kir6	NN	O	kir6	nn	28	SENT_62	[p4l998t2942r1228b3007],
27	.2	NN	NUMBER	.2	nn	28	SENT_62	[p4l998t2942r1228b3007],
28	channel	NN	O	channel	prep_of	23	SENT_62	[p4l1262t2942r1541b3007],
29	to	TO	O	to	_	0	SENT_62	[p4l1569t2951r1636b3007],
30	ATP	NN	ORGANIZATION	atp	prep_to	21	SENT_62	[p4l1666t2943r1825b3006],
31	in	IN	O	in	_	0	SENT_62	[p4l1857t2942r1925b3006],
32	functional	JJ	O	functional	amod	33	SENT_62	[p4l1956t2942r2141b3007, p4l7t3040r211b3105],
33	studies	NNS	O	study	prep_in	30	SENT_62	[p4l236t3040r481b3105],
34	[	VBP	O	[	_	0	SENT_62	[p4l510t3042r597b3122],
35	3	CD	NUMBER	3	nsubj	34	SENT_62	[p4l510t3042r597b3122],
36	,	,	O	,	_	0	SENT_62	[p4l510t3042r597b3122],
37	4	CD	NUMBER	4	num	38	SENT_62	[p4l621t3042r712b3122],
38	]	NN	O	]	appos	35	SENT_62	[p4l621t3042r712b3122],
39	.	.	O	.	_	0	SENT_62	[p4l621t3042r712b3122],

1	Despite	IN	O	despite	_	0	SENT_63	[p4l739t3040r1013b3124],
2	having	VBG	O	have	prepc_despite	18	SENT_63	[p4l1034t3040r1280b3124],
3	a	DT	O	a	det	5	SENT_63	[p4l1303t3062r1341b3105],
4	low	JJ	O	low	amod	5	SENT_63	[p4l1362t3040r1496b3105],
5	birthweight	NN	O	birthweight	dobj	2	SENT_63	[p4l1515t3040r1934b3124],
6	and	CC	O	and	_	0	SENT_63	[p4l1956t3040r2085b3105],
7	a	DT	O	a	det	9	SENT_63	[p4l2106t3062r2144b3105],
8	similar	JJ	O	similar	amod	9	SENT_63	[p4l10t3138r258b3203],
9	age	NN	O	age	conj_and	5	SENT_63	[p4l278t3159r400b3221],
10	at	IN	O	at	_	0	SENT_63	[p4l423t3147r486b3202],
11	diagnosis	NN	O	diagnosis	nn	12	SENT_63	[p4l506t3138r844b3221],
12	(	NN	O	(	prep_at	9	SENT_63	[p4l870t3138r990b3221],
13	<	JJR	O	<	amod	12	SENT_63	[p4l870t3138r990b3221],
14	6	CD	DURATION	6	num	15	SENT_63	[p4l870t3138r990b3221],
15	months	NNS	NUMBER	month	tmod	13	SENT_63	[p4l1013t3138r1307b3221],
16	)	RB	O	)	advmod	2	SENT_63	[p4l1013t3138r1307b3221],
17	there	EX	O	there	expl	18	SENT_63	[p4l1329t3138r1507b3203],
18	are	VBP	O	be	_	0	SENT_63	[p4l1530t3159r1635b3203],
19	some	DT	O	some	det	21	SENT_63	[p4l1660t3159r1846b3203],
20	striking	JJ	O	striking	amod	21	SENT_63	[p4l1871t3138r2142b3221],
21	differences	NNS	O	difference	nsubj	18	SENT_63	[p4l9t3236r404b3301],
22	between	IN	O	between	_	0	SENT_63	[p4l426t3236r729b3301],
23	our	PRP$	O	we	poss	24	SENT_63	[p4l752t3257r872b3301],
24	patient	NN	O	patient	prep_between	21	SENT_63	[p4l889t3236r1137b3320],
25	and	CC	O	and	_	0	SENT_63	[p4l1159t3236r1288b3301],
26	the	DT	O	the	det	29	SENT_63	[p4l1308t3236r1416b3301],
27	previously	RB	DATE	previously	advmod	28	SENT_63	[p4l1437t3236r1821b3320],
28	reported	VBN	O	report	amod	29	SENT_63	[p4l1842t3236r2144b3320],
29	cases	NNS	O	case	prep_between	21	SENT_63	[p4l9t3355r214b3399],
30	.	.	O	.	_	0	SENT_63	[p4l9t3355r214b3399],

1	Our	PRP$	O	we	poss	2	SENT_64	[p4l255t3335r395b3399],
2	patient	NN	O	patient	poss	5	SENT_64	[p4l425t3334r729b3417],
3	’s	POS	O	’s	_	0	SENT_64	[p4l425t3334r729b3417],
4	insulin	NN	O	insulin	nn	5	SENT_64	[p4l766t3334r1011b3399],
5	requirement	NN	O	requirement	nsubj	8	SENT_64	[p4l1043t3334r1480b3417],
6	was	VBD	O	be	cop	8	SENT_64	[p4l1512t3355r1650b3399],
7	substantially	RB	O	substantially	advmod	8	SENT_64	[p4l1689t3334r2143b3417],
8	lower	JJR	O	lower	dep	16	SENT_64	[p4l9t3432r214b3497],
9	than	IN	O	than	dep	8	SENT_64	[p4l236t3432r392b3497],
10	in	IN	O	in	_	0	SENT_64	[p4l418t3432r486b3496],
11	ten	CD	NUMBER	ten	num	15	SENT_64	[p4l509t3441r619b3497],
12	previously	RB	DATE	previously	advmod	13	SENT_64	[p4l641t3432r1025b3516],
13	reported	VBN	O	report	amod	15	SENT_64	[p4l1049t3432r1351b3516],
14	R20lH	NN	O	r20lh	nn	15	SENT_64	[p4l1375t3434r1637b3497],
15	carriers	NNS	O	carrier	prep_in	8	SENT_64	[p4l1664t3432r1928b3497],
16	(	VBP	O	(	_	0	SENT_64	[p4l1957t3433r2138b3515],
17	0.25	CD	NUMBER	0.25	dobj	16	SENT_64	[p4l1957t3433r2138b3515],
18	vs	CC	O	vs	_	0	SENT_64	[p4l7t3552r86b3596],
19	20.6	CD	NUMBER	20.6	num	20	SENT_64	[p4l117t3532r282b3602],
20	U/kg	NN	O	u/kg	conj_vs	17	SENT_64	[p4l312t3530r527b3614],
21	)	CD	NUMBER	)	num	22	SENT_64	[p4l312t3530r527b3614],
22	[	NN	O	[	dep	20	SENT_64	[p4l564t3532r654b3613],
23	3	CD	NUMBER	3	nsubj	16	SENT_64	[p4l564t3532r654b3613],
24	,	,	O	,	_	0	SENT_64	[p4l564t3532r654b3613],
25	4	CD	NUMBER	4	num	26	SENT_64	[p4l686t3532r780b3613],
26	]	NN	O	]	appos	23	SENT_64	[p4l686t3532r780b3613],
27	.	.	O	.	_	0	SENT_64	[p4l686t3532r780b3613],

1	In	IN	O	in	_	0	SENT_65	[p4l815t3533r890b3594],
2	keeping	VBG	O	keep	pcomp	1	SENT_65	[p4l917t3531r1213b3614],
3	with	IN	O	with	_	0	SENT_65	[p4l1242t3531r1407b3596],
4	this	DT	O	this	prep_with	2	SENT_65	[p4l1435t3531r1590b3609],
5	,	,	O	,	_	0	SENT_65	[p4l1435t3531r1590b3609],
6	both	DT	O	both	advmod	11	SENT_65	[p4l1622t3531r1788b3596],
7	his	PRP$	O	he	poss	11	SENT_65	[p4l1816t3530r1922b3596],
8	basal	JJ	O	basal	amod	11	SENT_65	[p4l1952t3530r2143b3596],
9	C-peptide	NN	MISC	c-peptide	nn	11	SENT_65	[p4l9t3628r375b3712],
10	concentration	NN	O	concentration	nn	11	SENT_65	[p4l407t3628r897b3693],
11	(	NN	O	(	conj_and	4	SENT_65	[p4l926t3629r1082b3711],
12	443	CD	NUMBER	443	dep	11	SENT_65	[p4l926t3629r1082b3711],
13	vs	CC	O	vs	_	0	SENT_65	[p4l1116t3650r1194b3693],
14	<	JJR	O	<	conj_vs	11	SENT_65	[p4l1223t3630r1362b3693],
15	20	CD	NUMBER	20	num	17	SENT_65	[p4l1223t3630r1362b3693],
16	pmol/l	NN	O	pmol/l	nn	17	SENT_65	[p4l1390t3628r1655b3712],
17	)	NN	O	)	dep	14	SENT_65	[p4l1390t3628r1655b3712],
18	and	CC	O	and	_	0	SENT_65	[p4l1686t3628r1815b3693],
19	his	PRP$	O	he	poss	21	SENT_65	[p4l1840t3628r1943b3693],
20	peak	JJ	O	peak	amod	21	SENT_65	[p4l1971t3628r2144b3712],
21	increase	NN	O	increase	prep_with	2	SENT_65	[p4l9t3727r301b3792],
22	in	IN	O	in	_	0	SENT_65	[p4l329t3727r397b3790],
23	insulin	NN	O	insulin	nn	24	SENT_65	[p4l423t3726r668b3792],
24	response	NN	O	response	prep_in	21	SENT_65	[p4l692t3748r1008b3810],
25	during	IN	O	during	_	0	SENT_65	[p4l1036t3726r1269b3810],
26	an	DT	O	a	det	27	SENT_65	[p4l1297t3748r1380b3791],
27	IVGTT	NN	O	ivgtt	prep_during	2	SENT_65	[p4l1406t3728r1674b3792],
28	before	IN	O	before	_	0	SENT_65	[p4l1699t3726r1929b3792],
29	treatment	NN	O	treatment	prep_before	27	SENT_65	[p4l1955t3735r2140b3792, p5l7t23r188b79],

1	with	IN	O	with	_	0	SENT_66	[p5l217t14r378b79],
2	sulphonylureas	NN	O	sulphonylurea	prep_with	20	SENT_66	[p5l412t14r956b98],
3	(	CD	NUMBER	(	number	4	SENT_66	[p5l992t14r1106b97],
4	70	CD	NUMBER	70	dep	2	SENT_66	[p5l992t14r1106b97],
5	vs	CC	O	vs	_	0	SENT_66	[p5l1139t36r1217b79],
6	<	JJR	O	<	amod	19	SENT_66	[p5l1250t16r1339b79],
7	3	CD	NUMBER	3	num	9	SENT_66	[p5l1250t16r1339b79],
8	pmol/1	NN	O	pmol/1	nn	9	SENT_66	[p5l1375t14r1639b98],
9	)	NN	O	)	nsubj	12	SENT_66	[p5l1375t14r1639b98],
10	were	VBD	O	be	cop	12	SENT_66	[p5l1672t35r1845b79],
11	considerably	RB	O	considerably	advmod	12	SENT_66	[p5l1879t14r2141b79, p5l9t112r232b196],
12	higher	JJR	O	higher	ccomp	6	SENT_66	[p5l256t112r490b196],
13	than	IN	O	than	_	0	SENT_66	[p5l512t112r668b177],
14	those	DT	O	those	prep_than	6	SENT_66	[p5l691t112r881b178],
15	in	IN	O	in	_	0	SENT_66	[p5l909t113r977b176],
16	the	DT	O	the	det	18	SENT_66	[p5l1000t112r1109b178],
17	other	JJ	O	other	amod	18	SENT_66	[p5l1137t113r1322b178],
18	R20lH	NN	O	r20lh	prep_in	14	SENT_66	[p5l1345t114r1607b177],
19	carriers	NNS	O	carrier	prep_with	20	SENT_66	[p5l1634t113r1897b178],
20	[	VBP	O	[	_	0	SENT_66	[p5l1931t114r2017b195],
21	3	CD	NUMBER	3	nsubj	20	SENT_66	[p5l1931t114r2017b195],
22	,	,	O	,	_	0	SENT_66	[p5l1931t114r2017b195],
23	4	CD	NUMBER	4	num	24	SENT_66	[p5l2046t114r2137b195],
24	]	NN	O	]	appos	21	SENT_66	[p5l2046t114r2137b195],
25	.	.	O	.	_	0	SENT_66	[p5l2046t114r2137b195],

1	These	DT	O	these	det	2	SENT_67	[p5l9t210r222b275],
2	results	NNS	O	result	nsubj	4	SENT_67	[p5l247t210r479b275],
3	are	VBP	O	be	cop	4	SENT_67	[p5l508t232r613b275],
4	consistent	JJ	O	consistent	_	0	SENT_67	[p5l641t210r1001b275],
5	with	IN	O	with	_	0	SENT_67	[p5l1024t210r1184b275],
6	our	PRP$	O	we	poss	7	SENT_67	[p5l1211t232r1331b275],
7	patient	NN	O	patient	prep_with	4	SENT_67	[p5l1351t210r1599b294],
8	having	VBG	O	have	dep	7	SENT_67	[p5l1623t210r1869b294],
9	greater	JJR	O	greater	amod	12	SENT_67	[p5l1895t219r2145b294],
10	endogenous	JJ	O	endogenous	amod	12	SENT_67	[p5l9t308r430b392],
11	beta	NN	O	beta	nn	12	SENT_67	[p5l452t308r602b374],
12	cell	NN	O	cell	nsubj	21	SENT_67	[p5l623t308r746b374],
13	function	NN	O	function	dep	21	SENT_67	[p5l770t309r1061b374],
14	than	IN	O	than	_	0	SENT_67	[p5l1082t308r1235b373],
15	others	NNS	O	other	prep_than	13	SENT_67	[p5l1257t308r1468b374],
16	with	IN	O	with	_	0	SENT_67	[p5l1491t308r1648b374],
17	the	DT	O	the	det	19	SENT_67	[p5l1669t308r1775b374],
18	same	JJ	O	same	amod	19	SENT_67	[p5l1801t330r1978b374],
19	mutation	NN	O	mutation	prep_with	15	SENT_67	[p5l2000t330r2141b374, p5l7t406r224b485],
20	,	,	O	,	_	0	SENT_67	[p5l2000t330r2141b374, p5l7t406r224b485],
21	supporting	VBG	O	support	xcomp	8	SENT_67	[p5l258t406r632b489],
22	the	DT	O	the	det	23	SENT_67	[p5l659t406r766b471],
23	presence	NN	O	presence	dobj	21	SENT_67	[p5l792t427r1101b489],
24	of	IN	O	of	_	0	SENT_67	[p5l1130t406r1213b471],
25	phenotypic	JJ	O	phenotypic	amod	26	SENT_67	[p5l1226t406r1621b489],
26	heterogeneity	NN	O	heterogeneity	prep_of	23	SENT_67	[p5l1648t406r2137b489],
27	.	.	O	.	_	0	SENT_67	[p5l1648t406r2137b489],

1	Its	PRP$	O	its	poss	2	SENT_68	[p5l8t507r93b570],
2	cause	NN	O	cause	nsubjpass	5	SENT_68	[p5l125t526r322b570],
3	is	VBZ	O	be	auxpass	5	SENT_68	[p5l353t505r408b570],
4	not	RB	O	not	neg	5	SENT_68	[p5l437t514r553b570],
5	known	VBN	O	know	_	0	SENT_68	[p5l580t504r847b584],
6	,	,	O	,	_	0	SENT_68	[p5l580t504r847b584],
7	but	CC	O	but	_	0	SENT_68	[p5l878t504r995b570],
8	it	PRP	O	it	nsubj	10	SENT_68	[p5l1023t505r1071b569],
9	could	MD	O	could	aux	10	SENT_68	[p5l1099t504r1299b570],
10	represent	VB	O	represent	conj_but	5	SENT_68	[p5l1325t513r1657b588],
11	polygenic	JJ	O	polygenic	amod	14	SENT_68	[p5l1682t504r2039b588],
12	or	CC	O	or	_	0	SENT_68	[p5l2071t526r2145b570],
13	environmental	JJ	O	environmental	amod	14	SENT_68	[p5l9t602r530b667],
14	factors	NNS	O	factor	dobj	10	SENT_68	[p5l553t602r812b667],
15	.	.	O	.	_	0	SENT_68	[p5l553t602r812b667],

1	These	DT	O	these	nsubj	3	SENT_69	[p5l840t602r1053b667],
2	might	MD	O	might	aux	3	SENT_69	[p5l1075t602r1287b685],
3	include	VB	O	include	_	0	SENT_69	[p5l1308t602r1571b667],
4	the	DT	O	the	det	6	SENT_69	[p5l1593t602r1702b667],
5	allele	NN	O	allele	nn	6	SENT_69	[p5l1726t602r1915b667],
6	status	NN	O	status	dobj	3	SENT_69	[p5l1941t611r2141b667],
7	at	IN	O	at	_	0	SENT_69	[p5l9t709r72b765],
8	other	JJ	O	other	amod	9	SENT_69	[p5l97t700r282b766],
9	KCNJ11	NN	O	kcnj11	prep_at	3	SENT_69	[p5l300t702r604b766],
10	polymorphic	JJ	O	polymorphic	amod	11	SENT_69	[p5l633t700r1096b784],
11	sites	NNS	O	site	tmod	3	SENT_69	[p5l1126t701r1300b779],
12	,	,	O	,	_	0	SENT_69	[p5l1126t701r1300b779],
13	since	IN	O	since	mark	21	SENT_69	[p5l1331t701r1532b779],
14	,	,	O	,	_	0	SENT_69	[p5l1331t701r1532b779],
15	surprisingly	RB	O	surprisingly	advmod	21	SENT_69	[p5l1563t700r2006b784],
16	,	,	O	,	_	0	SENT_69	[p5l1563t700r2006b784],
17	the	DT	O	the	det	18	SENT_69	[p5l2033t700r2142b766],
18	proband	NN	O	proband	nsubj	21	SENT_69	[p5l6t798r306b881],
19	was	VBD	O	be	cop	21	SENT_69	[p5l327t819r466b863],
20	a	DT	O	a	det	21	SENT_69	[p5l493t819r530b863],
21	homozygote	NN	O	homozygote	dep	11	SENT_69	[p5l552t798r1000b881],
22	for	IN	O	for	_	0	SENT_69	[p5l1026t798r1130b863],
23	the	DT	O	the	det	25	SENT_69	[p5l1150t798r1259b863],
24	K	NNP	O	K	nn	25	SENT_69	[p5l1283t801r1350b862],
25	allele	NN	O	allele	prep_for	21	SENT_69	[p5l1372t798r1562b863],
26	at	IN	O	at	_	0	SENT_69	[p5l1588t807r1651b863],
27	residue	NN	O	residue	prep_at	21	SENT_69	[p5l1672t798r1931b863],
28	23	CD	NUMBER	23	num	27	SENT_69	[p5l1956t800r2039b863],
29	of	IN	O	of	_	0	SENT_69	[p5l2071t798r2154b863],
30	the	DT	O	the	det	31	SENT_69	[p5l7t896r116b962],
31	protein	NN	O	protein	prep_of	27	SENT_69	[p5l139t897r415b980],
32	,	,	O	,	_	0	SENT_69	[p5l139t897r415b980],
33	which	WDT	O	which	nsubj	34	SENT_69	[p5l442t896r665b962],
34	predisposes	VBZ	O	predispose	rcmod	31	SENT_69	[p5l687t897r1109b980],
35	to	TO	O	to	_	0	SENT_69	[p5l1135t906r1202b962],
36	type	NN	O	type	amod	41	SENT_69	[p5l1227t905r1382b980],
37	2	CD	NUMBER	2	number	36	SENT_69	[p5l1408t898r1448b960],
38	diabetes	NN	O	diabetes	nn	41	SENT_69	[p5l1477t896r1769b962],
39	[	NN	O	[	nn	41	SENT_69	[p5l1801t898r1916b979],
40	7	CD	NUMBER	7	num	41	SENT_69	[p5l1801t898r1916b979],
41	]	NN	O	]	prep_to	34	SENT_69	[p5l1801t898r1916b979],
42	.	.	O	.	_	0	SENT_69	[p5l1801t898r1916b979],

1	Interestingly	RB	O	interestingly	advmod	14	SENT_70	[p5l1947t899r2141b962, p5l9t994r307b1077],
2	,	,	O	,	_	0	SENT_70	[p5l1947t899r2141b962, p5l9t994r307b1077],
3	the	DT	O	the	det	6	SENT_70	[p5l334t994r443b1059],
4	ﬁve	NN	O	ﬁve	nn	6	SENT_70	[p5l471t994r606b1059],
5	R20lH	NN	O	r20lh	nn	6	SENT_70	[p5l633t996r895b1059],
6	carriers	NNS	O	carrier	nsubj	14	SENT_70	[p5l922t994r1185b1059],
7	with	IN	O	with	_	0	SENT_70	[p5l1211t994r1372b1059],
8	the	DT	O	the	det	13	SENT_70	[p5l1396t994r1504b1059],
9	more	RBR	O	more	advmod	10	SENT_70	[p5l1530t1015r1713b1059],
10	severe	JJ	O	severe	amod	13	SENT_70	[p5l1743t1015r1968b1059],
11	beta	NN	O	beta	nn	13	SENT_70	[p5l1992t994r2144b1059],
12	cell	NN	O	cell	nn	13	SENT_70	[p5l9t1092r135b1157],
13	defect	NN	O	defect	prep_with	6	SENT_70	[p5l163t1092r381b1157],
14	carried	VBD	O	carry	_	0	SENT_70	[p5l407t1092r654b1157],
15	at	IN	O	at	quantmod	17	SENT_70	[p5l681t1101r744b1157],
16	least	JJS	O	least	mwe	15	SENT_70	[p5l769t1092r932b1157],
17	one	CD	NUMBER	one	num	18	SENT_70	[p5l958t1114r1085b1157],
18	E	NN	O	e	dobj	14	SENT_70	[p5l1112t1095r1164b1156],
19	variant	JJ	O	variant	amod	20	SENT_70	[p5l1189t1092r1441b1157],
20	[	NN	O	[	dep	18	SENT_70	[p5l1471t1094r1558b1174],
21	3	CD	NUMBER	3	num	20	SENT_70	[p5l1471t1094r1558b1174],
22	,	,	O	,	_	0	SENT_70	[p5l1471t1094r1558b1174],
23	and	CC	O	and	_	0	SENT_70	[p5l1589t1092r1718b1158],
24	E.	NNP	PERSON	E.	nn	25	SENT_70	[p5l1743t1095r1813b1157],
25	E.	NNP	PERSON	E.	conj_and	18	SENT_70	[p5l1845t1095r1940b1171],
26	,	,	PERSON	,	_	0	SENT_70	[p5l1845t1095r1940b1171],
27	S.	NNP	PERSON	S.	nn	28	SENT_70	[p5l1973t1094r2035b1158],
28	E.	NNP	PERSON	E.	conj_and	18	SENT_70	[p5l2066t1095r2137b1157],
29	and	CC	O	and	_	0	SENT_70	[p5l9t1190r139b1255],
30	A.	NNP	O	A.	nn	34	SENT_70	[p5l163t1191r245b1255],
31	H.	NNP	O	H.	nn	34	SENT_70	[p5l277t1193r359b1255],
32	unpublished	JJ	O	unpublished	amod	34	SENT_70	[p5l390t1190r836b1273],
33	data	NNS	O	datum	nn	34	SENT_70	[p5l863t1190r1057b1272],
34	]	NN	O	]	conj_and	18	SENT_70	[p5l863t1190r1057b1272],
35	.	.	O	.	_	0	SENT_70	[p5l863t1190r1057b1272],

1	Further	JJ	O	further	amod	2	SENT_71	[p5l1089t1190r1356b1255],
2	studies	NNS	O	study	nsubjpass	4	SENT_71	[p5l1383t1190r1628b1255],
3	are	VBP	O	be	auxpass	4	SENT_71	[p5l1659t1211r1764b1255],
4	needed	VBN	O	need	_	0	SENT_71	[p5l1791t1190r2048b1255],
5	to	TO	O	to	xcomp	4	SENT_71	[p5l2073t1199r2140b1255],

1	Insulin	NN	O	insulin	nn	3	SENT_72	[p5l442t1669r474b1806],
2	(	NN	O	(	nn	3	SENT_72	[p5l441t1504r483b1655],
3	pmol/l	NN	O	pmol/l	_	0	SENT_72	[p5l441t1504r483b1655],
4	)	CD	NUMBER	)	dep	3	SENT_72	[p5l441t1504r483b1655],

1	Time	NNP	O	Time	_	0	SENT_73	[p5l1032t2015r1131b2048],
2	(	CD	NUMBER	(	num	4	SENT_73	[p5l1146t2015r1248b2055],
3	min	NN	DURATION	min	nn	4	SENT_73	[p5l1146t2015r1248b2055],
4	)	NN	O	)	dep	1	SENT_73	[p5l1146t2015r1248b2055],

1	Fig	NN	O	fig	_	0	SENT_74	[p5l38t2102r97b2136],
2	.	.	O	.	_	0	SENT_74	[p5l38t2102r97b2136],

1	1	CD	NUMBER	1	_	0	SENT_75	[p5l115t2103r129b2128],
2	The	DT	O	the	det	4	SENT_75	[p5l156t2102r212b2129],
3	insulin	NN	O	insulin	nn	4	SENT_75	[p5l226t2102r325b2129],
4	response	NN	O	response	dep	1	SENT_75	[p5l337t2110r466b2136],
5	to	TO	O	to	_	0	SENT_75	[p5l479t2106r506b2129],
6	a	DT	O	a	det	7	SENT_75	[p5l520t2111r536b2128],
7	ﬁ	NN	O	ﬁ	prep_to	4	SENT_75	[p5l548t2102r699b2136],
8	'	''	O	'	_	0	SENT_75	[p5l548t2102r699b2136],
9	equently	RB	O	equently	advmod	10	SENT_75	[p5l548t2102r699b2136],
10	sampled	VBN	O	sample	partmod	1	SENT_75	[p5l713t2102r834b2136],
11	IVGTT	NNP	O	IVGTT	dobj	10	SENT_75	[p5l847t2102r956b2129],
12	in	IN	O	in	_	0	SENT_75	[p5l969t2102r996b2128],
13	the	DT	O	the	det	14	SENT_75	[p5l1009t2102r1053b2129],
14	Bagsvaerd	NNP	O	Bagsvaerd	prep_in	11	SENT_75	[p5l1101t2102r1265b2136],
15	,	,	O	,	_	0	SENT_75	[p5l1101t2102r1265b2136],
16	Denmark	NNP	LOCATION	Denmark	appos	14	SENT_75	[p5l1283t2102r1439b2136],
17	)	CD	NUMBER	)	num	16	SENT_75	[p5l1283t2102r1439b2136],
18	.	.	O	.	_	0	SENT_75	[p5l1283t2102r1439b2136],

1	Aﬁer	NNP	O	Aﬁer	nsubj	2	SENT_76	[p5l1458t2102r1536b2129],
2	taking	VBG	O	take	partmod	14	SENT_76	[p5l1551t2102r1643b2136],
3	baseline	NN	O	baseline	nn	4	SENT_76	[p5l1659t2102r1780b2129],
4	samples	NNS	O	sample	dobj	2	SENT_76	[p5l1798t2102r1923b2136],
5	,	,	O	,	_	0	SENT_76	[p5l1798t2102r1923b2136],
6	0.3	CD	NUMBER	0.3	num	7	SENT_76	[p5l1942t2102r1985b2129],
7	g/kg	NN	O	g/kg	nsubj	14	SENT_76	[p5l2005t2102r2069b2136],
8	of	IN	O	of	_	0	SENT_76	[p5l2087t2102r2121b2129],
9	R20lH	NN	O	r20lh	nn	11	SENT_76	[p5l38t2140r145b2166],
10	mutation	NN	O	mutation	nn	11	SENT_76	[p5l158t2139r289b2166],
11	carrier	NN	O	carrier	prep_of	7	SENT_76	[p5l303t2139r398b2166],
12	before	IN	O	before	_	0	SENT_76	[p5l410t2139r503b2166],
13	(	NN	O	(	prep_before	11	SENT_76	[p5l518t2139r606b2174],
14	ﬁlled	VBD	O	ﬁlled	_	0	SENT_76	[p5l518t2139r606b2174],
15	circles	NNS	O	circle	dobj	14	SENT_76	[p5l618t2139r721b2172],
16	,	,	O	,	_	0	SENT_76	[p5l618t2139r721b2172],
17	dotted	VBN	O	dot	amod	19	SENT_76	[p5l736t2139r829b2166],
18	line	NN	O	line	nn	19	SENT_76	[p5l842t2139r907b2174],
19	)	NN	O	)	dobj	14	SENT_76	[p5l842t2139r907b2174],
20	and	CC	O	and	_	0	SENT_76	[p5l921t2139r974b2166],
21	after	IN	O	after	mark	24	SENT_76	[p5l988t2139r1054b2166],
22	glucose	NN	O	glucose	nsubjpass	24	SENT_76	[p5l1102t2139r1213b2174],
23	was	VBD	O	be	auxpass	24	SENT_76	[p5l1224t2148r1281b2166],
24	given	VBN	O	give	dobj	14	SENT_76	[p5l1293t2139r1374b2174],
25	intravenously	RB	O	intravenously	advmod	24	SENT_76	[p5l1385t2139r1590b2174],
26	.	.	O	.	_	0	SENT_76	[p5l1385t2139r1590b2174],

1	Blood	NN	O	blood	nn	2	SENT_77	[p5l1603t2139r1694b2166],
2	samples	NNS	O	sample	nsubjpass	4	SENT_77	[p5l1705t2139r1822b2174],
3	were	VBD	O	be	auxpass	4	SENT_77	[p5l1833t2148r1904b2166],
4	obtained	VBN	O	obtain	_	0	SENT_77	[p5l1915t2139r2042b2166],
5	at	IN	O	at	_	0	SENT_77	[p5l2053t2143r2079b2166],
6	1	CD	NUMBER	1	prep_at	4	SENT_77	[p5l2093t2140r2115b2172],
7	,	,	O	,	_	0	SENT_77	[p5l2093t2140r2115b2172],
8	(	CD	NUMBER	(	num	10	SENT_77	[p5l39t2177r132b2211],
9	black	JJ	O	black	amod	10	SENT_77	[p5l39t2177r132b2211],
10	triangles	NNS	O	triangle	appos	6	SENT_77	[p5l141t2177r279b2212],
11	,	,	O	,	_	0	SENT_77	[p5l141t2177r279b2212],
12	solid	JJ	O	solid	amod	14	SENT_77	[p5l290t2177r364b2204],
13	line	NN	O	line	nn	14	SENT_77	[p5l373t2177r438b2212],
14	)	NN	O	)	dep	4	SENT_77	[p5l373t2177r438b2212],
15	3	CD	DURATION	3	num	16	SENT_77	[p5l450t2178r465b2204],
16	weeks	NNS	NUMBER	week	tmod	14	SENT_77	[p5l477t2177r568b2204],
17	of	IN	O	of	_	0	SENT_77	[p5l580t2177r614b2204],
18	5	CD	NUMBER	5	num	21	SENT_77	[p5l621t2178r636b2204],
19	mg	NN	O	mg	nn	21	SENT_77	[p5l648t2186r695b2212],
20	glipizide	NN	O	glipizide	nn	21	SENT_77	[p5l706t2177r833b2212],
21	GITS	NNS	O	git	prep_of	14	SENT_77	[p5l845t2178r924b2204],
22	therapy	NN	O	therapy	dep	14	SENT_77	[p5l936t2177r1051b2212],
23	.	.	O	.	_	0	SENT_77	[p5l936t2177r1051b2212],

1	2	CD	NUMBER	2	nsubjpass	18	SENT_78	[p5l1101t2178r1127b2210],
2	,	,	O	,	_	0	SENT_78	[p5l1101t2178r1127b2210],
3	3	CD	NUMBER	3	nsubjpass	18	SENT_78	[p5l1139t2178r1164b2210],
4	,	,	O	,	_	0	SENT_78	[p5l1139t2178r1164b2210],
5	5	CD	NUMBER	5	nsubjpass	18	SENT_78	[p5l1176t2178r1201b2210],
6	,	,	O	,	_	0	SENT_78	[p5l1176t2178r1201b2210],
7	6	CD	NUMBER	6	conj_and	1	SENT_78	[p5l1213t2178r1238b2210],
8	,	,	O	,	_	0	SENT_78	[p5l1213t2178r1238b2210],
9	8	CD	NUMBER	8	conj_and	1	SENT_78	[p5l1251t2178r1275b2210],
10	,	,	O	,	_	0	SENT_78	[p5l1251t2178r1275b2210],
11	and	CC	DURATION	and	_	0	SENT_78	[p5l1287t2177r1339b2204],
12	10	CD	DURATION	10	num	13	SENT_78	[p5l1353t2178r1384b2204],
13	min	NN	DURATION	min	conj_and	1	SENT_78	[p5l1395t2177r1452b2204],
14	and	CC	O	and	_	0	SENT_78	[p5l1462t2177r1515b2204],
15	plasma	NN	O	plasma	nn	16	SENT_78	[p5l1523t2177r1628b2212],
16	insulin	NN	O	insulin	conj_and	13	SENT_78	[p5l1638t2177r1738b2204],
17	was	VBD	O	be	auxpass	18	SENT_78	[p5l1747t2186r1803b2204],
18	assayed	VBN	O	assay	_	0	SENT_78	[p5l1815t2177r1935b2212],
19	.	.	O	.	_	0	SENT_78	[p5l1815t2177r1935b2212],

1	The	DT	O	the	det	2	SENT_79	[p5l1948t2177r2004b2204],
2	second	JJ	ORDINAL	second	_	0	SENT_79	[p5l2015t2177r2116b2204],
3	The	DT	O	the	det	5	SENT_79	[p5l39t2216r95b2243],
4	initial	JJ	O	initial	amod	5	SENT_79	[p5l106t2216r190b2242],
5	IVGTT	NN	O	ivgtt	nsubjpass	7	SENT_79	[p5l201t2216r310b2243],
6	was	VBD	O	be	auxpass	7	SENT_79	[p5l318t2225r375b2243],
7	performed	VBN	O	perform	rcmod	2	SENT_79	[p5l385t2216r539b2250],
8	24	CD	NUMBER	24	num	9	SENT_79	[p5l549t2216r585b2242],
9	h	NN	O	h	dobj	7	SENT_79	[p5l596t2216r614b2242],
10	aﬁer	IN	O	aﬁer	mark	14	SENT_79	[p5l625t2216r692b2243],
11	the	DT	O	the	det	12	SENT_79	[p5l701t2216r745b2243],
12	patient	NN	O	patient	nsubj	14	SENT_79	[p5l755t2216r856b2250],
13	had	VBD	O	have	aux	14	SENT_79	[p5l865t2216r919b2243],
14	received	VBN	O	receive	advcl	7	SENT_79	[p5l929t2216r1053b2243],
15	IVGTT	NNP	O	IVGTT	nn	16	SENT_79	[p5l1101t2216r1211b2243],
16	test	NN	O	test	nsubjpass	18	SENT_79	[p5l1221t2220r1272b2243],
17	was	VBD	O	be	auxpass	18	SENT_79	[p5l1281t2225r1337b2243],
18	performed	VBN	O	perform	ccomp	14	SENT_79	[p5l1347t2216r1501b2250],
19	according	VBG	O	accord	_	0	SENT_79	[p5l1512t2216r1656b2250],
20	to	TO	O	to	prepc_according_to	18	SENT_79	[p5l1666t2220r1693b2243],
21	the	DT	O	the	det	23	SENT_79	[p5l1704t2216r1748b2243],
22	same	JJ	O	same	amod	23	SENT_79	[p5l1759t2225r1833b2243],
23	protocol	NN	O	protocol	pobj	18	SENT_79	[p5l1842t2216r1966b2250],
24	24	CD	NUMBER	24	num	25	SENT_79	[p5l1976t2216r2012b2242],
25	h	NN	O	h	dep	2	SENT_79	[p5l2022t2216r2040b2242],
26	after	IN	O	after	mark	37	SENT_79	[p5l2051t2216r2117b2243],
27	his	PRP$	O	he	poss	30	SENT_79	[p5l38t2254r80b2281],
28	regular	JJ	O	regular	amod	30	SENT_79	[p5l96t2254r200b2288],
29	insulin	NN	O	insulin	nn	30	SENT_79	[p5l216t2254r315b2281],
30	dose	NN	O	dose	nsubj	37	SENT_79	[p5l331t2254r397b2281],
31	of	IN	O	of	_	0	SENT_79	[p5l414t2254r448b2281],
32	7	CD	NUMBER	7	num	33	SENT_79	[p5l460t2255r475b2281],
33	U	NN	O	u	prep_of	30	SENT_79	[p5l491t2255r518b2281],
34	of	IN	O	of	_	0	SENT_79	[p5l534t2254r568b2281],
35	Insulatard	NNP	ORGANIZATION	Insulatard	nn	36	SENT_79	[p5l579t2254r726b2281],
36	HM	NNS	ORGANIZATION	hm	prep_of	33	SENT_79	[p5l741t2255r800b2280],
37	(	VBP	O	(	dep	25	SENT_79	[p5l816t2254r909b2288],
38	Novo	NNP	ORGANIZATION	Novo	nn	39	SENT_79	[p5l816t2254r909b2288],
39	Nordisk	NNP	ORGANIZATION	Nordisk	nsubj	46	SENT_79	[p5l924t2254r1052b2286],
40	,	,	O	,	_	0	SENT_79	[p5l924t2254r1052b2286],
41	the	DT	O	the	det	43	SENT_79	[p5l1101t2254r1145b2281],
42	last	JJ	O	last	amod	43	SENT_79	[p5l1157t2254r1207b2281],
43	dose	NN	O	dose	appos	39	SENT_79	[p5l1218t2254r1284b2281],
44	of	IN	O	of	_	0	SENT_79	[p5l1296t2254r1330b2281],
45	sulphonylurea	NN	O	sulphonylurea	prep_of	43	SENT_79	[p5l1338t2254r1546b2288],
46	determine	VBP	O	determine	ccomp	37	SENT_79	[p5l9t2446r366b2511],
47	whether	IN	O	whether	_	0	SENT_79	[p5l392t2446r686b2511],
48	the	DT	O	the	det	49	SENT_79	[p5l707t2446r815b2511],
49	interaction	NN	O	interaction	prep_whether	46	SENT_79	[p5l843t2446r1227b2511],
50	between	IN	O	between	_	0	SENT_79	[p5l1250t2446r1553b2511],
51	the	DT	O	the	det	53	SENT_79	[p5l1576t2446r1685b2511],
52	R20lH	NN	O	r20lh	nn	53	SENT_79	[p5l1711t2448r1973b2511],
53	mutation	NN	O	mutation	prep_between	49	SENT_79	[p5l1998t2467r2141b2511, p5l7t2544r212b2609],

1	and	CC	O	and	dep	3	SENT_80	[p5l236t2544r366b2609],
2	the	DT	O	the	det	3	SENT_80	[p5l387t2544r495b2609],
3	variant	NN	O	variant	_	0	SENT_80	[p5l518t2544r770b2609],
4	at	IN	O	at	_	0	SENT_80	[p5l793t2553r856b2609],
5	residue	NN	O	residue	nn	7	SENT_80	[p5l876t2544r1135b2609],
6	23	CD	NUMBER	23	num	7	SENT_80	[p5l1160t2546r1243b2609],
7	inﬂuence	NN	O	inﬂuence	prep_at	3	SENT_80	[p5l1273t2544r1606b2609],
8	the	DT	O	the	det	9	SENT_80	[p5l1630t2544r1738b2609],
9	severity	NN	O	severity	dep	7	SENT_80	[p5l1765t2544r2047b2628],
10	of	IN	O	of	_	0	SENT_80	[p5l2071t2544r2154b2609],
11	beta	NN	O	beta	nn	13	SENT_80	[p5l6t2642r158b2707],
12	cell	NN	O	cell	nn	13	SENT_80	[p5l186t2642r311b2707],
13	dysfunction	NN	O	dysfunction	prep_of	3	SENT_80	[p5l340t2642r783b2725],
14	.	.	O	.	_	0	SENT_80	[p5l340t2642r783b2725],

1	In	IN	O	in	_	0	SENT_81	[p5l100t2743r174b2804],
2	summary	NN	O	summary	prep_in	6	SENT_81	[p5l220t2762r567b2824],
3	,	,	O	,	_	0	SENT_81	[p5l220t2762r567b2824],
4	we	PRP	O	we	nsubj	6	SENT_81	[p5l614t2762r717b2805],
5	have	VBP	O	have	aux	6	SENT_81	[p5l762t2740r932b2805],
6	described	VBN	O	describe	_	0	SENT_81	[p5l979t2740r1323b2805],
7	the	DT	O	the	det	10	SENT_81	[p5l1366t2740r1475b2805],
8	successful	JJ	O	successful	amod	10	SENT_81	[p5l1523t2740r1890b2805],
9	initial	JJ	O	initial	amod	10	SENT_81	[p5l1936t2740r2142b2805],
10	transfer	NN	O	transfer	dobj	6	SENT_81	[p5l7t2838r283b2903],
11	of	IN	O	of	_	0	SENT_81	[p5l309t2838r392b2903],
12	a	DT	O	a	det	13	SENT_81	[p5l410t2859r447b2903],
13	patient	NN	O	patient	prep_of	10	SENT_81	[p5l471t2838r718b2921],
14	with	IN	O	with	_	0	SENT_81	[p5l743t2838r903b2903],
15	Kir6	NN	O	kir6	nn	17	SENT_81	[p5l929t2838r1159b2903],
16	.2	NN	NUMBER	.2	nn	17	SENT_81	[p5l929t2838r1159b2903],
17	mutation	NN	O	mutation	prep_with	6	SENT_81	[p5l1188t2838r1510b2903],
18	from	IN	O	from	_	0	SENT_81	[p5l1539t2838r1712b2903],
19	insulin	NN	O	insulin	prep_from	17	SENT_81	[p5l1738t2838r1983b2903],
20	to	TO	O	to	_	0	SENT_81	[p5l2008t2847r2075b2903],
21	a	DT	O	a	det	23	SENT_81	[p5l2106t2859r2144b2903],
22	sustained-release	JJ	O	sustained-release	amod	23	SENT_81	[p5l10t2936r622b3001],
23	sulphonylurea	NN	O	sulphonylurea	prep_to	6	SENT_81	[p5l658t2936r1186b3020],
24	.	.	O	.	_	0	SENT_81	[p5l658t2936r1186b3020],

1	The	DT	O	the	det	4	SENT_82	[p5l1225t2936r1362b3001],
2	lowest	JJS	O	lowest	amod	4	SENT_82	[p5l1396t2936r1631b3001],
3	adult	JJ	O	adult	amod	4	SENT_82	[p5l1663t2936r1842b3001],
4	dose	NN	O	dose	nsubj	11	SENT_82	[p5l1874t2936r2036b3001],
5	of	IN	O	of	_	0	SENT_82	[p5l2071t2936r2154b3001],
6	glipizide	NN	O	glipizide	prep_of	4	SENT_82	[p5l9t3034r321b3117],
7	(	CD	NUMBER	(	num	6	SENT_82	[p5l352t3034r418b3117],
8	5	CD	NUMBER	5	num	10	SENT_82	[p5l352t3034r418b3117],
9	mg	NN	O	mg	nn	10	SENT_82	[p5l450t3034r592b3117],
10	)	NN	O	)	dep	6	SENT_82	[p5l450t3034r592b3117],
11	resulted	VBD	O	result	_	0	SENT_82	[p5l621t3034r907b3099],
12	in	IN	O	in	_	0	SENT_82	[p5l935t3034r1002b3098],
13	a	DT	O	a	det	18	SENT_82	[p5l1030t3055r1068b3099],
14	markedly	RB	O	markedly	amod	18	SENT_82	[p5l1093t3034r1435b3117],
15	increased	VBN	O	increase	dep	14	SENT_82	[p5l1463t3034r1802b3099],
16	acute	JJ	O	acute	acomp	15	SENT_82	[p5l1831t3043r2016b3099],
17	insulin	NN	O	insulin	nn	18	SENT_82	[p5l2046t3034r2141b3098, p5l10t3132r183b3197],
18	response	NN	O	response	prep_in	11	SENT_82	[p5l216t3154r532b3216],
19	to	TO	O	to	_	0	SENT_82	[p5l566t3141r634b3197],
20	an	DT	O	a	det	21	SENT_82	[p5l672t3154r755b3197],
21	IVGTT	NNP	O	IVGTT	prep_to	11	SENT_82	[p5l789t3134r1071b3211],
22	,	,	O	,	_	0	SENT_82	[p5l789t3134r1071b3211],
23	despite	IN	O	despite	_	0	SENT_82	[p5l1110t3132r1363b3216],
24	the	DT	O	the	det	25	SENT_82	[p5l1398t3132r1506b3197],
25	fact	NN	O	fact	prep_despite	11	SENT_82	[p5l1543t3132r1675b3197],
26	that	IN	O	that	complm	31	SENT_82	[p5l1708t3132r1843b3197],
27	the	DT	O	the	det	29	SENT_82	[p5l1875t3132r1984b3197],
28	last	JJ	O	last	amod	29	SENT_82	[p5l2021t3132r2144b3197],
29	dose	NN	O	dose	nsubjpass	31	SENT_82	[p5l9t3230r167b3295],
30	was	VBD	O	be	auxpass	31	SENT_82	[p5l189t3251r324b3295],
31	administered	VBN	O	administer	dep	25	SENT_82	[p5l349t3230r796b3295],
32	24	CD	NUMBER	24	num	33	SENT_82	[p5l817t3231r902b3294],
33	h	NN	O	h	dobj	31	SENT_82	[p5l926t3230r971b3294],
34	before	IN	O	before	_	0	SENT_82	[p5l990t3230r1211b3295],
35	the	DT	O	the	det	36	SENT_82	[p5l1233t3230r1339b3295],
36	investigation	NN	O	investigation	prep_before	31	SENT_82	[p5l1363t3230r1824b3313],
37	.	.	O	.	_	0	SENT_82	[p5l1363t3230r1824b3313],

1	The	DT	O	the	det	2	SENT_83	[p5l1853t3230r1986b3295],
2	heterogeneity	NN	O	heterogeneity	nsubj	13	SENT_83	[p5l2008t3230r2141b3295, p5l9t3328r374b3412],
3	of	IN	O	of	_	0	SENT_83	[p5l421t3328r505b3393],
4	beta	NN	O	beta	nn	6	SENT_83	[p5l539t3328r691b3393],
5	cell	NN	O	cell	nn	6	SENT_83	[p5l739t3328r866b3393],
6	function	NN	O	function	prep_of	2	SENT_83	[p5l915t3328r1215b3393],
7	in	IN	O	in	_	0	SENT_83	[p5l1263t3328r1331b3392],
8	association	NN	O	association	prep_in	6	SENT_83	[p5l1380t3328r1779b3393],
9	with	IN	O	with	_	0	SENT_83	[p5l1826t3328r1986b3393],
10	the	DT	O	the	det	12	SENT_83	[p5l2033t3328r2142b3393],
11	R20lH	NN	O	r20lh	nn	12	SENT_83	[p5l8t3427r270b3491],
12	mutation	NN	O	mutation	prep_with	8	SENT_83	[p5l303t3426r625b3491],
13	suggests	VBZ	O	suggest	_	0	SENT_83	[p5l660t3434r961b3509],
14	that	IN	O	that	complm	21	SENT_83	[p5l996t3426r1131b3490],
15	the	DT	O	the	det	16	SENT_83	[p5l1162t3426r1270b3491],
16	response	NN	O	response	nsubj	21	SENT_83	[p5l1303t3447r1619b3509],
17	to	TO	O	to	_	0	SENT_83	[p5l1652t3435r1720b3491],
18	sulphonylurea	NN	O	sulphonylurea	nn	19	SENT_83	[p5l1758t3426r2141b3509, p5l6t3546r163b3589],
19	treatment	NN	O	treatment	prep_to	16	SENT_83	[p5l188t3533r529b3589],
20	may	MD	O	may	aux	21	SENT_83	[p5l554t3546r710b3608],
21	vary	VB	O	vary	ccomp	13	SENT_83	[p5l736t3546r896b3608],
22	considerably	RB	O	considerably	advmod	21	SENT_83	[p5l925t3524r1385b3608],
23	between	IN	O	between	_	0	SENT_83	[p5l1411t3524r1714b3589],
24	individuals	NNS	O	individual	prep_between	21	SENT_83	[p5l1742t3524r2140b3589],
25	even	RB	O	even	advmod	28	SENT_83	[p5l9t3643r178b3687],
26	if	IN	O	if	dep	28	SENT_83	[p5l213t3622r275b3686],
27	they	PRP	O	they	nsubj	28	SENT_83	[p5l298t3622r453b3705],
28	have	VBP	O	have	ccomp	21	SENT_83	[p5l486t3622r656b3687],
29	the	DT	O	the	det	31	SENT_83	[p5l690t3622r799b3687],
30	same	JJ	O	same	amod	31	SENT_83	[p5l837t3643r1017b3687],
31	mutation	NN	O	mutation	dobj	28	SENT_83	[p5l1052t3622r1390b3687],
32	.	.	O	.	_	0	SENT_83	[p5l1052t3622r1390b3687],

1	Acknowledgements	NNP	O	Acknowledgements	nn	3	SENT_84	[p6l7t102r648b172],
2	T.	NNP	PERSON	T.	nn	3	SENT_84	[p6l723t102r777b156],
3	Klupa	NNP	PERSON	Klupa	nsubj	8	SENT_84	[p6l799t100r989b172],
4	and	CC	O	and	_	0	SENT_84	[p6l1007t100r1118b156],
5	E.	NNP	PERSON	E.	nn	7	SENT_84	[p6l1135t102r1195b156],
6	L.	NNP	PERSON	L.	nn	7	SENT_84	[p6l1217t102r1278b156],
7	Edghill	NNP	PERSON	Edghill	nsubj	8	SENT_84	[p6l1300t100r1527b172],
8	contributed	VBD	O	contribute	_	0	SENT_84	[p6l1547t100r1899b156],
9	equally	RB	O	equally	advmod	8	SENT_84	[p6l1917t100r2143b172],
10	to	TO	O	to	_	0	SENT_84	[p6l7t188r64b237],
11	this	DT	O	this	det	12	SENT_84	[p6l87t181r196b237],
12	work	NN	O	work	prep_to	8	SENT_84	[p6l217t181r391b237],
13	.	.	O	.	_	0	SENT_84	[p6l217t181r391b237],

1	We	PRP	O	we	nsubj	2	SENT_85	[p6l416t183r516b237],
2	thank	VBP	O	thank	_	0	SENT_85	[p6l537t181r710b236],
3	A.	NN	PERSON	a.	nn	4	SENT_85	[p6l729t182r799b237],
4	Gloyn	NNP	PERSON	Gloyn	nsubj	21	SENT_85	[p6l826t181r1019b253],
5	for	IN	O	for	_	0	SENT_85	[p6l1040t181r1129b237],
6	her	PRP$	O	she	poss	8	SENT_85	[p6l1147t181r1247b237],
7	considerable	JJ	O	considerable	amod	8	SENT_85	[p6l1267t181r1655b237],
8	assistance	NN	O	assistance	prep_for	4	SENT_85	[p6l1679t181r1985b237],
9	with	IN	O	with	_	0	SENT_85	[p6l2006t181r2143b237],
10	this	DT	O	this	det	11	SENT_85	[p6l7t262r116b318],
11	project	NN	O	project	prep_with	8	SENT_85	[p6l133t262r365b334],
12	,	,	O	,	_	0	SENT_85	[p6l133t262r365b334],
13	including	VBG	O	include	_	0	SENT_85	[p6l387t262r678b334],
14	setting	VBG	O	set	prepc_including	8	SENT_85	[p6l699t262r901b334],
15	up	RP	O	up	prt	14	SENT_85	[p6l918t280r994b334],
16	the	DT	O	the	det	17	SENT_85	[p6l1012t262r1105b318],
17	sequencing	NN	O	sequencing	dobj	14	SENT_85	[p6l1126t262r1473b334],
18	of	IN	O	of	_	0	SENT_85	[p6l1492t262r1563b318],
19	K	NNP	O	K	nn	20	SENT_85	[p6l1567t264r1627b317],
20	CNJI	NNP	O	CNJI	prep_of	17	SENT_85	[p6l1627t263r1794b318],
21	I	PRP	O	I	xcomp	2	SENT_85	[p6l1799t263r1828b317],
22	in	IN	O	in	dep	21	SENT_85	[p6l1852t262r1910b317],
23	Exeter	NNP	LOCATION	Exeter	pobj	22	SENT_85	[p6l1927t264r2138b318],
24	.	.	O	.	_	0	SENT_85	[p6l1927t264r2138b318],

1	M.	NNP	PERSON	M.	nn	3	SENT_86	[p6l7t345r90b399],
2	T.	NNP	PERSON	T.	nn	3	SENT_86	[p6l135t345r189b399],
3	Malecki	NNP	PERSON	Malecki	nsubjpass	5	SENT_86	[p6l233t343r486b399],
4	is	VBZ	O	be	auxpass	5	SENT_86	[p6l527t343r574b399],
5	supported	VBN	O	support	_	0	SENT_86	[p6l617t343r921b415],
6	by	IN	O	by	_	0	SENT_86	[p6l958t343r1037b415],
7	the	DT	O	the	det	16	SENT_86	[p6l1075t343r1168b399],
8	National	NNP	ORGANIZATION	National	dep	16	SENT_86	[p6l1206t343r1474b399],
9	Institutes	NNPS	ORGANIZATION	Institutes	dep	8	SENT_86	[p6l1514t343r1794b399],
10	of	IN	ORGANIZATION	of	_	0	SENT_86	[p6l1837t343r1908b399],
11	Health	NNP	ORGANIZATION	Health	nn	15	SENT_86	[p6l1937t343r2143b399],
12	Fogarty	NNP	ORGANIZATION	Fogarty	nn	15	SENT_86	[p6l7t426r249b496],
13	International	NNP	ORGANIZATION	International	nn	15	SENT_86	[p6l264t424r657b480],
14	Research	NNP	ORGANIZATION	Research	nn	15	SENT_86	[p6l674t424r957b480],
15	Collaboration	NNP	ORGANIZATION	Collaboration	prep_of	8	SENT_86	[p6l974t424r1399b480],
16	Award	NN	ORGANIZATION	award	agent	5	SENT_86	[p6l1413t424r1618b480],
17	(	CD	NUMBER	(	num	23	SENT_86	[p6l1635t424r1834b496],
18	Grant	NNP	O	Grant	nn	23	SENT_86	[p6l1635t424r1834b496],
19	no.	NNP	O	no.	nn	23	SENT_86	[p6l1848t442r1941b480],
20	1	CD	NUMBER	1	num	23	SENT_86	[p6l1969t425r1990b479],
21	R03	NN	O	r03	nn	23	SENT_86	[p6l2013t425r2137b480],
22	TW01351-01	NN	O	tw01351-01	nn	23	SENT_86	[p6l9t505r444b576],
23	)	NN	O	)	tmod	16	SENT_86	[p6l9t505r444b576],
24	and	CC	O	and	_	0	SENT_86	[p6l465t505r575b561],
25	the	DT	O	the	det	37	SENT_86	[p6l591t505r683b561],
26	J	NN	O	j	dep	27	SENT_86	[p6l703t507r732b561],
27	agiellonian	JJ	O	agiellonian	amod	37	SENT_86	[p6l734t505r1068b577],
28	University	NNP	O	University	nn	37	SENT_86	[p6l1085t505r1407b577],
29	(	NNP	O	(	nn	37	SENT_86	[p6l1427t505r1697b576],
30	Medical	NNP	O	Medical	nn	37	SENT_86	[p6l1427t505r1697b576],
31	College	NNP	O	College	nn	37	SENT_86	[p6l1718t505r1951b577],
32	Grant	NNP	O	Grant	nn	37	SENT_86	[p6l1972t506r2144b561],
33	no.	NNP	O	no.	nn	37	SENT_86	[p6l7t604r98b642],
34	501/KL/439	NNP	O	501/KL/439	nn	37	SENT_86	[p6l122t586r599b657],
35	/	:	O	/	punct	36	SENT_86	[p6l122t586r599b657],
36	L	NN	O	l	dep	37	SENT_86	[p6l122t586r599b657],
37	)	NN	O	)	conj_and	23	SENT_86	[p6l122t586r599b657],
38	.	.	O	.	_	0	SENT_86	[p6l122t586r599b657],

1	E.	NNP	PERSON	E.	nn	3	SENT_87	[p6l620t588r681b642],
2	L.	NNP	PERSON	L.	nn	3	SENT_87	[p6l702t588r762b642],
3	Edghill	NNP	PERSON	Edghill	nsubjpass	9	SENT_87	[p6l783t586r1007b658],
4	and	CC	O	and	_	0	SENT_87	[p6l1024t586r1134b642],
5	A.	NNP	PERSON	A.	nn	7	SENT_87	[p6l1149t587r1219b642],
6	T.	NNP	PERSON	T.	nn	7	SENT_87	[p6l1241t588r1294b642],
7	Hattersley	NNP	PERSON	Hattersley	nsubjpass	9	SENT_87	[p6l1316t586r1626b658],
8	are	VBP	O	be	auxpass	9	SENT_87	[p6l1644t604r1732b642],
9	supported	VBN	O	support	_	0	SENT_87	[p6l1752t586r2051b658],
10	by	IN	O	by	_	0	SENT_87	[p6l2065t586r2144b658],
11	the	DT	O	the	det	13	SENT_87	[p6l7t667r98b723],
12	Wellcome	NNP	O	Wellcome	nn	13	SENT_87	[p6l129t667r434b724],
13	Trust	NNP	O	Trust	agent	9	SENT_87	[p6l466t670r636b723],
14	.	.	O	.	_	0	SENT_87	[p6l466t670r636b723],

1	A.	NN	PERSON	a.	nn	3	SENT_88	[p6l669t668r739b723],
2	T.	NNP	PERSON	T.	nn	3	SENT_88	[p6l775t670r828b723],
3	Hattersley	NNP	PERSON	Hattersley	nsubj	4	SENT_88	[p6l862t667r1172b739],
4	is	VBZ	O	be	_	0	SENT_88	[p6l1203t667r1250b723],
5	a	DT	O	a	det	8	SENT_88	[p6l1282t686r1314b723],
6	Wellcome	NNP	ORGANIZATION	Wellcome	nn	8	SENT_88	[p6l1343t667r1649b724],
7	Trust	NNP	ORGANIZATION	Trust	nn	8	SENT_88	[p6l1680t670r1837b723],
8	Research	NNP	ORGANIZATION	Research	nsubj	9	SENT_88	[p6l1865t667r2144b723],
9	Leave	VB	O	leave	ccomp	4	SENT_88	[p6l8t750r192b803],
10	Fellow	NNP	O	Fellow	dobj	9	SENT_88	[p6l214t747r435b803],
11	.	.	O	.	_	0	SENT_88	[p6l214t747r435b803],

1	References	NNS	O	reference	_	0	SENT_89	[p6l11t1017r436b1088],

1	1	LS	NUMBER	1	_	0	SENT_90	[p6l81t1213r126b1268],
2	.	.	O	.	_	0	SENT_90	[p6l81t1213r126b1268],

1	Polak	NNP	PERSON	Polak	nn	2	SENT_91	[p6l157t1212r335b1268],
2	M	NNP	O	M	nsubj	6	SENT_91	[p6l368t1214r453b1280],
3	,	,	O	,	_	0	SENT_91	[p6l368t1214r453b1280],
4	Shield	NNP	O	Shield	nn	5	SENT_91	[p6l494t1212r690b1268],
5	J	NNP	O	J	appos	2	SENT_91	[p6l724t1214r753b1268],
6	(	VBD	O	(	_	0	SENT_91	[p6l789t1212r992b1284],
7	2004	CD	DATE	2004	dobj	6	SENT_91	[p6l789t1212r992b1284],
8	)	CD	NUMBER	)	number	9	SENT_91	[p6l789t1212r992b1284],
9	Neonatal	JJ	O	neonatal	dep	7	SENT_91	[p6l1026t1212r1309b1268],
10	and	CC	O	and	_	0	SENT_91	[p6l1345t1212r1456b1268],
11	very-early-onset	JJ	O	very-early-onset	amod	12	SENT_91	[p6l1489t1212r1999b1284],
12	diabetes	NN	O	diabetes	dep	7	SENT_91	[p6l2035t1212r2151b1268, p6l156t1291r314b1348],

1	mellitus	NN	O	mellitus	_	0	SENT_92	[p6l343t1291r607b1348],
2	.	.	O	.	_	0	SENT_92	[p6l343t1291r607b1348],

1	Semin	NNP	O	Semin	nn	2	SENT_93	[p6l645t1291r840b1348],
2	Neonatol	NNP	O	Neonatol	_	0	SENT_93	[p6l865t1291r1152b1348],
3	9:59	CD	TIME	9:59	num	4	SENT_93	[p6l1182t1293r1433b1348],
4	-65	CD	NUMBER	-65	dep	2	SENT_93	[p6l1182t1293r1433b1348],

1	2	LS	NUMBER	2	_	0	SENT_94	[p6l73t1373r126b1428],
2	.	.	O	.	_	0	SENT_94	[p6l73t1373r126b1428],

1	Hattersley	NNP	PERSON	Hattersley	dep	7	SENT_95	[p6l157t1371r475b1444],
2	AT	IN	O	at	_	0	SENT_95	[p6l515t1373r610b1427],
3	(	CD	NUMBER	(	num	4	SENT_95	[p6l654t1372r857b1443],
4	1998	CD	DATE	1998	prep_at	1	SENT_95	[p6l654t1372r857b1443],
5	)	CD	NUMBER	)	dep	7	SENT_95	[p6l654t1372r857b1443],
6	Maturity-onset	JJ	O	maturity-onset	amod	7	SENT_95	[p6l899t1371r1362b1444],
7	diabetes	NN	O	diabetes	dep	13	SENT_95	[p6l1404t1371r1654b1428],
8	of	IN	O	of	_	0	SENT_95	[p6l1698t1371r1770b1428],
9	the	DT	O	the	det	10	SENT_95	[p6l1801t1371r1894b1428],
10	young	JJ	O	young	prep_of	7	SENT_95	[p6l1934t1390r2147b1444],
11	:	:	O	:	_	0	SENT_95	[p6l1934t1390r2147b1444],
12	clinical	JJ	O	clinical	amod	13	SENT_95	[p6l159t1453r384b1509],
13	heterogeneity	NN	O	heterogeneity	_	0	SENT_95	[p6l400t1453r824b1525],
14	explained	VBN	O	explain	partmod	13	SENT_95	[p6l841t1453r1143b1525],
15	by	IN	O	by	_	0	SENT_95	[p6l1157t1453r1236b1525],
16	genetic	JJ	O	genetic	amod	17	SENT_95	[p6l1253t1453r1474b1525],
17	heterogeneity	NN	O	heterogeneity	agent	14	SENT_95	[p6l1491t1453r1925b1525],
18	.	.	O	.	_	0	SENT_95	[p6l1491t1453r1925b1525],

1	Diabet	NNP	O	Diabet	nn	2	SENT_96	[p6l1946t1453r2153b1509],
2	Med	NNP	O	Med	_	0	SENT_96	[p6l157t1533r300b1589],
3	15:15	CD	TIME	15:15	num	4	SENT_96	[p6l331t1534r617b1589],
4	-24	CD	NUMBER	-24	dep	2	SENT_96	[p6l331t1534r617b1589],

1	3	LS	NUMBER	3	_	0	SENT_97	[p6l75t1614r126b1669],
2	.	.	O	.	_	0	SENT_97	[p6l75t1614r126b1669],

1	Gloyn	NNP	ORGANIZATION	Gloyn	nn	2	SENT_98	[p6l159t1612r353b1685],
2	AL	NNP	ORGANIZATION	AL	_	0	SENT_98	[p6l390t1614r511b1681],
3	,	,	O	,	_	0	SENT_98	[p6l390t1614r511b1681],
4	Pearson	NNP	ORGANIZATION	Pearson	nn	5	SENT_98	[p6l553t1615r800b1669],
5	ER	NN	ORGANIZATION	er	appos	2	SENT_98	[p6l839t1615r954b1681],
6	,	,	O	,	_	0	SENT_98	[p6l839t1615r954b1681],
7	Antcliff	NNP	O	Antcliff	nn	8	SENT_98	[p6l996t1612r1249b1669],
8	JF	NNP	O	JF	appos	2	SENT_98	[p6l1279t1615r1349b1669],
9	et	FW	O	et	dep	8	SENT_98	[p6l1392t1620r1446b1669],
10	al	FW	O	al	nn	13	SENT_98	[p6l1486t1612r1538b1668],
11	(	FW	O	(	dep	13	SENT_98	[p6l1579t1613r1783b1684],
12	2004	CD	DATE	2004	num	13	SENT_98	[p6l1579t1613r1783b1684],
13	)	CD	NUMBER	)	advmod	14	SENT_98	[p6l1579t1613r1783b1684],
14	Activating	VBG	O	activate	partmod	2	SENT_98	[p6l1823t1612r2151b1685],
15	mutations	NNS	O	mutation	dobj	14	SENT_98	[p6l157t1692r462b1749],
16	in	IN	O	in	_	0	SENT_98	[p6l498t1692r557b1748],
17	the	DT	O	the	det	18	SENT_98	[p6l588t1692r682b1749],
18	gene	NN	O	gene	prep_in	15	SENT_98	[p6l717t1711r861b1765],
19	encoding	VBG	O	encode	partmod	18	SENT_98	[p6l897t1692r1181b1765],
20	the	DT	O	the	det	25	SENT_98	[p6l1214t1692r1307b1749],
21	ATP-sensitive	JJ	O	atp-sensitive	amod	25	SENT_98	[p6l1340t1692r1777b1749],
22	potassiumchannel	NN	O	potassiumchannel	nn	25	SENT_98	[p6l1809t1692r2151b1765, p6l159t1774r399b1830],
23	subunit	NN	O	subunit	nn	25	SENT_98	[p6l420t1774r648b1830],
24	Kir6	NN	O	kir6	nn	25	SENT_98	[p6l664t1774r862b1830],
25	.2	NN	NUMBER	.2	dobj	19	SENT_98	[p6l664t1774r862b1830],
26	and	CC	O	and	_	0	SENT_98	[p6l885t1774r996b1830],
27	permanent	JJ	O	permanent	amod	29	SENT_98	[p6l1012t1782r1342b1846],
28	neonatal	JJ	O	neonatal	amod	29	SENT_98	[p6l1359t1774r1623b1830],
29	diabetes	NN	O	diabetes	dobj	19	SENT_98	[p6l1642t1774r1909b1830],
30	.	.	O	.	_	0	SENT_98	[p6l1642t1774r1909b1830],

1	N	NN	O	n	nn	3	SENT_99	[p6l1930t1776r1988b1830],
2	Engl	NNP	O	Engl	nn	3	SENT_99	[p6l2006t1774r2152b1846],
3	J	NNP	O	J	nsubj	4	SENT_99	[p6l158t1856r187b1910],
4	Med	VBD	O	med	_	0	SENT_99	[p6l209t1854r353b1910],
5	35021838-1849	CD	NUMBER	35021838-1849	dobj	4	SENT_99	[p6l377t1855r865b1910],

1	4	LS	NUMBER	4	_	0	SENT_100	[p6l73t1936r126b1991],
2	.	.	O	.	_	0	SENT_100	[p6l73t1936r126b1991],

1	Sagen	NNP	PERSON	Sagen	nn	2	SENT_101	[p6l161t1936r348b2007],
2	JV	NNP	O	JV	_	0	SENT_101	[p6l368t1937r460b2003],
3	,	,	O	,	_	0	SENT_101	[p6l368t1937r460b2003],
4	Raeder	NNP	PERSON	Raeder	nn	5	SENT_101	[p6l484t1935r706b1991],
5	H	NNP	O	H	appos	2	SENT_101	[p6l724t1937r796b2003],
6	,	,	O	,	_	0	SENT_101	[p6l724t1937r796b2003],
7	Hathout	NNP	PERSON	Hathout	nn	8	SENT_101	[p6l820t1935r1072b1991],
8	E	NNP	O	E	appos	2	SENT_101	[p6l1092t1937r1137b1990],
9	et	FW	O	et	nn	11	SENT_101	[p6l1160t1942r1214b1991],
10	al	FW	O	al	nn	11	SENT_101	[p6l1235t1935r1288b1990],
11	(	FW	O	(	rcmod	8	SENT_101	[p6l1310t1935r1514b2006],
12	2004	CD	DATE	2004	dobj	11	SENT_101	[p6l1310t1935r1514b2006],
13	)	CD	NUMBER	)	num	16	SENT_101	[p6l1310t1935r1514b2006],
14	Permanent	JJ	O	permanent	amod	16	SENT_101	[p6l1536t1937r1869b1991],
15	neonatal	JJ	O	neonatal	amod	16	SENT_101	[p6l1889t1935r2152b1991],
16	diabetes	NNS	O	diabetes	dep	12	SENT_101	[p6l159t2016r410b2072],
17	due	JJ	O	due	_	0	SENT_101	[p6l440t2016r550b2072],
18	to	TO	O	to	_	0	SENT_101	[p6l578t2023r636b2072],
19	mutations	NNS	O	mutation	prep_due_to	11	SENT_101	[p6l665t2016r970b2072],
20	in	IN	O	in	_	0	SENT_101	[p6l1001t2016r1059b2071],
21	KCNJII	NNP	O	KCNJII	prep_in	19	SENT_101	[p6l1084t2017r1345b2072],
22	encoding	VBG	O	encode	partmod	8	SENT_101	[p6l1380t2016r1664b2088],
23	Kir6	NN	O	kir6	nn	24	SENT_101	[p6l1692t2016r1909b2072],
24	.2	NN	NUMBER	.2	dobj	22	SENT_101	[p6l1692t2016r1909b2072],
25	:	:	O	:	_	0	SENT_101	[p6l1692t2016r1909b2072],
26	patient	NN	O	patient	nn	27	SENT_101	[p6l1940t2016r2153b2088],
27	characteristics	NNS	O	characteristic	tmod	2	SENT_101	[p6l159t2097r597b2153],
28	and	CC	O	and	_	0	SENT_101	[p6l623t2097r735b2153],
29	initial	JJ	O	initial	amod	30	SENT_101	[p6l758t2097r935b2153],
30	response	NN	O	response	conj_and	27	SENT_101	[p6l957t2115r1229b2169],
31	to	TO	O	to	_	0	SENT_101	[p6l1252t2105r1310b2153],
32	sulfonylurea	NN	O	sulfonylurea	nn	33	SENT_101	[p6l1337t2097r1724b2169],
33	therapy	NN	O	therapy	prep_to	30	SENT_101	[p6l1745t2097r1988b2169],
34	.	.	O	.	_	0	SENT_101	[p6l1745t2097r1988b2169],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_102	[p6l2016t2097r2151b2153, p6l156t2177r314b2233],
2	5322713-2718	CD	NUMBER	5322713-2718	dep	1	SENT_102	[p6l342t2178r789b2233],

1	5	CD	NUMBER	5	_	0	SENT_103	[p6l75t2260r126b2314],
2	.	.	O	.	_	0	SENT_103	[p6l75t2260r126b2314],

1	Berelowitz	NNP	PERSON	Berelowitz	nn	2	SENT_104	[p6l157t2258r497b2314],
2	M	NN	O	m	nsubj	19	SENT_104	[p6l535t2260r619b2326],
3	,	,	O	,	_	0	SENT_104	[p6l535t2260r619b2326],
4	Fischette	NN	O	fischette	nn	5	SENT_104	[p6l659t2258r938b2314],
5	C	NN	O	c	appos	2	SENT_104	[p6l978t2259r1044b2326],
6	,	,	O	,	_	0	SENT_104	[p6l978t2259r1044b2326],
7	Cefalu	NNP	PERSON	Cefalu	nn	8	SENT_104	[p6l1085t2258r1291b2314],
8	W	NNP	O	W	appos	2	SENT_104	[p6l1327t2260r1409b2326],
9	,	,	O	,	_	0	SENT_104	[p6l1327t2260r1409b2326],
10	Schade	NNP	PERSON	Schade	nn	11	SENT_104	[p6l1453t2258r1673b2314],
11	DS	NN	O	d	appos	2	SENT_104	[p6l1711t2259r1826b2326],
12	,	,	O	,	_	0	SENT_104	[p6l1711t2259r1826b2326],
13	Sutﬁn	NN	ORGANIZATION	sutﬁn	nn	14	SENT_104	[p6l1870t2258r2056b2314],
14	T	NN	ORGANIZATION	t	appos	2	SENT_104	[p6l2093t2260r2149b2326],
15	,	,	O	,	_	0	SENT_104	[p6l2093t2260r2149b2326],
16	Kourides	NNPS	ORGANIZATION	Kourides	nn	17	SENT_104	[p6l157t2339r427b2395],
17	IA	NNP	ORGANIZATION	IA	appos	2	SENT_104	[p6l442t2340r521b2394],
18	(	CD	NUMBER	(	num	19	SENT_104	[p6l536t2339r729b2410],
19	1994	CD	DATE	1994	_	0	SENT_104	[p6l536t2339r729b2410],
20	)	NNP	O	)	nn	22	SENT_104	[p6l536t2339r729b2410],
21	Comparative	JJ	O	comparative	amod	22	SENT_104	[p6l746t2339r1125b2411],
22	eﬁcacy	NN	O	eﬁcacy	dobj	19	SENT_104	[p6l1142t2339r1374b2411],
23	of	IN	O	of	_	0	SENT_104	[p6l1389t2339r1458b2395],
24	a	DT	O	a	det	27	SENT_104	[p6l1464t2357r1496b2394],
25	once-daily	JJ	O	once-daily	amod	27	SENT_104	[p6l1510t2339r1819b2411],
26	controlledrelease	NN	O	controlledrelease	nn	27	SENT_104	[p6l1834t2339r2151b2395, p6l157t2420r370b2476],
27	formulation	NN	O	formulation	prep_of	22	SENT_104	[p6l394t2420r760b2476],
28	of	IN	O	of	_	0	SENT_104	[p6l782t2420r854b2476],
29	glipizide	NN	O	glipizide	nn	32	SENT_104	[p6l866t2420r1135b2492],
30	and	CC	O	and	_	0	SENT_104	[p6l1160t2420r1271b2476],
31	immediate-release	NN	O	immediate-release	nn	32	SENT_104	[p6l1293t2420r1858b2476],
32	glipizide	NN	O	glipizide	prep_of	27	SENT_104	[p6l1882t2420r2151b2492],
33	in	IN	O	in	_	0	SENT_104	[p6l158t2501r217b2556],
34	patients	NNS	O	patient	prep_in	19	SENT_104	[p6l238t2501r479b2573],
35	with	IN	O	with	_	0	SENT_104	[p6l502t2501r641b2557],
36	NIDDM	NN	ORGANIZATION	niddm	prep_with	34	SENT_104	[p6l661t2504r942b2557],
37	.	.	O	.	_	0	SENT_104	[p6l661t2504r942b2557],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_105	[p6l970t2501r1240b2557],
2	Care	NNP	O	Care	_	0	SENT_105	[p6l1266t2502r1409b2558],
3	17	CD	NUMBER	17	num	2	SENT_105	[p6l1442t2503r1527b2557],
4	:	:	O	:	_	0	SENT_105	[p6l1442t2503r1527b2557],
5	1460-1464	CD	DATE	1460-1464	dep	2	SENT_105	[p6l1542t2503r1885b2557],

1	6	CD	NUMBER	6	_	0	SENT_106	[p6l75t2583r126b2638],
2	.	.	O	.	_	0	SENT_106	[p6l75t2583r126b2638],

1	Edghill	NNP	PERSON	Edghill	nn	2	SENT_107	[p6l158t2582r375b2654],
2	EL	NNP	O	EL	nsubj	35	SENT_107	[p6l398t2584r505b2650],
3	,	,	O	,	_	0	SENT_107	[p6l398t2584r505b2650],
4	Gloyn	NNP	ORGANIZATION	Gloyn	nn	5	SENT_107	[p6l532t2582r719b2654],
5	AG	NNP	ORGANIZATION	AG	appos	2	SENT_107	[p6l740t2583r866b2650],
6	,	,	O	,	_	0	SENT_107	[p6l740t2583r866b2650],
7	Gillespie	NNP	PERSON	Gillespie	nn	8	SENT_107	[p6l893t2582r1157b2654],
8	KM	NNP	O	KM	appos	2	SENT_107	[p6l1180t2584r1303b2637],
9	et	FW	O	et	dep	8	SENT_107	[p6l1327t2589r1380b2638],
10	al	FW	O	al	nn	13	SENT_107	[p6l1403t2582r1453b2637],
11	(	FW	O	(	dep	13	SENT_107	[p6l1478t2582r1673b2653],
12	2004	CD	DATE	2004	num	13	SENT_107	[p6l1478t2582r1673b2653],
13	)	CD	NUMBER	)	advmod	14	SENT_107	[p6l1478t2582r1673b2653],
14	Activating	VBG	O	activate	partmod	2	SENT_107	[p6l1696t2582r2008b2654],
15	mutations	NNS	O	mutation	dobj	14	SENT_107	[p6l2031t2600r2151b2638, p6l157t2663r352b2719],
16	in	IN	O	in	_	0	SENT_107	[p6l378t2663r436b2718],
17	the	DT	O	the	det	19	SENT_107	[p6l460t2663r553b2719],
18	KCNJ11	NN	O	kcnj11	nn	19	SENT_107	[p6l577t2664r838b2719],
19	gene	NN	O	gene	prep_in	15	SENT_107	[p6l870t2681r1014b2735],
20	encoding	VBG	O	encode	xcomp	14	SENT_107	[p6l1042t2663r1326b2735],
21	the	DT	O	the	det	24	SENT_107	[p6l1351t2663r1444b2719],
22	KATP	NN	O	katp	nn	24	SENT_107	[p6l1470t2665r1630b2731],
23	channel	NN	O	channel	nn	24	SENT_107	[p6l1657t2663r1897b2719],
24	subunit	NN	O	subunit	dobj	20	SENT_107	[p6l1926t2663r2153b2719],
25	Kir6	NN	O	kir6	nn	26	SENT_107	[p6l157t2744r347b2800],
26	.2	NN	NUMBER	.2	nsubj	28	SENT_107	[p6l157t2744r347b2800],
27	are	VBP	O	be	cop	28	SENT_107	[p6l373t2763r460b2800],
28	rare	JJ	O	rare	rcmod	24	SENT_107	[p6l482t2763r596b2800],
29	in	IN	O	in	_	0	SENT_107	[p6l620t2744r676b2799],
30	clinically	RB	O	clinically	advmod	31	SENT_107	[p6l699t2744r971b2816],
31	deﬁned	JJ	O	deﬁned	amod	34	SENT_107	[p6l994t2744r1217b2800],
32	Type	NN	O	type	nn	34	SENT_107	[p6l1238t2747r1386b2816],
33	1	CD	NUMBER	1	num	34	SENT_107	[p6l1417t2746r1438b2799],
34	diabetes	NN	O	diabetes	prep_in	28	SENT_107	[p6l1469t2744r1709b2800],
35	diagnosed	VBD	O	diagnose	_	0	SENT_107	[p6l1734t2744r2037b2816],
36	before	IN	O	before	_	0	SENT_107	[p6l2057t2744r2151b2800, p6l159t2825r275b2881],
37	2	CD	DURATION	2	num	38	SENT_107	[p6l297t2827r332b2880],
38	years	NNS	NUMBER	year	prep_before	35	SENT_107	[p6l357t2844r536b2897],
39	.	.	O	.	_	0	SENT_107	[p6l357t2844r536b2897],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_108	[p6l563t2825r832b2881],
2	53:2998	CD	DURATION	53:2998	num	3	SENT_108	[p6l860t2827r1303b2881],
3	-3001	CD	DURATION	-3001	dep	1	SENT_108	[p6l860t2827r1303b2881],

1	7	CD	NUMBER	7	_	0	SENT_109	[p6l75t2908r126b2962],
2	.	.	O	.	_	0	SENT_109	[p6l75t2908r126b2962],

1	Gloyn	NNP	ORGANIZATION	Gloyn	nn	2	SENT_110	[p6l159t2906r353b2978],
2	AL	NNP	ORGANIZATION	AL	nsubj	33	SENT_110	[p6l385t2907r506b2974],
3	,	,	O	,	_	0	SENT_110	[p6l385t2907r506b2974],
4	Weedon	NNP	PERSON	Weedon	nn	5	SENT_110	[p6l543t2906r798b2962],
5	MN	NN	O	mn	appos	2	SENT_110	[p6l831t2908r973b2974],
6	,	,	O	,	_	0	SENT_110	[p6l831t2908r973b2974],
7	Owen	NNP	PERSON	Owen	nn	8	SENT_110	[p6l1012t2907r1197b2962],
8	KR	NNP	PERSON	KR	appos	2	SENT_110	[p6l1231t2908r1340b2961],
9	et	FW	O	et	nn	11	SENT_110	[p6l1375t2914r1428b2962],
10	al	FW	O	al	nn	11	SENT_110	[p6l1464t2906r1516b2962],
11	(	FW	O	(	rcmod	8	SENT_110	[p6l1553t2906r1756b2978],
12	2003	CD	DATE	2003	number	13	SENT_110	[p6l1553t2906r1756b2978],
13	)	CD	NUMBER	)	num	16	SENT_110	[p6l1553t2906r1756b2978],
14	Large-scale	JJ	MISC	large-scale	amod	16	SENT_110	[p6l1792t2906r2152b2978],
15	association	NN	O	association	nn	16	SENT_110	[p6l159t2987r503b3043],
16	studies	NNS	O	study	dobj	11	SENT_110	[p6l529t2987r740b3043],
17	of	IN	O	of	_	0	SENT_110	[p6l768t2987r839b3043],
18	variants	NNS	O	variant	prep_of	16	SENT_110	[p6l852t2987r1096b3043],
19	in	IN	O	in	_	0	SENT_110	[p6l1124t2987r1182b3042],
20	genes	NNS	O	gene	prep_in	11	SENT_110	[p6l1207t3005r1381b3059],
21	encoding	VBG	O	encode	partmod	2	SENT_110	[p6l1408t2987r1692b3059],
22	the	DT	O	the	det	31	SENT_110	[p6l1715t2987r1809b3043],
23	pancreatic	JJ	O	pancreatic	amod	27	SENT_110	[p6l1833t2987r2150b3059],
24	beta-cell	NN	O	beta-cell	nn	27	SENT_110	[p6l156t3067r423b3124],
25	KATP	NN	O	katp	nn	27	SENT_110	[p6l459t3070r617b3136],
26	channel	NN	O	channel	nn	27	SENT_110	[p6l655t3067r896b3124],
27	subunits	NNS	O	subunit	nn	31	SENT_110	[p6l934t3067r1190b3124],
28	Kir6	JJ	O	kir6	amod	31	SENT_110	[p6l1227t3067r1425b3124],
29	.2	NN	NUMBER	.2	nn	31	SENT_110	[p6l1227t3067r1425b3124],
30	(	CD	NUMBER	(	num	31	SENT_110	[p6l1466t3068r1713b3139],
31	KCNJ1	NN	O	kcnj1	nsubj	32	SENT_110	[p6l1466t3068r1713b3139],
32	I	PRP	O	I	xcomp	21	SENT_110	[p6l1719t3069r1747b3123],
33	)	VBP	O	)	_	0	SENT_110	[p6l1755t3068r1777b3139],
34	and	CC	O	and	_	0	SENT_110	[p6l1816t3067r1927b3124],
35	SURl	VBP	O	surl	conj_and	33	SENT_110	[p6l1965t3069r2143b3124],
36	(	CD	NUMBER	(	num	39	SENT_110	[p6l159t3149r445b3220],
37	ABCC8	NN	O	abcc8	nn	39	SENT_110	[p6l159t3149r445b3220],
38	)	NN	O	)	nn	39	SENT_110	[p6l159t3149r445b3220],
39	conﬁrm	NN	O	conﬁrm	dobj	33	SENT_110	[p6l476t3148r720b3205],
40	that	IN	O	that	complm	46	SENT_110	[p6l747t3148r863b3204],
41	the	DT	O	the	det	44	SENT_110	[p6l890t3148r983b3205],
42	KCNJII	NNP	O	KCNJII	nn	44	SENT_110	[p6l1009t3150r1270b3205],
43	E23K	NN	O	e23k	nn	44	SENT_110	[p6l1303t3150r1487b3204],
44	variant	NN	O	variant	nsubjpass	46	SENT_110	[p6l1512t3148r1729b3205],
45	is	VBZ	O	be	auxpass	46	SENT_110	[p6l1756t3148r1803b3205],
46	associated	VBN	O	associate	dep	39	SENT_110	[p6l1835t3148r2153b3205],
47	with	IN	O	with	_	0	SENT_110	[p6l156t3230r295b3286],
48	type	NN	O	type	nn	50	SENT_110	[p6l322t3238r455b3302],
49	2	CD	NUMBER	2	num	50	SENT_110	[p6l484t3231r519b3285],
50	diabetes	NN	O	diabetes	prep_with	46	SENT_110	[p6l551t3230r819b3286],
51	.	.	O	.	_	0	SENT_110	[p6l551t3230r819b3286],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_111	[p6l851t3230r1121b3286],
2	522568-572	CD	NUMBER	522568-572	dep	1	SENT_111	[p6l1153t3231r1523b3286],

